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ABSTRACT 
SYNTHETIC AND MECHANISTIC STUDIES OF RUTHENIUM CATALYZED C-H 
and C-O BOND ACTIVATION REACTIONS 
 
 
Junghwa Kim, B.Sc. M.Sc. 
 
Marquette University, 2016 
Etherification of alcohols is one of the most fundamental transformations in organic 
synthesis. Williamson ether synthesis is the most well-known synthetic method of 
unsymmetrical ether synthesis which is still being used in both industrial and academic 
laboratories. We have developed a novel catalytic etherification reaction using two 
different alcohols by using a well-defined cationic ruthenium catalyst. The reaction scope 
as well as the mechanistic study of the reaction are described.  
 
Hydroacylation is considered to be a powerful synthetic transformation for 
producing functionalized ketones from relatively simple olefin substrates. Despite 
remarkable progress in intra and intermolecular hydroacylations, the substrate scope of the 
reaction was limited to chelate assisted aldehydes and alkenes. We developed a highly 
regioselective intermolecular hydroacylation by using a well-defined cationic ruthenium 
catalyst. The reaction scope as well as the mechanistic study of the reaction are described.  
 
Transition metal catalyzed C(sp3)-H bond activation is highly challenging but very 
important in a number of catalytic reforming processes in the petroleum industries. Tandem 
reactions are a powerful strategy due to the reduction of work-up procedures and multiple 
purification steps. We developed a novel tandem catalytic reaction involving C(sp3)-H 
bond activation and functionalization by using a well-defined tetra ruthenium catalyst. The 
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1 Unsymmetrical Etherification Reactions 
Ether synthesis is an important organic transformation in both industrial and 
academic laboratories. Especially, the synthesis of unsymmetrical ethers is ubiquitous in 
the synthesis of simple organic molecules for highly valuable pharmaceutical drugs and 
complex natural products such as carbohydrates and lignins.1-5 Willamson developed the 
first synthetic protocol to prepare unsymmetrical ethers.4 Since the development of 
Williamson ether synthesis2 via nucleophilic substitution reaction of alkoxides to alkyl 
halides, the Williamson ether synthesis remains the most widely used method for 
synthesizing unsymmeterical ethers.3 Various synthetic methods of unsymmetrical ethers 
have been developed and are widely used in industrial process for pharmaceutical drugs, 
fuels, and other industrial commodities.3 Even though the modified Williamson ether 
synthesis are still actively used for the synthesis of heteroethers, there are still a number of 
drawbacks including stoichiometric amount of carcinogenic halogenated byproducts, harsh  
reaction conditions, expensive and rare starting materials, and limited substrate scope.2,3 In 
this chapter, the Williamson ether synthesis and other related synthetic methods for 
unsymmetrical ethers will be described.   
1.1 Williamson Ether Synthesis 
In 1850, Williamson reported the synthesis of ethers from the nucleophilic 
substitution reaction of alkyl halides with alkoxides.3 The Williamson etherification 
method opened up a new way to synthesize both symmetrical and unsymmetrical ethers. 
2 
 
The general reaction scheme is the substitution reaction of an alkyl halide by an alkoxide 
generated from an alcohol (eq 1.1).  
 
Typically, alkoxides are prepared from the treatment of alcohols with sodium or 
potassium metal or by deprotonation of alcohols with metal hydroxides. This alkoxide 
reacts with the alkyl halide via a nucleophilic substitution reaction to form heteroether 1 
(Scheme 1.1).6 The main drawback is its limited reaction scope which only applies to 
primary alkyl halides. With secondary and tertiary alkyl halides, E2-elimiation reaction 
over SN2-substitution reaction is favored, and as a result, alkene 2 is generated as the major 
product over the ether products (Scheme 1.1).  
 
Scheme 1.1: Mechanism of Williamson Ether Synthesis and Side Reaction 
Additionally, there are a couple of major limitations for Williamson ether synthesis 
from both economic and environmental points of view. The starting alkyl halides are often 
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not available and expensive to prepare. Furthermore, the stoichiometric amount of 
halogenated byproduct is environmentally harmful (eq 1.1).6 With respect to green 
chemistry, the halogenated byproduct is undesired substance for industrial applications. 
Much research effort has been devoted to overcome these drawbacks.  
1.2 Modifications of Williamson Ether Synthesis 
1.2.1 Using Weak Alkylation Agents 
Many attempts to develop greener Williamson ether synthesis have been made with 
the use of weak alkylating agents and BrØnsted acids.7 In 1939, King and Wright reported 
the synthesis of anisole by using a weak alkylating agent, methyl benzoate (eq. 1.2). This 
reaction was promoted by nucleophilic attack of phenoxide to alkyl group on methyl 
benzoate to form potassium benzoate and anisole at 190-200 oC in 3 hours.7 The reaction 
condition was very harsh, and stoichiometric amount of salt byproduct was formed (eq. 
1.2).  
 
In 2005, Fuhrmann and Talbiersky improved the method which can eliminate 
stoichiometric amounts of salt byproduct. The coupling reaction of phenol with methanol 




The proposed mechanism of this reaction is described in Scheme 1.2. Phenol 4 is 
added to potassium benzoate 3 to form potassium phenolate 6 and benzoic acid 5.  
Methanol 7 is added to benzoic acid 5 to form methyl benzoate 8 by the esterification. 
Phenolate 6 then attacks the alkyl group on methyl benzoate 8 to generate anisole 9. This 
step allows potassium benzoate 3 to be regenerated. The main advantage of this reaction is 
that the formation of halogenated salt byproduct was eliminated by using a catalytic amount 
of benzoic acid. However, high temperature was required above 300 oC, and the reaction 
pressure was raised up to 60 bar due to the elevated temperature. The harsh condition and 
low yield (46 %) still remain as the main drawbacks for industrial applications.  
 
Scheme 1.2: Proposed Mechanism of the Synthesis of Anisole  
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1.2.2 Ullmann Condensation 
In 1903, Ullmann and coworkers reported a copper-mediated aromatic nucleophilic 
substitution reaction.9-11 This reaction, which is called the Ullmann reaction, is a coupling 
reaction between aryl halide and an amine, phenol, or thiophenol. The etherification 
reaction from the coupling of aryl halide with phenol is described in eq. 1.4. This coupling 
reaction requires a stoichiometric amount of copper salts and base at high reaction 
temperature (> 200 oC) and a long reaction time (> 30 h). 9-11 Even with these drawbacks, 
numerous pharmaceutical and chemical industrial applications have been developed by 
using Ullmann condensation reaction.12  
 
The proposed mechanism of the Ullmann Reaction is described in Scheme 1.3. The 
mechanism begins with the Cu catalyst activation step. The first step of the activation is 
the oxidative addition of aryl halide 10 to Cu(0) 11. Cu(II) complex 12 undergoes a 
transmetallation with Cu(0) 11 to form Cu(I) halide 13 and Cu(I) phenyl species 14. Then, 
activated Cu(I) halide 13 enters into the catalytic cycle  (Scheme 1.3. bottom). Cu(I) halide 
13 undergoes ligand substitution reaction with phenoxide to form Cu(I) aroxyl complex 15. 
An oxidative addition of aryl halide to Cu(I) complex 15 forms Cu(III) intermediate 16. 
Reductive elimination of complex 16 generates ether product with the regeneration of Cu(I) 




Scheme 1.3: Mechanism of the Ullmann Reaction 
Since Ullmann's pioneering work on copper-catalyzed aromatic nucleophilic 
substitution reactions, numerous improvements on the Ullmann reaction have been made 
over the years. These modified Ullmann reactions have overcome a number of drawbacks 
such as high reaction temperature, long reaction time, high metal loading, and narrow 
substrate scope. The modified Ullmann procedure involves the coordination of various 
ligands such as diamines, amino acids, phenanthrolines, diols, nitrogen and oxygen 
containing ligands. These ligands enable increased solubility of the copper precursor to 
lower the reaction temperature, time, catalyst loading, and broader substrate scope.12 
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In 2009, Ding’s group published a report on the modified Ullmann condensation 
procedure by employing the ligand, 1-pyridin-2-yl-propa-2-one, 17 (eq 1.5). The reaction 
was carried out at 80-120 oC to form the ether product (80~97 % yield) in 8-24 h.13 
 
In 2006, a large-scale industrial production has been developed by using the modified 
Ullmann reaction.12 Even in advanced Ullmann reactions, the Ullmann reaction still 
requires expensive and toxic halogenated starting materials, excess amount of base, and 
forms stoichiometric amount of halogenated byproducts.   
1.3 Catalytic Etherification Methods 
1.3.1 Rhenium Catalyzed Methods 
The development of catalytic etherification method is needed to eliminate many of 
the disadvantages associated with stoichiometric reactions such as Williamson ether 
synthesis (Section 1.1), the Ullmann condensation (Section 1.2.2), and other acid catalyzed 
etherifications described in section 1.2. In 2003, Toste and co-workers reported the 
coupling reaction between aliphatic alcohols and propargyl alcohols by using rhenium (V)-
oxo catalyst 18.14,15 In this reaction, a catalytic amount (1 mol %) of rhenium (V)-oxo 
complex 18 was used to synthesize ethers in 60-88 % yields (eq 1.6). However, the 
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substrate scope of this catalytic reaction was limited to the secondary alcohol containing 
phenyl derivatives (eq 1.6).14,15 The coupling reaction of the enantiomerically enriched 
propargyl alcohols with aliphatic alcohols formed racemic ethers 19. 
 
In 2004, Qiu16 and co-workers reported further improvement on the synthesis of 
unsymmetrical ethers by using a similar rhenium (I) catalyst. Benzyl alcohol (1.0 mmol) 
and 1-butanol (5.0 mmol) with ReBr(CO)5 (0.03 mmol) were autoclaved at 160 
oC for 12 
h (eq 1.7). Only unsymmetrical benzyl-butyl ether was formed with 90 % yield as 
developed by gas chromatography method. Above 160 oC, homocoupling products 
(dibenzyl ether and dibutyl ether) were detected. Even with long optimization effort, the 
substrate scope of the reaction was limited to benzyl alcohols with aliphatic alcohols. 
 
The author proposed a mechanism based on the following supporting information 
(Scheme 1.4).16  The coupling reaction of benzyl alcohol with butanol under an inert 
atmospheric condition showed very low yield (<5 %). This indicated oxygen is essential 
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for the formation of ether. Re(I) complex 20 reacts with oxygen to give Re(III) oxide 21.  
Decarboxylation of Re(III) oxide 21 affords the 16-electron intermediate Re(III) complex 
22. Benzyl alcohol is coordinated to 22. -hydrogen addition to oxygen forms Re(III) 
complex 23. Re(III) complex 23 released carbocation 25 and Re(III) complex 24. Benzyl 
cation reacted with another alcohol produces unsymmetrical ethers 26. Dehydration of 
dihydroxo-rhenium(III) 27 is regenerated to 22.16 
 
Scheme 1.4: Mechanism of Rhenium (I) Catalytic Etherification Cycle 
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The main salient feature are that catalytic amount of rhenium(I) complex (3 mol %) 
was used to achieve high selectivity (> 90 %) and yields (78-99 %). Water is the only side 
product which is in accordance with environmentally friendly chemistry. However, the 
main drawbacks are the reaction temperature was too high for accommodating common 
functional groups. Moreover, an excess amount of aliphatic alcohol (5 equiv) was required 
to attain high selectivity. The reaction scope was limited to benzyl alcohols with aliphatic 
alcohols.16 
1.3.2 Reduction of Esters with InBr3 Catalyst 
In 2005, Konakahra17 and co-workers reported the reductive C-O bond cleavage of 
propargylic acetates by using InBr3 (28) /Et3SiH catalytic system (eq. 1.8).  
 
The author extended the substrate scope of unsymmetrical etherification reaction.18 
Carbonyl oxygen of phenethyl acetates were deoxygenated to form ethers with the same 
catalyst 28 (eq 1.9). From extensive screening process, Konakahra’s group found the 
optimal reaction condition (0.05 equiv. of InBr3 and 4 equiv. of Et3SiH in chloroform at 60 
oC) which gave the highest product yield (99 %).18 This reaction with the nitro group 
showed good functional tolerance but low reactivity (3 h reaction time and 61 % yield). 
Overall, the moderate reaction yields were obatained from 53 to 86 % except for the 





For the mechanism study, a radical scavenger, TEMPO (2,2,6,6,-tetramethyl-1-
piperidinyloxy radical), was used to detect any radical specie in the reaction mixture. In 
this experiment, the desired product was dramatically suppressed and the starting material 
of ester was recovered, which suggested that the indium radical species plays as a key 
intermediate in the promotion of the reduction reaction.17,18 A plausible mechanism was 
proposed as shown in Scheme 1.5. Triethylsilane undergoes a transmetallation with 
indium(III) complex 28 to form indium hydride 29. Next, hemolytic decomposition of the 
metal hydride from In(III) hydride enables to form an indium radical 30.19 Then, this 
radical species reacts with carbonyl oxygen of ester to form radical acetal intermediate 31. 
The radical acetal intermediate 31 abstracts the hydrogen from Et3SiH to form Et3SiOInBr2 
33 and radical ether intermediate 32. Et3SiOInBr2 33 reacts with Et3SiH to release indium 
hydride 29. Radical ether intermediate 32 abstracts hydrogen from indium hydride 29 to 




Scheme 1.5: Mechanism of In(III) Catalyzed Deoxygenation of Ester 
1.3.3 Etherification by [IrCl2Cp*(NHC)] Catalyst 
Fujita et al.20 reported Ir-catalyzed dehydrogenation reaction of alcohols which 
employs hydrogen borrowing catalytic access to a variety of very valuable organic 
molecules such as alcohols and ethers (eq. 1.10).  
 
Inspired by the Fujita report, Peris and co-workers21 investigated the dehydrogenation of 
benzyl alcohols with Cp*Ir(III) catalyst 34.  While exploring dehydrogenation of benzyl 
alcohols, they synthesized dibenzyl ethers with benzaldehyde. With this finding, they 
further investigated various types of alcohols and optimized the unsymmetrical 
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etherification conditions (eq. 1.11). With screening of various catalysts and bases, catalyst 
34 and AgOTf led to the highest yield. The reaction with AgOTf showed better yield than 
with a weak base, Cs2CO3. 
 
 The reaction scope is described in Table 1.1. The coupling reaction of benzyl 
alcohols with aliphatic alcohols showed excellent selectivity. Excess amounts of aliphatic 
alcohols were however required for high selectivity.  
Table 1.1: Selectivity of Synthesis of Unsymmetrical Ethersa (eq. 1.11) 
substrate 1 substrate 2 
yield (%) of ethersc 
PhCH2O-R PhCH2-O-CH2Ph R-O-R 
PhCH2OH methanol 88 6 0 
PhCH2OH n-butanol 95 0 6 
PhCH2OH n-hexanol 94 5 10 
PhCH2OH benzyl alcohol 10
b - - 
PhCH2OH allyl alcohol 85 8 15 
PhCH2OH isopropyl alcohol 80 16 10 
aReaction conditions: benzyl alcohol (0.4 mmol), primary or secondary alcohol (2 mmol), 
catalyst 34 (0.004 mmol, 1 mol %) and AgOTf (0.012 mmol), bMore than 80 % was 
benzyl aldehyde. cThe product yield is based on benzyl alcohol.  
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A proposed mechanism is shown in Scheme 1.6. Initially, AgOTf activates Ir(III) 
complex 35 to generate Ir(III) complex 36. Alcohol is added to the Ir(III) center to form 
the cationic Ir(V) hydride 37. The key complex of the reaction is the formation of Ir(V) 
hydride species 37. Ir(V) hydride complex 37 acts as a BrØnsted acid and activates another 
alcohol. Coupling of the alkyl group of activated alcohol to the coordinated alkoxide 
produces water as a byproduct and ethers as a product.  
 




As shown in Table 1.1, this reaction showed moderate efficiency (80-95 % yield) 
and toxic halogenated staring materials was avoided (eq 1.11). The drawbacks of this 
reaction include the limited substrate scope and the consumption of excess amounts of 
aliphatic alcohol for high selectivity (Table 1.1).  
1.4 Other Etherificaiton Reactions 
1.4.1 Mitsunobu Etherification 
Since the discovery of Mitsunobu reaction in 1967, the reaction has become a useful 
tool in organic synthesis due to its effectiveness and versatility.22 The reaction converts a 
hydroxyl group into a potent leaving group that is displaced by a variety of nucleophiles 
(eq. 1.12).22 Here, phenol is only considered as a nucleophile for the synthesis of 
unsymmetrical ethers.  
 
The Mitsunobu reaction has been widely used in pharmaceutical and natural products 
syntheses. However, there are a couple of limitations of the Mitsunobu reaction. The first 
limitation is that the coupling with bulky alcohols is not efficient in terms of yield and 
reaction time. In the case of neopentyl alcohol with methyl salicylate,  the synthesis of 
alkyl-aryl ethers takes 7 days to achieve synthetically useful yield, 70~75 %. The second 
limitation is the use of explosive diethyl azodicarboxylate (DEAD). The third limitation 
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is the stoichiometric amount of byproducts DEAD and phosponium oxide which requires 
a complicated purification process for the isolation of products.  
1.4.2 Modified of Mitsunobu Reaction 
Shi23 et al. reported the etherification reaction of tertiary alcohols with various 
phenols via Mitsunobu reaction. Electron rich diisopropylazodicarboxylate (DIAD) was 
used instead of diethyl azodicarboxylate (DEAD).  This modified condition produced 51-
58 % of unsymmetrical ethers within 4 h (eq. 1.13).23  
 
In the same year, Lepore and He24 reported the sonification process to synthesize 
unsymmetrical ethers by using bulky alcohols with phenol derivatives. With the assistance 
of sonification method, yield was improved to 75 % in 15 min.24 However, the coupling 
from the chiral secondary alcohol with phenol led to the racemic product 38 unlike 
Mitsunobu etherification (eq 1.14). Inversion of stereocenter at the reaction site is the 
unique property of the Mitsunobu reaction (eq. 1.12). the author explained this notion with 
the free radicals process, but the mechanism of radical reaction has not been clearly 
elucidated. Even though the reaction time and yield were improved significantly, 
unsymmetrical etherification reported by Lepore and He loses this unique property of 




Etherification reaction between sterically demanding alcohols via Mitsunobu 
reaction takes 7 days with 70 % yield. Replacement of DEAD to DIAD reduced reaction 
time to 4 h with 51-58 % yield. Sonication process presented a significant reduction of 
reaction time and high yield. However, its radical generation pathway is different than the 
Mitsunobu reaction pathway of etherification (Table 1.2).  
Table 1.2: Comparison of Mitsunobu and Modified Mitsunobu Reactions 
group additive reaction time yield sonication 
Mitsunobu DEAD/PPh3 7 days 70 % No 
Shi DIAD/PPh3 4 hrs. 51-58 % No 
Lepore DIAD/PPh3 15 min 42-75 % Yes 
 
Overall, the two main limitations of Mitsunobu reaction are the use stoichiometric 
amount of DEAD and triphenylphosphine. DEAD often causes the explosion of Mitsunobu 
reaction at high temperature. Additionally, the side product of DEAD, diethyl 
hydrazodicarboxylate, requires complicated purification steps to isolate the product.25 To 
resolve these issues, di-tert-buylazodicarboxylate instead of DEAD is used often. The by-
product of di-tert-buylazodicarboxylate is easily purified with trifluoroacetic acid work 
up.26 Another way to resolve the above issues is use of di-4-chlorobenzylazodicarboxylate 
(DCAD). By-product of DCAD can be separated easily by a filteration.27  
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Triphenylphosphine oxide also requires a complicated purification step to isolate 
the product. This purification issue may be resolved by replacement with diphenyl (2-
pyridyl) phosphine, (4-methyl-aminophenyl) diphenylphosphine, or tris-(4-
dimethylaminophenyl) phosphine.25 In these cases, the corresponding phosphine oxide can 
be eliminated by washing the reaction mixture with dilute hydrochloric acid.  This method 
is considerably expensive. However, the main limitations of the Mitsunobu reaction are its 
limited scope and stoichiometric amounts of waste.  
1.4.3 Etherification by using Dialkylphosphites 
In 1971, Kashmann28 reported the etherification reaction of cholesterol with 
dialkyl- or diaryl-phosphite by using a catalytic amount of acid (eq 1.15).  Before this 
finding, there was great difficulty in the synthesis of cholesteryl aryl ethers.29 This method 
is able to produce cholestryl phenyl ethers in a one-step reaction. 
 
The first step of the mechanism is the protonation of dialkyl phosphite by catalytic 
amount of acid (TsOH). Nucleophilic hydroxyl of cholesterol attacks methoxy carbon of 
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phosphite and forms carbocation and 39. The deprotonation of carbocation by TsO- forms 
unsymmetrical ethers (Scheme 1.7). 
 
Scheme 1.7: Mechanism of Etherification of Cholesterol 
Cholesterol and dimethyl or diphenylphosphite are used to synthesize 
unsymmetrical ethers with a bioactive molecule.28 Excess amount of alkyl or aryl phosphite 
are consumed and the yield of reaction is relatively low (50 %) based on cholesterol. The 
reaction can tolerate alkene and carbonyl groups, and copious amount of phosphite 39 is 
formed as the byproduct (Scheme 1.7). Etherification reaction of cholesterol is a very 
impressive result because it is the first etherification example of large molecular coupling 
in one step.  
1.4.4 Etherification by Addition of Alcohols to Alkenes 
One of largest quantity of unsymmetrical ethers is the methyl tertiary butyl ether 
(MTBE)30 which is produced by the addition reaction of alcohols to alkene. This MTBE 
was produced more than 200,000 barrels per day in the United States in 1999.30 General 
synthetic mechanism is SN1 substitution reaction via the stable carbocation intermediate. 
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The carbonation is generated by protonation of alkene by using a strong acid catalyst (eq. 
1.16). 33 
 
In 1984, Thompson31-33 reported the synthesis of unsymmetrical ethers by using 
mercuric acetate. This reaction is now known as Alkoxymercuration–Demercuration. The 
initial step is Alkoxymercuration which is the addition of mercuric acetate to unsaturated 
alkene in the presence of a 50:50 tetrahydrofuran-water mixture. Mercuric acetate binds to 
alkene via cyclic mercurium ion 40 which is resonated to 41. Then, the hydroxyl group of 
an alcohol attacks more stable carbocation of 41 via a Markovnikov fashion.31,32 Then, 
sodium borohydride in the presence of sodium hydroxide removes the mercuric acetate 
(Scheme 1.8). 
 
Scheme 1.8: General Mechanistic Scheme of Alkoxymeruation 
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In this synthetic method, stoichiometric amount of environmentally unfavorable 
mercuric acetate is used on the basis of the amount of alkenes. Thus, the generation of 
stoichiometric amount of mercury waste is the main drawback for Alkoxymercuration 
reaction. Additionally, reaction efficiency is very low. The ratio between alkene and 
alcohol is 1:10. Sterically demanded alcohols reduced the yield to less than 50 %. Sterically 
demanded alkene, 2-Methyl-1-butene, reduces yield significantly as well. Low yield by 
stericcally demanded substrates is another drawback.31 
1.4.5 Etherification by Using BiBr3   
In 1998, Boyer et al.34,35 reported the synthetic method of unsymmetrical ethers by 
using bismuth (III) complex. Coupling reaction of benzyl derivative alcohols with aliphatic 
alcohols produced unsymmetrical ethers in Scheme 1.9. 
 
Scheme 1.9: General Scheme of Unsymmetrical Etherification by BiBr3 
The coupling reaction between benzyl alcohol and aliphatic alcohol showed high 
yield (70-100 %) in short reaction time (5 min - 120 min) at mild condition (rt) (Table 1.3). 
The reactivity of 2-phenylpropan-2-ol was higher than 1-phenylethanol and especially 
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higher than benzyl alcohol.34 This reactivity is consisted with the order of electron donating 
power toward the hydroxyl group of alcohol.   
Table 1.3: Selectivity of Synthesis of Unsymmetrical Ethers of Scheme 1.6a 







benzyl alcohol   
42c 
butanol 100 100 100 
2-methylbutanol 100 92 90 
2-butanol 100 73 82 
t-butanol 98 100 82 
cylcohexanol 98 82 70 
aThe reaction condition: R1OH (1 equiv), R2OH (1.2 equiv.), BiBr3 (1 equiv), rt, 
bThe 
product yield is based on the quantity of benzyl alcohol derivatives  
The next year, Boyer and Keramane36 reported a mechanistic study of the 
etherification reaction (Scheme 1.10). Primary, secondary, and tertiary benzyl alcohol were 
tested in CCl4 at room temperature with an equimolar amount of BiCl3. Only secondary 
and tertiary alcohols had a halogen exchange with BiCl3 in 5 min to 3 hours. Interestingly, 
primary alcohol did not show any halogen exchange, while the tertiary alcohol showed the 
highest exchange rate in terms of reaction time. The mechanism of etherification was 
further investigated with interesting results (Scheme 1.10). The reaction between an 
primary alcohol and BiCl3 generates dichloroalkoxy bismuthane 43 and HCl. Nucelophilic 
addition of another alcohol generates ethers via SN2 in pathway A (Scheme 1.10). For 
secondary and tertiary alcohol, the dichloroalkoxy bismuthane 43 gives bismuth oxy 
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chloride 44, alkyl halide and hydrochloric acid by pathway B. Nucelophilic hydroxyl group 
of alcohol attacks toward alkyl halide 45. A leaving group, chloride, deprotonates of 
carbocation intermediate 46. This will generate unsymmetrical ether (Scheme 1.10). 
  
Scheme 1.10: Mechanism of Unsymmetrical Etherification by BiBr3 
This method showed a very simple and easy one step reaction. The reaction was 
completed within 2 hours of the reaction time at room temperature. However, the further 
investigation of substrate scope on the reaction was not performed. Additionally, using 
stoichiometric amount of bismuth oxychloride is the main limitation.  
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1.4.6 Etherification by Using Perfluoroimidates 
Benzyl-type of protecting groups such as benzyl (Bn), 4-methoxybenzyl (MPM or 
PMB) and 3,4–dimethoxybenzyl (DMPM or DMB) groups are used in organic chemistry 
very often.37-40 For the installations of those protecting groups, benzyl trichloro 
acetimidate has been used widely with catalytic amount of acid such as 0.3 mol % triflic 
acid (TfOH) in ether at room temperature (eq. 1.17).38 Benzyl Tricholoracetimate is very 
reactive and not sufficiently stable. Thus, it has to be prepared fresh.  
 
In 1998, to overcome high activity of benzyl tricholoracetimidate, Ubukata43, 44 and 
coworkers found perfluoronitrile which is a more stable compound than trichloroacetimate. 
This compound resolved the stability issue. To prepare perfluoroimidates, this group used 
Swern oxidation agents (oxalyl chloride, DMSO, and triethyl amine). Like Swern oxidation 
mechanism, dimethylchlorosulfonium chloride 48 is formed by reaction of oxalyl chloride 
47 and DMSO. This dimethylcholorosulfonium chloride 48 is added to perfluoroimidate 
49 via the assistance of base, trimethylamine 50, and forms trifluoroacetonitrile 51. Benzyl 




Scheme 1.11: Mechanism of Preparation of Trifluoroacetimidates 
The prepared imidates 52 from Scheme 1.11 reacted with another alcohol with catalytic 
amount of acid, camphorsulfonic acid 53 (eq 1.18). The reaction gave around 56-95 % of 
ether product.41 This research group found a stable substance for protecting primary and 
secondary alcohol by using benzyl alcohol derivatives.41   
 
Synthesis of imidates is required for unsymmetrical etherification. To broaden 
substrate scopes, different alcohol has to be installed on imidates via Swern oxidation 
reagents.  Also, excess amount of imidate (1.3-2.6 equiv) are required for the reaction. 
Thus the excess amount of amide is produced as a waste.  
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1.4.7 Dehydrative Coupling of Alcohols by Sodium Bisulfite 
Compared to previous examples using halide, phosphite, DEAD/TPP, and 
perfluoimidates, the direct preparation of ethers from two different alcohols is preferred 
due to the consideration of cost and availability of starting materials and the formation of 
waste byproduct. Dehydrative coupling reaction by using two different alcohols is 
commonly used to synthesize the symmetrical ethers due to the selectivity issue.  
As an example, the coupling reaction of ethanol with methanol in sulfuric acid generates 
three different forms of ethers which are 1 equivalent of diethyl ethers, 1 equivalent of 
dipropyl ether, and 2 equivalent of unsymmetrical ethylpropyl ether (Scheme 1.12). 
Additionally, elimination reaction (Elimination reaction in Scheme 1.12) competes with 
dehydration of the alcohol. With the consideration of this selectivity issue, the synthesis of 
unsymmetrical ethers by using two different alcohols is not desired.   
 




Among many dehydrative alcohols etherification reactions, the publication from 
Li42 and coworkers showed more effective ways to synthesize unsymmetrical ethers. 
Unsymmetrical ethers were synthesized by using two different alcohols in catalytic amount 
of sodium bisulfite (eq 1.19 and 1.20)41. Unfortunately, the substrate scopes of this 
coupling reaction were limited to benzyl alcohol derivatives with various aliphatic alcohols 
(Table 1.4 and 1.5). The yield of ethers was moderated between 70-87 %.   
 
Table 1.4: Yield (%) of Unsymmetrical Ethers in eq 1.19 
R1 ratioa temp (oC) time (h) yield (%)b 
CH3(CH2)3OH 1:4 110 1 80 
CH3(CH2)6OH 1:4 110 1 85 
CH3(CH2)11OH 1:1 100 1 77 
(CH3)2CH(CH2)2OH 1:10 110 1 83 
(CH3)3COH 1:10 90 14 NR
c 
CH3OH 1:10 90 14 87 
aRatio of 2-(p-methoxyphenyl)-ethanol over aliphatic alcohol (R1), 
bThe product yield is 




Table 1.5: Yield (%) of Unsymmetrical Ethers in eq 1.20 
R1 ratioa temp (oC) time (h) yield (%)b 
CH3(CH2)3OH 1:4 100 1 82 
CH3(CH2)6OH 1:4 100 1 84 
CH3(CH2)11OH 1:4 100 1 86 
(CH3)2CH(CH2)2OH 1:4 100 1 82 
CH3CH(OH)CH2CH3 1:4 100 12 70 
aRatio of 4-methoxybenzyl alcohol over aliphatic alcohol (R1), 
bThe product yield is based 
on 4-methoxybenzyl alcohol.  
1.4.8 Etherification by Palladium Catalyst  
Palladium catalyzed unsymmetrical etherification has been using widely in both 
academic and industrial laboratories. We are going to introduce a palladium catalyzed C-
O coupling reactions of aryl halides with primary alcohol by Matthias’ group (eq 1.21).  
The reaction generated unsymmetrical ethers from activated, nonatctivaetd, and aryl 




The reaction showed high selective etherification reaction of aryl substrates with primary 
alcohol over secondary and tertiary alcohols (scheme 1.13). The protocol presented the 
functional group tolerance of amine.  
 
Scheme 1.13: Arylation of Primary Alcohol over Secondary and Tertiary Alcohols 
From synthetic and environmental view, the etherification by [IrCl2Cp*(NHC)] 
(Section 1.3.3) and by palladium catalyst (Section 1.4.8) are the most effective and efficient 
etherification reactions among many etherification methods are described herein. These 
two reactions use two different alcohols, and eliminate the needs for costly and rare starting 
materials such as halide, nitro, phosphite, and other functional group starting materials. 
Both catalytic etherification reactions eliminated the formation of halogenation byproduct 
(Williamson and Ullmann etherification reactions) and the purification issue and the 
formation of explosive intermediate (Mitsunobu etherification reaction). Even though 
significant improvements have been made on the catalytic etherification method. Further 
improvements such as maximizing atom efficiency, broadening reaction scopes, and 





2 Introduction of Synthesis of Unsymmetrical Ethers from the Ruthenium 
(II) Catalyzed Dehydrative Coupling of Alcohols 
The synthesis of ethers is one of the fundamentally important organic transformations 
in both industrial and academic laboratories. From the view point of the development of 
economically and environmentally sustainable processes, cheaper and greener ways to 
synthesize ethers have been intensively studied. As surveyed in Chapter 1, many synthetic 
methods of unsymmetrical ethers have been developed over the years. Even though 
significant improvements have been made on the existing etherification methods such as 
Williamson ether synthesis, Mitsunobu reaction, the Ullmann condensation, and other 
catalytic methods, these methods require pre-functionalized substrates, formed copious 
amounts of byproducts, and exhibit a relatively limited range of substrate scope and 
functional group tolerance in forming unsymmetrical ether products. Herein, we describe 
a novel unsymmetrical etherification method from the dehydrative coupling of alcohols by 
using ruthenium (II) catalyst. We recently published a part of this chapter in ACS catalysis.1  
2.1 Result and Discussion 
Our research group reported the dehydrogenation of saturated amines and carbonyl 
compounds by using the tetrameric ruthenium catalyst {[(PCy3)(CO)RuH]4(μ-O)(μ-OH)2} 
3.1-5 In the same year, a cationic ruthenium-hydride complex [(ɳ6-
C6H6)(PCy3)(CO)RuH]
+BF4
- 4, formed from the protonation reactions of the tetrameric 
ruthenium complex 3, was found to be a highly effective catalyst for the intermolecular 
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coupling reaction of aryl ketones and 1-alkenes to give the substituted indene and ortho-
C-H insertion products.3 Since then, a number of dehydrative C-H coupling reactions have 
been reported by using the tetraruthenium catalyst.2-5 The synthetic method of ruthenium-
hydride complex 4 is described in Scheme 2.1. The ruthenium-hydride complex 1 was 
reacted with KOH in 2-propanol to form the bimetallic complex 2, which was obtained in 
85% yield after recrystallization in hexane. Reaction of 2 with acetone at 95 ⁰C produced 
complex 3 in 84% yield. The molecular structure of ruthenium-hydride complex 1 was 
determined by X-ray crystallography (Figure 2.1).3 The reaction of tetrameric ruthenium 
complex 3 with HBF4•OEt2 in C6H6 at room temperature cleanly afforded the cationic 
ruthenium hydride complex 4 in 95% yield (Figure 2.2). This ruthenium-hydride complex 
4 is analyzed by 1H and 31P{1H} NMR spectroscopy in CD2Cl2 showed a doublet at δ -
10.39 (d, JPH = 25.9 Hz) and a single phosphine signal at δ 72.9 ppm respectively.  
 






Figure 2.1: Molecular Structure of 3 Drawn with 50% Thermal Ellipsoids. Cyclohexyl 






Figure 2.2: Molecular Structure of Cationic Ruthenium Hydride Complex 4 
 By using the cationic ruthenium-hydride complex 4, we recently devised selective 
catalytic C-H alkylation of alkenes with alcohols6 (eq 2.1) and dehydrative C−H 
alkenylation of phenols with alcohols7 (eq 2.2). During the course of optimization for these 
reactions, the formation of ethers was observed as a side product when excess alcohol 
substrate was employed. With this initial finding, the scope of alcohol dehydration reaction 
was explored by using the cationic ruthenium hydride catalyst 4. Interestingly, 
unsymmetrical ethers were selectively formed from the direct etherification of two 
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different alcohols (eq 2.3). This chapter delineates the scope and synthetic utility of the 
unsymmetrical etherification of alcohols.  
 
2.2 Optimization Studies 
2.2.1 Catalyst Screening 
We initially screened the catalytic activity of ruthenium complex for the etherification 
of 1-phenylethanol and 1-hexanol. In a glove box, 1-phenylethanol (122 mg, 1.0 mmol), 1-
hexanol (122 mg, 1.2 mmol) and a ruthenium catalyst (1.0 mol %) were dissolved in 
C6H5Cl (1 mL) in a 25 mL Schlenk tube equipped with a Teflon stopcock and a magnetic 
stirring bar (eq. 2.3). The tube was brought out of the box, and was stirred for 3 h in an oil 
bath which was preset at 50 °C. The reaction tube was taken out of the oil bath and the 
solution mixture was analyzed by GC and GC-MS. The results are summarized in Table 
2.1. Among the surveyed ruthenium catalysts, complex 4 exhibited a uniquely high activity 




Table 2.1: Catalyst Survey for the Reaction of 1-Phenylethanol with 1-Hexanola 
entry catalyst additive yield (%)b 
1 [(C6H6)(PCy3)(CO)RuH]BF4 (4)  95 
2 HBF4·OEt2  3 
3 [RuH(CO)(PCy3)]4(O)(OH)2 (3)  5 
4 [RuH(CO)(PCy3)]4(O)(OH)2 (3) HBF4·OEt2 61 
5 RuCl3·3H2O HBF4·OEt2 2 
6 RuCl2(PPh3)3  0 
7 RuCl2(PPh3)3 HBF4·OEt2 0 
8 RuH2(CO)(PPh3)3  trace 
9 RuH2(CO)(PPh3)3 HBF4·OEt2 trace 
10 [RuCl2(COD)]x HBF4·OEt2 0 
11 [RuH(CO)(PCy3)2(CH3CN)2]
+BF4
-  <7 
12 [(p-cymene)RuCl2]2  0 
13 Ru3(CO)12 NH4PF6 0 
14 CF3SO3H  trace 
15 BF3·OEt2  trace 
16 Cy3PH
+BF4
-  trace 
17 AlCl3  trace 
18 FeCl3·H2O  <5 
19 Eu(OTf)3  <5 
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aReaction conditions: 1-phenylethanol (122 mg, 1.0 mmol), 1-hexanol (122 mg, 1.2 
mmol), catalyst (1.0 mol %), additive (1.0 equivalent to Ru), chlorobenzene (1 mL), 
50 °C, 3 h. bThe product yield was determined by GC and GC-MS. 
2.2.2 Solvent and Temperature Effects 
A number of different non-protic solvents were examined for the optimization of 
the unsymmetrical etherification reaction (Table 2.2). The reaction of 1-phenylethanol (122 
mg, 1.0 mmol), 1-hexanol (122 mg, 1.2 mmol) and catalyst 4 (1.0 mol %) in a solvent at 
60 ⁰C was analyzed by GC-MS after 3 hours of the reaction time. Both solvent and 
temperature significantly affected the activity and selectivity on the formation of the 
unsymmetrical ether products. 
Table 2.2: Solvent Effect on the Reaction of 1-Phenylethanol with 1-Hexanola 
entry solvent temp (⁰C) yield (%)b 
1 toluene 60 63 
2 chlorobenzene 60 82 
3 dioxane 60 0 
4 CH2Cl2 60 74 
5 CHCl3 60 78 
6 THF 60 40 
7 chlorobenzene 70 90 
8 chlorobenzene 80 95 
9 chlorobenzene 90 84 
aReaction conditions: 1-phenylethanol (122 mg, 1.0 mmol), 1-hexanol (122 mg, 1.2 mmol), 
catalyst 4 (1.0 mol %), in solvent (1 mL) at different temperatures, 3 h. bThe product yield 
was determined by GC-MS analysis using C6Me6 as an internal standard 
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Chlorobenzene was found to be the most effective for the unsymmetrical 
etherification reaction among screened solvents (entry 1-6). Polar solvents, CHCl3 and 
CH2Cl2 exhibited higher conversion (>98 %) at 60 ⁰C and gave both unsymmetrical and 
symmetrical ethers based on 1-phenylethanol. However, selectivity of the desired 
unsymmetrical ether product was relatively low (75 %).  Thus, overall yield dropped to 74 
and 78 % in CH2Cl2 and CHCl3, respectively, due to low selectivity even though polar 
solvents showed high conversion. On the other hand, a less polar solvent, chlorobenzene, 
at 60 ⁰C exhibited a lower conversion of ethers (83 %), but with the highest selectivity 
(>95 %) for the desired unsymmetrical ethers, which thus gave a higher yield (82 %) of 
desired product was obtained. At higher temperature of 70-80 ⁰C, higher conversion (> 
90 %) and selectivity (> 95 %) of unsymmetrical ethers was achieved in chlorobenzene. 
Above 90 ⁰C, the synthesis of ether was suppressed due to the formation of side coupling 
products. Therefore, the optimal temperature for the unsymmetrical etherification reaction 
was maintained at or below 80 ⁰C.  
2.2.3 Optimization of Turnover Number (TON) and Turnover Frequency 
(TOF) 
The turnover number (TON) of unsymmetrical etherification reaction was 
measured under the optimized reaction conditions. The etherification reaction of two 
benzylic alcohols, benzyl alcohol (33 mmol) and 4-methoxybenzyl alcohol (30 mmol), 
with 4 (0.3 mol)/HBF4·OEt2 (1.2 mol) in C6H5Cl at 70 °C showed the selective 
formation of unsymmetrical ethers with an initial TOF = 7200 h-1 and TON = 80000 after 
12 h (eq. 2.4). This coupling reaction was also performed in neat condition (TOF = 7800 
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h-1 and TON = 75000 after 12 h). The coupling reaction between two different benzyl 
alcohols gave much higher selectivity and conversion at a lower temperature than that of 
aliphatic alcohols.  
 
2.3 Reaction Scope 
2.3.1 Synthesis of Unsymmetrical Ethers from the Dehydrative Coupling of 
Alcohols 
Substrate scope of the etherification reaction was explored by using the catalyst 4 
(Table 2.3).  The coupling reaction of two different alcohols gave very high selectivity 
toward the formation of unsymmetrical ether products over the symmetrical ether products 
(eq 2.5).  
 
In general, the coupling reactions between two benzyl alcohols required less reaction 
time than those between two aliphatic alcohols under mild conditions (entry 6). As shown 
in Table 2.3, the coupling reaction of aliphatic alcohol (1-hexanol) with benzyl alcohol, 
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secondary benzyl alcohol (1-phenyl-ethanol), and aliphatic alcohol (3-phenyl-butanol) 
gave high selectivity and yield for the unsymmetrical ether products (entries 1-3) under 
mild temperature (50-70 oC) in a short reaction time (2-4 h). Similarly, the coupling 
reactions of ethanol with benzyl alcohol, secondary benzyl alcohol (1-phenyl-ethanol), and 
4-methoxy-secondary benzyl alcohol generated highly selective cross coupling products 
(entries 4-6) at mild temperature from 50-70 oC within a short reaction time (2-4 h).  
We next explored the coupling reactions between two different benzyl alcohols. The 
coupling reaction of 1-phenylethanol with benzyl alcohol derivatives 5h-5k (entries 7-10) 
showed generally high yields (91-94 %) at the mild condition (50 oC) and a short reaction 
time (2-4 h). In case of indanol derivatives, unsymmetrical ethers 5l-5o were formed at 
room temperature in high yield (85-94 %) (entries 11- 14). Generally, the reaction of benzyl 
alcohol derivatives 5a-5o (entries 1-14) with both aliphatic and benzyl alcohols resulted in 
high yields (85 to 94 %) under mild reaction conditions (25-70 oC). The reaction of para-
substituted-phenol with both aliphatic and benzyl alcohols gave high yields (79-92 %) of 
the cross coupling products 5p-5s (entries 15-18). The reaction of 3-hydroxypropionitrile 
with phenol resulted in a cross-coupling product 5s which showed the nitrile functional 
group tolerance. The reaction of one equivalent of glycol with two equivalents of 1-(1-
naphthyl)ethanol  generated the 2 to 1 cross coupling product 5t (entry 19). Intramolecular 
coupling reaction of -diols showed 81-86 % yield at 80 oC and 3-8 h of reaction time 
5u-5w (entries 20-24).   
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Table 2.3 Cont… 
 
aReaction conditions: ROH (1.0 mmol), R’OH (1.2 mmol), C6H5Cl (2 mL), 4 (1 mol %). 
bThe product yield is determined by GC. c The product yield is determined by GC. 
2.3.2 Synthesis of Bioactive Unsymmetrical Ethers  
To further demonstrate synthetic utility, we employed a number of highly 
functionalized bioactive alcohol substrates to synthesize unsymmetrical ethers (Table 2.4). 
The first example was the coupling reaction of (-)-cholesterol with estrone. Unsymmetrical 
ether 5ad from the coupling of these bioactive molecules was formed at 110 oC in 24 h 
from a mixed solvent of chlorobenzene (2.0 mL) and toluene (2.0 mL).  The next example 
was the coupling reaction of (-)-cholesterol with protected tyrosine, N-acetyl-D-tyrosine 
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ethyl ester. Unsymmetrical ether from these bioactive molecules 5ae was formed at 110 oC 
for 24 h of the reaction time in a mixed solvent of chlorobenzene (2.0 mL) and toluene (2.0 
mL). The products (-)-5ad and (-)-5ae are formed with the retention of stereochemistry on 
cholesteryl carbon. A relatively stronger C-O bond of phenolic group is less likely activated 
than the aliphatic ones. Thus, the exclusive C-O bond cleavage on cholesterol substrate 
was resulted in forming the ether products. Further, the coupling reactions of (-)-cholesterol 
with (R)-methyl mandelate, 4-methoxybenzyl alcohol, (-)-pyranose generated a highly 
diastereoselctive unsymmetrical ethers (-)-5af, (-)-5ag, and (-)-5ah respectively at 70 oC 
and 24 h of the reaction time in a mixed solvents of toluene (2.0 mL) and dichloromethane 
(2.0 mL). Those unsymmetrical ethers (-)-5ad to (-)-5ah from the coupling reaction of (-)-
cholesterol gave α-chiral nonracemic ether products with stereoretention on the cholesterol 
carbon. This implied a SNi types of mechanism on ether formation step.  The structure of 
unsymmetrical (-)-5ag was determined by X-ray crystallography in Figure 2.4. On the 
other hand, the coupling reaction of (-)-cholesterol with cortisone gave a 1:1 diasteromeric 
mixture of 5ai, which was resulting from the epimerization of the alcoholic carbon. The 
coupling reaction of a protected furanose with 4-methoxybenzyl alcohol yielded the 
corresponding product 5aj. The next example of unsymmetrical ether 5ak was generated 
from the coupling reaction of a dye molecule (Sudan red G) with indanol.  This dye 
molecule has been used for tracking substance of chemicals, foods, and medical field. The 
last example 5af was fromed from the coupling reaction of polyhedral oligomeric 
silsesquioxane (POSS) with 1-(4-methoxyphenyl) ethanol. POSS is a cage like structure 
which is used as a support for catalysts, pH-responsive materials, and organic light emitting 
diodes. The catalytic method is able to synthesize a variety of unsymmetrical ethers of 
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lipids, hormones, amino acids, and sugar molecules.  These coupling compounds formed 
from bioactive molecules can be used for screening pharmaceutically activity of drug 
candidates. 







Table 2.4 Cont…… 
a Reaction conditions: alcohol (1.0 mmol), alcohol (1.0 mmol), toluene (2 mL)/ 




2.3.3 Stereochemical and X-ray Crystallographic Determination of the 
Unsymmetrical Ethers 
The unsymmetrical ethers 5ad, 5ae, 5af, 5ag and 5ah, were formed in a highly 
diastereoselective fashion. The stereochemistry of major diastereomers of ether products 
5ad-5ah was determined in comparison with the coupling constant of (-),(S)-cholesterol 
shown in Figure 2.3.  
 
Figure 2.3: Assignment of Absolute Stereochemistry of Highly Functionalized Bioactive 
Unsymmetrical Ethers 
The proton coupling constants of (-),(S)-cholesterol were matched with those of 
products (-)-5ad, (-)-5ae, (-)-5af, (-)-5ag and (-)-5ah. The axial-axial and equatorial-axial 
coupling constant of (-),(S)-cholesterol were determined as δ 3.52 (tt, J = 11.1, 4.5 Hz, 1H) 
as shown in Figure 2.3. The coupling constants of (-)-5ad, (-)-5ae, (-)-5af, (-)-5ag and (-)-
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5ah were analyzed as δ 4.08 (tt, J = 11.1, 4.6 Hz, 1H), δ 4.07 (tt, J = 11.1, 4.6 Hz, 1H), 
and δ 3.22 (tt, J = 11.1, 4.6 Hz, 1H), respectively. By comparing the coupling constants of 
(-),(S)-cholesterol with (-)-5ad, (-)-5ae, (-)-5af, (-)-5ag and (-)-5ah confirmed the 
stereocenter of highly diasteroselective unsymmetrical ethers was assigned to be (S)-5ad, 
(S)-5ae, (S)-5af, (S)-5ag and (S)-5ah. The coupling reaction of (-)-cholesterol with 
bioactive molecules retained their stereochemistry of the cholesterol carbon during the 
etherification reaction.  
 
 
Figure 2.4 : X-ray Crystal Structure of (-)-5ad 
Single crystals of (-)-5ad suitable for X-ray crystallographic analysis were obtained 
from the evaporation of dichloromethane in benzene solution. The appearance of single 
crystals (-)-5ad was white needles. The absolute configuration in stereochemistry of 
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cholesterol carbon C3 (Figure 2.4) on unsymmetrical ether (-)-5ad was determined as (S)-
configuration. The stereochemical configuration of product (-)-5ad by X-ray 
crystallographic analysis matched exactly with the stereochemical assignment determined 
by the comparison of coupling constants of (-)-cholesterol with product (-)-5ad. Again, 
this crystal structure supported that the stereochemistry of (-)-cholesterol was retained 





Figure 2.5: X-ray Crystal Structure of 5ag 
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Single crystals of 5ag suitable for X-ray crystallographic analysis were obtained from slow 
evaporation of ethanol. Single crystals of 5ag were colorless needles. The stereochemical 
configuration of single crystal was established by X-ray crystallography. Epimerization on 
C2 carbon (Fig. 2.5) was not observed in this structure, and the furanose ring reatined a 
C2-envelope conformation with hydroxyl group oriented axially (Figure 2.5).   
2.4 Mechanistic Studies 
2.4.1 Determination of the Stereochemistry of Unsymmetrical Ethers 
To gain mechanistic insights into catalytic etherification, we examined the coupling of 
phenol and (R)-methyl mandalate with chiral alcohols to probe the stereochemistry in the 
synthesis of the unsymmetrical ethers (Table 2.5). The coupling reaction of (R)-indanol 
(R)-6 with phenol 7 in the presence of catalyst 4 in dichloromethane at room temperature 
led to a racemic mixture of the ether products (R)/(S)-8. The optical rotation ([α]20D= 0.0° 
(c= 0.5, CH2Cl2)) of (R)/(S)-8 was analyzed by the polarimeter and two chiral compounds 
were detected by a chiral gas chromatography.  Then, the coupling reaction of (R)-indanol  
(R)-6 with (R)-methyl mandalate (R)-9 in the presence of catalyst 4 under the same 
condition led to two diastereomeric ether products (R,R)-10 and (S,R)-10 (Table 2.5). 
These two diastereomers were separated by silica gel column chromatography, and the 
optical rotation of each isomers was analyzed by polarimeter ([α]20D = -48.0 and -14.3° (c 
= 0.5, CH2Cl2)) and by chiral gas chromatographic methods. To ensure the absolute 
stereochemistry of these two diastereomers, the coupling reaction of the racemic (±)-
indanol (R)/(S)-6 with (R)-methyl mandalate (R)-9 also was performed. The diasteromeric 
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mixture of ether products (R,R)-10 and (S,R)-10 were analyzed by polarimetry ([α]20D = -
46.8 and -13.8° (c = 0.5, CH2Cl2)) and chiral gas chromatographic method. However, the 
coupling reaction of (R)-indanol (R)-6 with (±)-methyl mandalate (R)/(S)-9 formed to 2 
sets of enantiomers (R,R)/(S,S)-10 and (S,R)/(R,S)-10. The results clearly indicated that 
only hydroxy group on indanol was epimerized during the etherification reaction. The 
difference between indanol and methyl mandalate was electronic effect. The electron 
donating group of indene group promoted the epimerization on secondary alcohol of (R)-
indanol. On the other hand, the electron withdrawing group by ester prohibited the 
epimerization on secondary alcohol of (R)-methyl mandalate. 
Table 2.5: Stereochemical Determination of Unsymmetrical Ethersa 
 
a Reaction conditions: alcohol (1.0 mmol), alcohol (1.0 mmol), solvent (1 mL), 4 (1 
mol %), 20 - 60 °C. 
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A separate set of experiments was performed to support the data in Table 2.5. (R)-
Methyl mandalate was treated with catalyst 4 in dichloromethane at various temperatures 
from 20 and 120 ⁰C.  The optical rotation of the starting material (R)-methyl mandalate 
(R)-9, was maintained as -209o after 12 h at 20 and 120 ⁰C (Table 2.6). The optical rotation 
of (R)-indanol (R)-6 was measured for 10 min at 20 ⁰C under the same conditions (Table 
2.6). The chirality of (R)-indanol lost totally after 5 min and symmetrical ether was started 
to be formed in 10 minute interval. Thus, this experiment supports that the hydroxy group 
promoted by electron donation group undergoes etherification and epimerization more 
rapidly than that with electron withdrawing group.   
Table 2.6: Epimerization of Alcohola 
 
a Reaction conditions: alcohol (1.0 mmol), solvent (1 mL), 33 (1 mol %), 20 - 120 °C. 
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We performed another experiment to describe the nature of high selectivity of 
catalyst 4 between electron donating group substituted alcohols. The coupling reaction of 
benzyl alcohol 11 with methyl mandalate 12 led to unsymmetrical ether 13 (83 %) and 
symmetrical dibenzyl ether 14 (17 %) (Table 2.6). There was no homocoupling of methyl 
mandalate in the reaction mixtures. The analogous experiment with coupling of 4-
methoxybenzyl alcohol 15 with methyl mandalate 12 led to the formation of unsymmetrical 
ether 16 and homocoupling ether of 4-methoxybenzyl alcohol 17. The coupling reaction of 
electron donating group substituted 4-methoxybenzyl alcohols 15 showed slightly higher 
yield than that of benzyl alcohols 11.  
Table 2.7: Selectivity of Unsymmetrical Ethers between Electron Donating Group 
Substituted Alcoholsa 
 
a Reaction conditions: alcohol (1.0 mmol), alcohol (1.0 mmol), solvent (1 mL), 33 (1 
mol %), 70 °C, 1 h. 
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This electronic effect was consistent with the previous results. Then, we brought two 
electron donating group substituted alcohols, benzyl alcohol 11 and 4-methoxy benzyl 
alcohol 15, and performed a similar experiment. Surprisingly, only homocoupling ether 
of 4-methoxybenzyl alcohols 17 was observed as well as major component of 
unsymmetrical ether 18. The coupling reaction of electron donating group substituted 
alcohols was formed dominantly compared to that of electronically less donating group 
substitution alcohol. The catalyst 4 is a very selective coupling catalyst for electronically 
rich alcohols. 
2.4.2 Hammett Study 
To gain mechanistic insights, we used Hammett study to probe electronic effects 
on the ether formation.  In a glove box, complex 4 (3 mg, 0.5 mol %), p-X-C6H4OH (X = 
OCH3, CH3, H, Br, Cl) (1.0 mmol) and 1-hexanol (1.2 mmol) were dissolved in C6H5Cl (1 
mL) in 6 separate 25 mL Schlenk tubes each equipped with a Teflon screw cap stopcock 
and a magnetic stirring bar. The tubes were brought out of the box, and were stirred in an 
oil bath at 50 °C. A small portion of the aliquot was drawn from each reaction tube in 5-10 
minute intervals, and the conversion was determined by GC by measuring the appearance 




The kobs was determined from a first-order plot of -ln([p-X-C6H4OH]t/[p-X-C6H4OH]0) vs 
time. The Hammett plot of log(kX/kH) versus p is shown in Figure 2.6. The analogous 
procedure was used to obtain the rate data from the coupling reaction of p-Y-C6H4CH2OH 
(Y = OCH3, CH3, H, Br, Cl) (1.0 mmol) with PhOH (1.1 mmol). The Hammett plot of 
log(kX/kH) versus p  led to a negative value of -1.3 ± 0.2 (Figure 2.6).  Similarly, the 
analogous plot of phenol with p-Y-C6H4CH2OH resulted in a lower ρvalue of -0.74 ± 0.1 
(X = Y = OCH3, CH3, H, Br, Cl) shown in Figure 2.7. The Hammett ρ values (-1.3 ± 0.2 
and -0.74 ± 0.1) indicated that the reaction rates were strongly accelerated by electron-
donating group (Figures 2.6 and 2.7). Again, the negative ρ values indicated electron 
donating groups substituted phenoxy and benzyl alkoxy group promoted the displacement 




Figure 2.6: Hammett Plot of the Dehydrative Coupling Reaction of p-X-C6H4OH (X = 
OCH3, CH3, H, Br, Cl) with 1-Hexanol. 
 
Figure 2.7: Hammett Plot of the Dehydrative Coupling Reaction of p-Y-C6H4CH2OH 






Figure 2.8: Proposed Transition State via a Ruthenium Alkoxy Species 
2.4.3 H/D Exchange Experiment 
To further gain mechanistic insight, H/D exchange experiment was performed. In a 
glove box, 4-methoxybenzyl alcohol (0.3 mmol), 2-propanol-d8 (0.9 mmol, 99 % D) and 4 
(2.5 mg, 2 mol %) were dissolved in CDCl3 (0.4 mL) in a J-Young NMR tube with a Teflon 
screw cap stopcock (eq. 2.8). The tube was brought out of the box, and the reaction 
progress was monitored by both 1H and 2H NMR at 25°C (Figure 2.9). After 1 h, the 
preferential formation of the unsymmetrical ether product 19 (55 %) was observed over 
the symmetrical ether product 20 (6 %). We could not observe any deuterium incorporation 
on any benzylic position of both ether products 19 and 20. The absence of H/D exchange 
to benzylic position is inconsistent with a mechanistic path via a reversible alcohol to 
aldehyde dehydrogenation. However, we cannot completely eliminate a reversible alcohol 





Figure 2.9: 1H and 2H NMR Spectra of the Reaction Mixture of 4-Methoxybenzyl 
Alcohol with 2-Propanol-d8 Recorded after 1 h of Reaction Time at 25 °C 
2.4.4 Carbon Isotopes Effect 
We successfully measured the 12C/13C kinetic isotope effect (KIE) for the 
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etherification reaction (Table 2.8). In a glove box, 3-phenyl-1-butanol (1.50 g, 10 mmol), 
1-hexanol (1.22 mg, 12 mmol) and complex 4 (60 mg, 1.0 mol %) were dissolved in 
C6H5Cl (20 mL) into each of three separate 100 mL Schlenk tubes equipped with a Teflon 
screw cap stopcock and a magnetic stirring bar. The tubes were brought out of the box, 
and were stirred for 10, 15 and 20 minutes, respectively, in an oil bath which was preset at 
70 °C (eq 2.9). The unsymmetrical ethers product 5e was isolated separately after filtering 
through a short silica gel column (hexanes/EtOAc = 40:1), and the product conversion for 
each solution was analyzed by GC (13, 14 and 18 % conversion). For the carbon isotope 
effect study, the lower mass of active 12C-O bond undergoes bond cleavage or formation 
reaction more rapidly than higher mass of 13C-O bond in the rate limiting step. More of the 
C-O bond at activated carbon undergoes faster 12C isotopic replacement than than 13C-O 
bond at the lower conversion sample. In other words, the amount of 13C in the product at 
activated carbon was lower at the sample of lower conversion compared to the high 
conversion sample. Indeed, this experiment showed the diminished 13C carbon isotopes on 
activated C(1)-O bond at the low conversion sample compared to that at the high 
converstion sample. Thus, the diminished 13C carbon isotopes study confirms the cleavage 








recovered   
(91% conv.) 
13%/91% change (%) 
1 1.075 1.103 0.975 2.54 
2 1.064 1.065 0.999 0.09 
3 1.073 1.071 1.002 -0.19 
4 2.229 2.232 0.999 0.13 
5  1.022 1.024 0.998 0.20 
6  1.054 1.055 0.999 0.09 
7 1.016 1.020 0.996 0.39 
8(ref) 1.000 1.000 1.000 0.00 
9 1.073 1.071 1.002 -0.19 






14%/91% change (%) 
1 1.069 1.103 0.969 3.08 
2 1.062 1.065 0.997 0.28 
3 1.069 1.071 0.998 0.19 
4 2.230 2.232 0.999 0.09 
5  1.023 1.024 0.999 0.10 
6  1.055 1.055 1.000 0.00 
7 1.020 1.020 1.000 0.00 
8(ref) 1.000 1.000 1.000 0.00 










18%/91% change (%) 
1 1.074 1.103 0.974 2.63 
2 1.068 1.065 1.003 -0.28 
3 1.051 1.071 0.981 1.87 
4 2.229 2.232 0.999 0.13 
5  1.026 1.024 1.002 -0.20 
6  1.053 1.055 0.998 0.19 
7 1.018 1.020 0.998 0.20 
8(ref) 1.000 1.000 1.000 0.00 
9 1.073 1.071 1.002 -0.19 
 
2.5 Proposed Mechanism 
The details of the reaction mechanism remain unclear even with the given 
mechanistic information at the present time. On the basis of mechanistic data, a working 
mechanistic hypothesis for the formation of unsymmetrical ethers is presented in Scheme 
2.2. Electronically rich hydroxyl group of alcohol promoted by electron donating group is 
selectively coordinated to an electrophilic Ru species 4 via H2 elimination reaction to form 
Ru alkoxy species 21. From H/D exchange pattern, the alkoxy group on Ru species 21 
undergoes β-hydrogen elimination to form 22. The chiral alcohol is epimerized in this rapid 
exchange step between 21 and 22. The dehydrogenation of alcohols to form carbonyl 
compounds is well known for many ruthenium catalysts.8-10 We observed the ketone 
product in 1H NMR of crude mixture which is formed from alcohol dehydrogenation. The 
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next step would be the coordination of less electronically rich alcohol to ruthenium 
complex 21 to form 23. Then, the coupling of two different alcohols forms unsymmetrical 
ether and released cationic ruthenium hydroxo species 24. In this step, Hammett study 
supported that nucleophilic species from electron donating group substituted phenoxy and 
benzyl alkoxy promote the displacement of electrophilic alkyl of ruthenium alkoxy species. 
Addtionally, the C-O bond cleavage reaction of electronically rich alcohol is determined 
as rate-limiting step as indicated by carbon isotope effect. The electronically rich alcohol 
is coordinated to Ru-hydroxo species 24 to form 25. H2O is then eliminated from 25. The 
regeneration of Ru alkoxy species 21 completes the catalytic cycle.  
 




In conclusion, we have developed a highly selective catalytic synthesis of 
unsymmetrical ethers from the dehydrogenative coupling reaction of alcohols. Compared 
to the previously reported synthetic routes, our catalytic dehydrative coupling method has 
a number of attractive features in that it employs cheaply available alcohols, and water is 
formed as byproduct under mild reaction condition (20-110 oC). Our catalyst exhibits high 
turnover number (80,000) and frequency (7,200 h-1). Equal amount of two different 
alcohols is needed to produce unsymmetrical ether selectively which is outstanding 
features compared to the previous unsymmetrical etherification methods that used excess 
amount of alcohols.  Lastly, our catalytic etherification method exhibited a broad substrate 
scope as well as high degree of functional group tolerance, as illustreated by the 






3 Introduction Hydroacylation Reaction with Transition Metal Catalysts 
The hydroacylation reaction constitutes an expedient synthetic method for 
introducing an acyl group to unsaturated hydrocarbons (eq 3.1).1 This reaction is 
considered to be a powerful synthetic transformation because synthetically valuable 
ketones are obtained from simple unsaturated hydrocarbons. This chapter will survey the 
recent literature on both intra and intermolecular hydroacylation reactions and their 
mechanistic insights.  
  
Tsuji’s group reported the decarbonylation reaction.1 The hydroacylation was 
discovered from the decarbonylation reaction. The mechanism of decarbonylation reaction 
has been well established and widely accepted as shown in Scheme 3.1.1 The first step, the 
mechanism step 1, is the oxidative addition of aldehydic C-H bond to active catalyst 1, 
which forms acyl metal hydride complex 2. Then, the acyl metal hydride readily transforms 
to decarbonylation intermediate, alkylmetal hydride 3. The metal hydride 3 undergoes the 
reductive elimination to form a metal carbonyl 4 and an alkane 5. The metal carbonyl 





Scheme 3.1: Mechanism of Hydroacylation Reaction 
During the last decades, much research effort has been conducted toward 
preventing this decarbonylation step from 2 to 3. Suppressing this decarbonylation pathway 
and the promotion of step 2 is critical for the formation of alkene coordinated acyl metal 
hydride complex 6. The resulting acyl olefin metal hydride complex 6 undergoes alkene 
insertion to forms two different alkyl metal acyl intermediates 7 and 8. The reductive 
elimination of these intermediates 7 and 8 leads to either Markovnikov or Anti-
Markovnikov selective hydroacylation products 9 or 10, respectively. Active metal catalyst 
is regenerated and completes the catalytic cycle.  
The suppression of the decarbonylation step and controlling the regioselectivity 
have been recognized as the main challenge for the hydroacylation reaction. Various 
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strategies have been applied in order to suppress the decarbonylation; for example, a stable 
metallocyclic complex and a chelate assisted group on alkenes and aldehydes1 which will 
be discussed later in this chapter. The nature of transition metal catalysts favorably adopts 
sterically less demanding intermediate 8 over the intermediate 7 as shown in Scheme 3.1. 
Thus far, most intermolecular hydroacylation methods lead to the formation of anti-
Markovnikov selective hydroacylation products 10 (via intermediate 8 in Scheme 3.1). In 
this regard, promoting Markovnikov selective intermolecular hydroacylation has been 
considered as a more difficult task to be achieved.1 Only a handful examples of 
Markovnikov selective hydroacylation reaction have been reported. This chapter will focus 
on the literature of Markovnikov selective hydroacylation reaction which is alternatively 
called a branch selective hydroacylation reaction.   
3.1 Intramolecular Hydroacylation of alkenes 
In 1972, Sakai’s group reported the first example of transition metal mediated 
hydroacylation of alkenes.2 During the course of a synthetic study of prostanoids, the 
reaction of 2, 3-disubstituted 4-pentenals 11 with the stoichiometric amount of Wilkinson’s 
catalyst 14 forms the hydroacylation product 12 (34 % yield) and a similar amount of 




Since Sakai’s pioneering work, many intramolecular hydroacylation reactions have been 
reported. Miller’s group presented the first catalytic intramolecular hydroacylation. The 
reaction of 4-pentenal 15 with 10 mol % of Wilkinson’s catalyst in chloroform at room 
temperature formed cyclopentanone 16 (14 % yield) (eq 3.3). The yield of this reaction 
was improved to 72 % when saturated ethylene in CHCl3 was used as a solvent. Saturated 
ethylene was coordinated to a vacant site of rhodium catalyst, and suppressed the 
decarbonylation reaction (eq 3.4). Since then, a great deal of research stereoseelctive 
intramolecular hydroacylation have been accomplished by using Rh catalysts.1  
 
3.2 Intermolecular Hydroacylation of alkenes  
Intermolecular hydroacylation reaction has been considered to be more challenging 
than the intramolecular hydroacylation because a competitive reductive decarbonylation 
reaction became more prevalent as shown in Scheme 3.1.1,3 To suppress the reductive 
decarbonylation pathway, Suggs introduced a five membered rhodocyclic intermediate 19 




They observed the five membered metallacyclic intermediate 19 which did not undergo a 
decarbonylation reaction to form a strained four-membered rhodocyclic complex. Since 
his pioneering work, a great deal of intermolecular hydroacylations have been achieved 
using a similar strategy, by using various chelate assisted aldehydes such as ortho-
(diphenylphsphino)benzaldehye5, olefinic aldehyde6, salicylic aldehyde7, -sulphur 
aldehydes8, and 2-pyridylaldimines4,9 (Figure 3.1).  
 
Figure 3.1: Aldehyde with Directing Group for Markovnikov Selective Intermolecular 
Hydroacylation 
Furthermore, Jun10(a), Hirano10(b), Tanaka10(c), Brookhart10(d),(e),(f), and Dong10(g) achieved 
intermolecular hydroacylation reaction by using non-chelating aldehydes.10(h) A 
breakthrough in intermolecular hydroacylation came from Jun’s report, that intermolecular 
hydroacylation reaction with non-chelate assisted aldehydes was accomplished by using 
Metal-Organic Cooperative Catalysis strategy (Wilkinson’s catalyst and 2-amino-3-
picoline). The mechanism of this reaction is described in Scheme 3.2. The first step is the 
aldehyde condensation with picoline 20 to form aldemine 21. This imine 21 undergoes C-
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H activation mediated by Wilkinson’s catalyst. The rhodium(III) catalyst 22 is readily 
coordinated to alkene. Alkene coordinated rhodium(III) catalyst 23 undergoes the alkene 
insertion step via a less hindered fashion 24. Then, the reductive elimination form ketamine 
25 which further undergoes hydrolysis to form the ketone product. The main drawbacks of 
this reaction are the use of a subcatalytic amount of organic catalyst 20, and employing 
additives, such as 40-100 mol % of 2-amino-3-picoline and 10-20 mol % of benzoic acid. 
Even with the drawbacks, this reaction showed a broad substrate scope on both aldehydes 
and olefins. 
 
Scheme 3.2: Intermolecular Hydroacylation with Non-chelating Aldehyde  
Additionally, other groups reported the intermolecular hydroacylation reactions with non-
chelating aldehydes and alkenes. Hirano and Tanka’s group reported the intermolecular 
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hydroacylation reaction of non-chelating aldehyde with acrylamide 26 to form –
ketoamide 27 (eq 3.6).10(b),(c) Brookhart’s group reported the coupling reaction of aryl 
aldehydes with aliphatic alkenes to form linear hydroacylation products 28 (eq 3.7).10(d),(e),(f) 
Dong’s group achieved the coupling reaction of aryl aldehydes with dienes 29 to form ,-




Even though the reactions achieved the formation of hydroacylation products with 
non-chelated aldehydes, the substrate scope of these reactions is still limited to either aryl 
aldehydes (Brookhart, Dong) or chelate assisted alkenes (Hirano, Tanka, and Dong).10 The 
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hydroacylation reaction resulted in the formation of linear-selective products,10 which is 
dictated by transition metal catalysts. Much research effort has been directed to develop 
toward the branch-selective hydroacylation reaction to form the ketone products. However, 
there are only a few literature reports related to branch selective hydroacylation, and these 
Markovnikov selective hydroacylation reactions will be discussed in this chapter.  
3.3 Markovnikov Selective Intermolecular Hydroacylation of Alkenes 
3.3.1 Hydroacylation with Salicylic Aldehydes and Dienes 
Markovnikov selective hydroacylation is considered to be more difficult to achieve 
due to the nature of transition metal catalysts which favorably adopts sterically less 
demanding intermediate 8 as shown in Scheme 3.1. In 2003, Suemune group11(a)  reported 
Markovnikov selective intermolecular hydroacylation with a transition metal catalyst. A 
mixture of branch 33 and linear 34 ketones was observed (branch vs liner ketone was 
3:5~20:1) (Scheme 3.3). 
 
Scheme 3.3: The Intermolecular Hydroacylation of Salicylic Aldehydes with Dienes  
The reaction scope of hydroacylation in this report was limited to salicylic aldehydes 31 
and dienes 32 as shown in Scheme 3.3. The reaction of salicylic aldehyde 31 with 
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cyclohexene, 1,3-cyclohexadiene, 1,4-cyclooctadiene, and 5-hexen-2-one did not give 
any hydroacylation product (Table 3.2). The reaction of non-chelating aldehydes such as 
aliphatic aldehyde and benzaldehyde with 1, 5–hexadiene did not form any 
hydroacylation product either.  
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Table 3.1: The Scope of Hydroacylation Reactiona 
 
aReaction conditions: RhCl(PPh3)3 (0.2 equiv), aldehyde (1 equiv), diene (6 equiv), rt, 
24-72 h.  
 
In the following year, Suemune reported another hydroacylation reaction11(b) with 
an extended substrate scope, and performed a deuterium labeling experiment (eq 3.9). The 
reaction of one equivalent of deuterated salicylic aldehyde (98% D) 35 and 0.9 equivalent 
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of 1,5-hexadiene 36 in the presence of 0.2 equivalent of rhodium catalyst gave 
hydroacylation product in 20 %, linear 37 and branch 38 ketone as 1:4 ratio (eq 3.10). 
Deuterium was transferred to phenolic hydrogen and 1,5 hexadiene (eq. 3.9). 
 
 On the basis of this experiment, the author proposed a rapid interconversion process 
between 1,5-hexadiene and salicylaldehyde-d via a rhodium catalyst as shown in Scheme 
3.4. Salicylic aldehyde reacts with the rhodium catalyst via an oxidative addition and diene 
coordination to form Rh(III) catalyst 39. Reductive elimination of intermediate 40, 41 
followed by alkene insertion generates the hydroacylation products 42, 43. However, this 




Scheme 3.4: Proposed Mechanism of Suemune’s Hydroacylation 
Generally, chelating groups such as hydroxyl and alkene on both salicylic aldehyde and 
diene are required in order to obtain Markovnikov selective hydroacylation reaction. The 
reaction of salicylic aldehyde with a simple alkene, 1-hexene, gives only 4% anti-
Markovnikov selective ketone product after 36 hours of the reaction time. Furthermore, the 
reaction of salicylic aldehyde with hydroxyl group containing alkenes, allyl alcohols, gives 
only 14 % hydroacylation products with a branch over liner selectivity in 1: 9 ratio. The 
reaction of salicylic aldehyde with internal alkenes did not give any hydroacylation product. 
Summeon’s group first achieved Markovnikov selective hydroacylation under a mild 
condition. However, poor regioselectivity of branch product and the limited substrate scope 




3.3.2 Hydroacylation of Salicylic Aldehyde and Homoallylic Sulfides or 
Homoallylic Alcohols 
In 2010, Dong group reported a highly Markovnikov selective intermolecular 
hydroacylation (Branch over linear ketone was 20:1) from using salicylic aldehyde 31 and 
homoallylic sulfides 44 (eq 3.10).12 The reaction required 10 mol % of phosphoramidite 
ligands 46 and 0.2 equiv of K3PO4 additionally. The reaction without phosphoramidite 
gave poor selectivity (the selectivity of branch over linear ketone was 4 to 1). Employ the 
chiral phosphoramidite ligand 46 gave a highly enantioselective branch product 45 (92 % 
ee).  
 
The substrate scope of alkenes was limited to homoallylic sulfide 47 for the formation of 
Markovinkov selective product 48 (eq. 3.11). The reaction of allylic sulfide 49 with 




 Dong’s group reported similar hydroacylation reaction of salicylic aldehyde with 
homoallyl alcohol 51.13 The reaction between salicylic aldehyde 31 with homoallylic 
alcohol 51 gave the branch selective ketone product 52 (eq 3.13). 
 
These results were rationalized by involving a preferential formation of five membered 
rhodacycle 55, 58 over six and four membered rhodocycles 54, 57 (Scheme 3.5).12 The 
hydroacylation reaction with homo-allylic sulfide prefered the formation of five-membered 
56 over six-membered structure 53 due to an accumulation of ring-strain 54 in the transition 
state.12 As shown in Scheme 3.5, six-membered rhodacycle 53 went through a highly 
distorted geometry 54 over 55. On the other hand, the hydroacylation reaction with allylic 
sulfide preferred a five-membered structure 58 over sterically demanded four-member 




Scheme 3.5: Five vs Six Membered Rhodacyclic Intermediates 
Thus far, the reaction scope of alkenes is limited to homoallylic sulfides and alcohols with 
salicylic aldehyde. The chelate group on both substrates was required to obtain 
Markovnikov selective hydroacylation products. The main drawback for this reaction is a 
limited reaction scope of both substrate.  
3.3.3 Hydroacylation of Nonchelating Aldehydes with Enones or Dienes  
In 2007, Ryu group reported the hydroacylation reaction of aldehyde and enones 
59 by using ruthenium catalyst 61,14 which was the first Markovnikov hydroacylation of 
non-chelate assisted aldehydes (eq 3.14). However, the activated alkenes such as ,-
unsaturated ketones, are required to achieve high activity and selectivity. Aliphatic and aryl 
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aldehydes were reacted with aliphatic ,-unsaturated ketones 59 to generate branch 
selective diketones 60 (eq 3.14). 
 
The coupling reaction of -acyl alkene 62 with aldehydes formed a branch selective 
diketone products 63 (eq 3.15). In this case, the -acyl alkene rapidly undergoes olefin 
isomerization prior to the hydroacylation reaction. 
 
In the next year, Ryu and Krische group reported a hydroacylation reaction of non-





Table 3.2: Scope of Aldehydes (eq 3.16)a 
 
aReaction conditions: aldehyde (1.0 mmol), alkene (2.5 mmol), Ru catalyst (5.0 mol %), 
trifluoroacetic acid (TFA) (5.0 mol %), 80 oC 
The broad substrate scope of aldehydes including aliphatic and aryl aldehydes was 
achieved (Table 3.2). On the other hand, the reaction required a directing group or chelating 
group on aldehydes. The scope of alkenes was limited to conjugated dienes 64 with high 
yields (84-98 %). 
The coupling reaction of conjugated diene 67 and aldehyde formed the same 
product 69, generated from the coupling reaction between homoallylic alkenes 66 and 
aldehydes (Scheme 3.6). Alkene isomerization occurred prior to hydroacylation reaction 
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similar to equation 3.15. A conjugated diene is stabilized by ruthenium catalyst to form 
bidentate diene ruthenium species 68, and further undergoes a coupling reaction with 
aldehyde to form , −unsaturated ketone 69.  
 
Scheme 3.6: Hydroacylation of Homoallylic Alkene vs Conjugated Diene with Aldehyde 
3.3.4 Hydroacylation with Nonchelating Aldehydes with 1-Vinylphenol 
Dong’s group reported another hydroacylation reaction of non-chelating aldehydes 
with 1-vinylphenols (eq 3.17).10(a)  The regioselectivity of this reaction showed 9:1 to >20:1 
branch vs linear selective products. According to the author, the scope of aldehydes showed 
a broad scope of non-chelating aliphatic, alkenyl, and aryl aldehydes. However, the scope 
of alkenes was limited to 1-vinylphenol derivatives in which the phenolic group was 




The author reported the mechanistic study of this reaction in a different paper in 
2015.16 To gain the insight of hydroacylation mechanism, the kinetics of hydroacylation 
reaction was studied using 4 mole % of Rh catalyst, 8 mole % of dcpm (bis-
dicyclohexylphosphino-methane) 70, and 1 mmole of 2-vinyl phenol with various 
quantities of aldehydes at 55 oC. The reaction rate was found to show the first order 
dependence on the aldehyde. Similarly, the reaction rate was performed with various 
amounts of 2-vinylphenol under the same conditions. The reaction came out to be a zero 
order rate dependence of the rate on 2-vinylphenol. Next, a deuterium labeling study was 
performed. According to recent articles of hydroacylation reactions, the extensive 
deuterium scrambling observed at the product indicates the rate determining step of 
reductive elimination. However, the deuterium labeling study shows monodeuterated 
ketone product, in which the result rules out the rate determining step of reductive 
elimination reaction. Further, kinetic isotope effect (KIE) was measured via intermolecular 
competition experiment of deuterium and protio aldehyde with 4-nitro-2-vinyl-phenol. 
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From this experiment, normal isotopes effect (KIE of 2.5  0.2) was observed. The results 
supported an oxidative addition of benzaldehyde as the rate limiting step. The mechanism 
was proposed based on these information (Scheme 3.7). The rhodium catalyst 
[Rh(cod)OMe]2 71 reacts with dcpm 72 and alkene to form alkene coordinated rhodium 
phenoxy species 73.  The aldehyde is coordinated to 73 by ligand substitution reaction to 
form 74. Then, aldehyde undergoes oxidative addition was determined to be the rate 
limiting step by kinetic isotope effect and Hammett study to form 75. Alkene insertion to 
75 forms 76 which undergoes reductive elimination of 76 form 77. Then, displacement of 
product with vinyl phenol released the product and active catalyst 73 and completed the 




Scheme 3.7: Dong’s Proposed Mechanism of Hydroacylation of Vinylphenol 
3.3.5 Current Issues and Challenges 
On the basis of the literature precedent, a number of anti-Markovnikov selective 
hydroacylation reactions have been reported due to the nature of transition metal catalysts 
which forms a sterically less demanding intermediate. On the other hand, only a few 
examples of Markovonikov selective addition of aldehydes to form branch ketone products 
have been found.1,10(h),16 The substrate scope of those examples was limited to aryl 
aldehyde derivatives or both of chelate assisted aldehydes and alkenes.10(h),16 Thus, the 
current challenges remained in the development of Markovnikov-selective hydroacylation 






4 Intermolecular Markovnikov-Selective Hydroacylation of Olefins 
Catalyzed by a Cationic Ruthenium-Hydride Complex 
4.1 Introduction 
The synthesis of functionalized organic compounds via a transition metal catalysis is 
an attractive research field. For example, hydroacylation of aldehydes with unsaturated 
hydrocarbons has drawn considerable interest in forming valuable ketones. In contrast to 
the intramolecular hydroacylation, intermolecular hydroacylation has been relatively less 
well developed due to the competing decarbonylation reaction (Scheme 4.1, Path A) which 
leads to an irreversible formation of inactive complex.10,2(h) To prevent decarbonylation 
reaction, chelate assisted aldehydes and alkenes were used for the hydroacylation reaction. 
The linear selective hydroacylation with non-chelating alkenes and aldehydes have been 
achieved (Scheme 4.1, Path B). However, highly branch selective hydroacylation with non-
chelating alkenes and aldehydes still remains a challenging problem (Scheme 4.1, Path c). 
Herein, we describe Markovnikov selective hydroacylation of non-chelate assisted 
aldehydes with styrene by using ruthenium (II) catalyst. We submitted a part of this chapter 






































Scheme 4.1: Decarbonylation Reaction 
4.2 Results and Discussion 
Previously, our group reported selective catalytic C-H alkylation of alkenes with 
alcohols (eq 4.1) and catalytic synthesis of unsymmetrical ethers from the dehydrative 




During the course of optimizing unsymmetrical etherification reaction (eq 4.2), 
unsymmetrical ester 2 was observed at the higher temperature >125 oC as shown in Scheme 
4.2.  
 
Scheme 4.2: The Formation of Ester by Ru Catalyst 1 
In this reaction, we observed the formation of a small amount of aldehyde, which is 
generated from the dehydrogenation of alcohol. We suspected that the dehydrogenated 
aldehydes were selectively coupled with another alcohols to form unsymmetrical esters 2 
(eq. 4.3).  With this result in mind, our group screened the reaction of alcohols with other 
substrates such as alkenes, alkynes, dienes, and other heterocyclic compounds. We 
discovered that the coupling reaction of an alcohol with styrene gave an -branch ketone 
product 3 (eq. 4.4). To ensure the formation of ketone products, we performed the 
following experiment. The mixture of cationic Ru catalyst 1 (5 mol %), benzyl alcohol (1 
mmole), and styrene (2 mmole) was prepared in toluene (2 mL).  The solution mixture was 
heated in an oil bath at 125 oC, and was analyzed by both 1H NMR spectroscopy and gas 
chromatography mass spectroscopy (GC-MS).  The reaction mixture showed a highly 
regioselective formation of the branch hydroacylation ketone product 3 (72 % yield, >20:1 
b:l) and ethyl benzene as a byproduct. An excess amount of styrene was used as a hydrogen 
acceptor for the oxidation of benzyl alcohol to form ethyl benzene and benzaldehyde. This 
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benzaldehyde underwent further coupling reaction with another styrene to form a 
hydroacylation product 3 (eq 4.4).  
 
To minimize the usage of starting material (styrene) and the generation of by-
products (ethylbenzene), we examined the reaction with benzaldehyde (dehydrogenated 
form of alcohol) with styrene under the same reaction conditions. The reaction of 
benzaldehyde with styrene generated the same hydroacylation product 3 with an improved 
yield (> 82% yield, > 20:1 b:l) as shown in eq. 4.5. Herein, we present the scope and 
synthetic utility of the intermolecular branch-selective hydroacylation by using a well-
defined cationic ruthenium hydride catalyst [(C6H6)(PCy3)(CO)RuH]
+BF4




4.3 Optimization Studies 
4.3.1 Solvent and Temperature Effects 
The optimization study was performed by using hydroacylation reaction of hexanal 
with styrene under various temperatures and solvent systems (Table 4.1). The reaction 
mixture of hexanal (50 mg, 0.5 mmol) and styrene (63 mg, 0.6 mmol) with catalyst 1 (5.0 
mol %) in 1 mL of toluene was prepared. The reaction mixture was heated to a certain 
temperature and analyzed by GC-MS after 8 h of the reaction time.  
Table 4.1: Solvent Effect for the Reaction of Styrene with Hexanala 
entry solvent temp (⁰C) yield (%)b 
1 toluene 150 12 
2 toluene 130 92 
3 toluene 120 35 
4 toluene 100 >5 
5 chlorobenzene 130 8 
6 dioxane 130 trace 
7 CH2Cl2 100 trace 
8 CHCl3 100 trace 
9 THF 100 trace 
10 toluene /CHCl3 130 18 
aReaction conditions: hexanal (100 mg, 1.0 mmol), styrene (125 mg, 1.2mmol), catalyst 1 
(5.0 mol %), in solvent (1 mL), 8 h. bThe product yield was determined by GC-MS analysis 




The reaction mixtures at 100 oC generated less than 5 % hydroacylation product 
with the alkylation product as the major product (56 %). The reaction mixture began to 
generate the mixture of the alkylation and hydroacylation products (7:2) at 110 oC. The 
reaction at 125-130 oC gave the highest conversion, yield, and selectivity of hydroacylation 
product, 98 %, 92 %, and >20:1 respectively. However, the formation of hydroacylation 
product was dramatically dropped at higher than 135 oC. With the optimal temperature 
range at 120-135 oC in hand, various solvent systems were screened. Less hydroacylation 
product was obtained in polar solvents such as dioxane, THF, CHCl3, and CH2Cl2. Instead, 
other products such as ether, ester, and alkylation product were obtained as a major 
component of the reaction. Freshly distilled anhydrous toluene gave the highest product 
yield (entry 2 in Table 4.1).    
4.3.2 Catalyst Screening 
We also screened other metal catalysts for the hydroacylation of styrene and 
benzaldehyde. In a glove box, benzaldehyde (52 mg, 0.5 mmol) and styrene (63 mg, 0.6 
mmol) were prepared in toluene (1 mL) with various catalysts (4.0 mol %) listed in Table 
4.4. The reaction mixture was heated for 4 h in an oil bath at 125 °C. The reaction mixture 
was analyzed by GC and GC-MS after the reaction. The results were summarized in Table 
4.2. Among all screened catalysts, only cationic Ru-H catalyst 1 (entries 1-5) and tetra-
ruthenium catalyst 2 with HBF4·OEt2 (entry 7) showed high activity for the hydroacylation 
reaction. For the tetraruthenium catalyst 2 with HBF4·OEt2 (entry 7), the desired product 
yield was dropped due to the formation of styrene dimers. The reaction with tetra-
ruthenium catalyst 2 did not generate any hydroacylation product (entry 6). Thus, we 
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assumed that the styrene dimers are solely generated by HBF4·OEt2. Many catalysts 
screened, we could not find any active catalyst for the hydroacylation reaction of aldehyde 
with styrene.  
Table 4.2: Catalyst Survey for the Reaction of Benzaldehyde with Styrenea 
entry catalyst additive solvent yield (%) 
1 [(C6H6)(PCy3)(CO)RuH]BF4 (1) --- toluene 95 
2 [(C6H6)(PCy3)(CO)RuH]BF4 (1) --- chlorobenzene 67 
3 [(C6H6)(PCy3)(CO)RuH]BF4 (1) --- 1,4-Dioxane <5 
4 [(C6H6)(PCy3)(CO)RuH]BF4 (1) --- CH2Cl2 <5 
5 [(C6H6)(PCy3)(CO)RuH]BF4 (1) HBF4·OEt2 toluene 43 
6 [RuH(CO)(PCy3)]4(O)(OH)2 (2) --- toluene 0 
7 [RuH(CO)(PCy3)]4(O)(OH)2  (2) HBF4·OEt2 toluene 54 
8 RuH(CO)H2(PPh3)4 HBF4·OEt2 toluene 0 
9 RuCl2(PPh3)3 HBF4·OEt2 toluene 0 
10 RuCl3·3H2O --- toluene 0 
11 RuH2(CO)(PPh3)3 HBF4·OEt2 toluene 0 
12 [RuCl2(COD)]x --- toluene 0 
13 [RuCl2(COD)]x HBF4·OEt2 toluene 0 
14 [RuCl2(p-cymene)]2 --- toluene 0 
15 [(PCy3)2(CO)(CH3CN)2RuH]BF4 --- toluene <5 
16 AlCl3 --- toluene 0 
17 FeCl3·H2O --- toluene 0 
18 --- HBF4·OEt2 toluene 0 
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aReaction conditions: benzaldehyde (52 mg, 0.5 mmol), styrene (63 mg, 0.6 mmol), 
catalyst (4.0 mol %), additive (2.0 equivalent to Ru), solvent (1 mL), 125 °C, 4 h. The 
product yield was determined by GC and GC-MS. 
4.4 Reaction Scopes 
4.4.1 Scope of the Intermolecular Markovnikov Selective Hydroacylation 
Reaction 
We explored the substrate scope of intermolecular Markovnikov selective 
hydroacylation reaction under the following standard conditions. In a glove box, an 
aldehyde (1.0 mmol), styrene derivative (1.2 mmol) and a catalyst 1 (4.0 mol %) were 
prepared in toluene (1 mL) in a 25 mL Schlenk tube. The reaction mixture was stirred in 
an oil bath which was preset at 130 °C for 6-24 hours. The explored substrate scope of the 
reaction is presented in Table 4.3. We found that styrene reacted with para-substituted aryl 
aldehydes both electron donating and withdrawing group to give highly branch selective 
hydrocylation products 3a-3e (entries 1 to 5). The reaction of electron deficient group para-
substituted aryl aldehyde with styrene generated the branch selective product with higher 
yield within 6 hours than that of electron donating group para-substituted aryl aldehyde. 
In the case of para-methoxy substituted aryl aldehyde, a linear selective hydroacylation 
product was observed with less than 10% yield and 1:10 selectivity (linear over branch 
ketone). The coupling reaction of aliphatic aldehydes with electron donating and 
withdrawing group para-substituted styrene gave also highly regioselective ketone 
products 3f through 3j (entries 6 to 10). In the case of para-methylstyrene, the branch 
selective ketone product was observed with a 1:10 ratio (linear vs branch ketone). The 
reaction of hexanal with para-chlorostyrene showed the ketone product 3h with less yield 
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(56%) due to the competing esterification reaction of hexanals. The coupling reaction of 
propanal with styrene needed 3 equivalents of propanal due to low boiling point of propanal 
in order to obtain the branch selective ketone product 3j in 71 % yield. The coupling 
reaction of functionalized aldehydes with styrene gave also highly regioselective ketone 
products 3k-3m (entries 10 to 13) which showed functional group tolerance of ,-
unsaturated ketone, naphthyl, and furan. The reaction of ,-unsaturated aldehydes with 
styrene required the low reaction temperature (100 oC) and benzene solvent was used 
instead of toluene to suppress the alkene dimerization of ,-unsaturated aldehydes. We 
extended the substrate scope to allyl benzene and monoallyl benzene (4-phenyl-1-butene), 
which readily reacted with both aliphatic and aryl aldehyde to afford hydroacylation 
products 3n-3p (entries 14 to 16) after the facile olefin isomerization. Similarly, the 
coupling reaction of -methyl substituted styrene with 4-chlorobenzaldehyde generated 3q 
(entry 17).  
The reaction of indene with both aliphatic and aromatic aldehydes produced a 
hydroacylation product, but showed a linear selective product which showed totally 
different selectivity. -ester and amide substituted styrene reacted with aryl and aliphatic 
aldehyde gave branch selective 1,4-diketone products 3t through 3v (entry 20 and 22). Next, 
optically active (R)-2-phenyl-propanal was investigated for the hydroacylation reaction 
with styrene. Two different diasteromers (dl:meso = 1:1) 3x (entry 23) were isolated. 
Optical rotation of both compounds was measured as [α]20D +31.2° and -26.4° (c = 0.4, 
CH2Cl2). The absolute configuration of stereochemistry on both compounds were 
determined as described in the next section (determination of the stereochemistry on 
hydroacylation products). Vinylnaphthalene also reacted with aryl aldehyde to form a 
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branch selective coupling product 3y, but with low yield 34 %. The reaction with 
vinylnaphthalene required high temperature, longer reaction times, and higher catalyst 
loading 1 (10 mol %). In most cases, the coupling reaction achieved highly branch selective 
hydroacylation products over the liner products. 















Table 4.3 Cont… 
aReaction conditions: aldehyde (1.0 mmol), alkene (1.2 mmol), toluene (1 mL), 1 (4-6 
mol %). bRegioselective of branch vs linear is (>20:1 b;l) unless indicated. The d.r. values 
were determined by 1H NMR spectroscopy.  
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4.4.2 Intermolecular Markovnikov Selective Hydroacyaltion Reaction with 
Highly Functionalized Bioactive Molecules 
We further explored a number of highly biologically active aldehyde and alkene 
substrates. A naturally occurring aldehyde, (1R)-(-)-myrtenal, has been shown to exhibit 
pharmacological activities against many diseases.80 The coupling reaction of styrene with 
(1R)-(-)-myrtenal generated two different diastereomers (1:1) of ketone products 3aa in 
86 % yield. The second naturally occurring aldehyde, (S)-(-)-perillaldehyde, is being used 
for food additives for flavor and perfumery. This (S)-(-)-perillaldehyde was reacted with 
styrene to form two diastereomers of 3ab in 56 % yield.  Biologically active myristicin 
aldehyde and tropional were used to synthesize hydroacylation products. The reaction 
between biologically active myristicin aldehyde and tropional with styrene formed two 
diasteromers of products 3ac and 3ad in 64 % and 73 % yield respectively. We next 
explored the reaction with a biologically important indole derivative. The coupling reaction 
of N-methyl-3-Indolecarboxaldehyde with methyl cinnamate generated 3ae in 60 % yield. 
Another bioactive molecules, isophthaldehyde and bis(2-formylphenyl)ether were used. 
These aldehyde compounds reacts with 2 equivalent of styrene formed 2 to 1 coupling 
products 3ae and 3af in 82 and 88 % yields. The reaction of vinylestrone with benzaldehyde 
formed a single diastereomer of (-)-3ah. From the survey of hydroacylation reaction scope, 






Table 4.4: Ruthenium-Catalyzed Markovnikov-Selective Hydroacylation of Biologically 
Active Aldehydes and Alkene Compoundsa 
 
aReaction conditions: aldehyde (1.0 mmol), alkene (1.2 mmol), toluene (1 mL), 1 (8-10 
mol %). Regioselective of branch vs linear is (>20:1 b;l) unless indicated. The d.r. values 




4.5 Mechanistic Study 
4.5.1 Determination of the Stereochemistry on the Hydroacylation Products 
To gain mechanistic insights into catalytic hydroacylation reaction, we investigated 
the coupling reaction of (R)-2-phenylpropanal with styrene and para-methylstyrene to 
probe the stereochemistry of branch selective hydroacylation products (Scheme 4.3). Both 
reactions generated a 1:1 ratio of diasteromers. First, we isolated each diasteromers 
generated from the reaction of (R)-2-phenylpropanal with styrene by silica gel column 
chromatography. The optical rotations of first and second eluted diastereomers were [α]20D 
= 0.00o and +34.8o (c= 0.5, CH2Cl2) respectively (Scheme 4.3 top). The first eluted sample 
was determined as (R,S)-2,4 diphenyl pentan-3-one (R,S)-3z because of the internal mirror 
plane on the product (Scheme 4.3 top). The second optically eluted samples was 
determined as (R,R)-2,4 diphenyl pentan-3-one (R,R)-3z. Similarly, we ran the coupling 
reaction of (R)-2-phenylpropanal with para-methylstyrene to get the unsymmetrical 
hydroacylation products. The reaction mixture generated two diastereomers which were 
isolated by silica gel column chromatography. The optical rotation of each sample was 
analyzed by the polarimetry method. The first and second eluted samples gave the negative 
([α]20D= -26.4° (c= 0.5, CH2Cl2)) and the positive value of optical rotation ([α]
20
D= 31.2° 
(c= 0.5, CH2Cl2)) respectively (Scheme 4.3 bottom). The second eluted product (R,R)-3x 
gave similar optical rotation value as the product (R,R)-3z. We assigned the product (R,R)-
3x as (R,R)-2-(4-methylphenyl)-4-phenyl pentan-3-one. The other product, first eluted 




Scheme 4.3: Stereochemistry of Hydroacylation Products 
4.5.2 Deuterium Isotope Effect 
     We studied the following experiments to gain mechanistic insights. Firstly, we 
examined the deuterium isotope effect of the aldehyde substrate to determine the rate-
limiting step of the coupling reaction (eq 4.6). The reaction rate of PhCHO and PhCDO 
with styrene in separate experiments was measured at 125 oC (eq 4.6). The kobs value of 
each substrate was observed with the first-order plots of the formation of 3a which shows 
a normal deuterium isotope effect of kH/kD = 2.6±0.1 (Figure 4.1). This kinetic data 





Figure 4.1: First Order Plots for the Reaction of Styrene with Benzaldehyde and 
Benzaldehyde-d1 
4.5.3 Carbon Isotope Study 
Singleton’s NMR technique was used to measure the 12C/13C kinetic isotope effect 
(KIE) from the coupling reaction of benzaldehyde and styrene (eq 4.7).51,72 In a glove box, 
benzaldehyde (506 mg, 5 mmol), styrene (625 mg, 6 mmol) and complex 1 (120 mg, 5.0 
mol %) were dissolved in toluene (10 mL) into each of two separate 100 mL Schlenk tubes 
equipped with a Teflon screw cap stopcock and a magnetic stirring bar. The tubes were 
brought out of the box, and were stirred for 50 and 60 minutes, respectively, in an oil bath 
which was preset at 125 °C. The product 3a was isolated separately after filtering through 
a short silica gel column (hexanes/diethyl ether = 40:1), and the product conversion for 


































KH/KD = 2.57  0.04
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 The 13C{1H} NMR analysis of the isolated product 3a was performed by following 
Singleton’s NMR method.5,10 The NMR sample was prepared identically by dissolving 
100 mg of isolated 3a in CDCl3 (0.5 mL) in a 5 mm high precision NMR tube. The 
13C{1H} 
NMR spectra were recorded with H-decoupling and 45 degree pulses. A 60 s delay 
between pulses was also imposed to minimize T1 variations (d1 = 60 s, at = 5.0 s, np = 
245098, nt = 768). The results are summarized in Table 4.5.  
The rate difference in carbon-carbon bond formation of 12C vs 13C atoms leads to 
carbon isotope effect in the transition state (due to the difference in the zero point energy).  
Lighter 12C-carbon facilitates the faster C-C bond formation over the heavier 13C-carbon. 
This notion results in high 12C isotopic replacement on low conversion hydroacylation 
product. On the other hand, high conversion sample expects to be obtaining natural 
abundance 13C isotopic quantity. The most pronounced carbon isotope effect was observed 
on the carbonyl carbon C(7) of 1,2-diphenyl-1-propanone (eq 4.7). The experiment showed 
diminished 13C carbon isotopes on activated carbonyl C(7) bond at low conversion 
compared to that of  high conversion sample. The average 12C/13C ratio of the high 
conversion sample (91 %) to that of the low conversion ones (average of 2 runs, at 13, 15% 
conversion; see Table 4.5) was 1.027 (2.7 % more 13C on high conversion sample). The 
result suggests that the alkene insertion step via nucleophilic metal-12C bond facilitates the 
fast C-C bond formation over the alkene insertion step via nucleophilic metal-(13C) bond 




Scheme 4.4: Alkene Insertion via Nucleophilic Insertion of Acyl Group 
 




recovered   
(13% conv.) 
91%/13% change (%) 
1 1.088 1.090 0.999 -0.15 
2 2.084 2.082 1.001 0.11 
3 1.894 1.890 1.002 0.22 
4 1.168 1.169 0.999 -0.10 
5 0.932 0.929 1.002 0.25 
6 1.027 1.028 0.999 -0.10 
7 1.126 1.092 1.031 3.06 
8 1.075 1.072 1.002 0.23 
9 1.890 1.880 1.005 0.52 
10 1.957 1.961 0.998 -0.23 






recovered   
(15% conv.) 
91%/15% change (%) 
1 1.088 1.088 1.001 0.06 
2 2.084 2.084 1.000 0.01 
3 1.894 1.894 1.001 0.09 
4 1.168 1.168 1.000 0.04 
5 0.932 0.932 1.001 0.05 
6 1.027 1.027 1.001 0.11 
7 1.126 1.126 1.022 2.15 
8 1.075 1.075 1.003 0.31 
9 1.890 1.890 1.002 0.21 
10 1.957 1.957 1.003 0.29 
11 (ref) 1.000 1.000 1.000 0.00 
4.5.4 Hammett Study 
Hammett study was performed to further probe electronic influence of the aldehyde 
substituents (eq 4.8). The experiment was prepared with complex 1 (15 mg, 4 mol %) and 
styrene (0.6 mmol) in toluene (1 mL) with a series of para-substituted benzaldehyde p-X-
C6H4CHO (X = OCH3, CH3, H, F, Cl) (0.5 mmol) in 4-6 separate 25 mL Schlenk tubes. 
The tubes were heated in an oil bath at 125 °C. A small portion of the aliquot was drawn 
from each reaction tube in 20 minute intervals, and the conversion was determined by GC 
by measuring the appearance of the product. The kobs was determined from a first-order 
plot of -ln([p-X-C6H4CHO]t/[p-X-C6H4COH]0) vs time. The Hammett plot of log(kX/kH) 
versus p was constructed from the reaction rate of styrene with a series of p-X-C6H4CHO 




A linear correlation from the relative rate versus the Hammett σp was observed with a 
positive slope (ρ = +0.83±0.08) (Figure 4.2).17b This result suggested that a strong 
promotional effect by para-electron-withdrawing groups lead to the buildup of substantial 
positive charge on the carbonyl carbon atom in the transition state. This  charge built up 
on carbonyl carbon would facilitate the aldehyde C-H bond cleavage.  
 
Figure 4.2: Hammett Plot of the Hydroacylation Reaction of p-X-C6H4COH (X = OCH3, 



























On the basis of these results, we propose two possible mechanistic pathways via 
C-H activation or migratory aldehyde insertion (Scheme 4.5 and 4.6). Both reaction 
mechanisms are promoted by substantial positive charge on carbonyl carbon atom. The 
first plausible mechanistic pathway is via C-H activation (Scheme 4.5 top). The aldehyde 
oxygen is coordinated to cationic ruthenium catalyst form 4. A stronger positive charge 
build-up on the carbonyl carbon 4 by electron withdrawing group induces fast C-H 
activation via transition state 5, and forms cationic ruthenium carbonyl hydride species 6. 
On the other hand, electron donation group on para-substituted benzaldehyde reduces the 
positive characteristic on the carbonyl carbon. It facilitates C-H activation of 7 slower via 
transition state 8, and forms cationic ruthenium carbonyl hydride species 9 (Scheme 4.5 
bot).  
 




Another possible mechanistic pathway that can result in positive -value from 
Hammett study is through the migratory acyl insertion (Scheme 4.6). A stronger positive 
charge build-up on carbonyl carbon by electron-withdrawing groups 10 is prone to be fast 
carbonyl insertion by nucleophilic metal-carbon bond over 13. As a result, Ru-alkoxy 
specie 11 are generated more likely over 14. Then, -hydrogen elimination forms 
Markovinikov selective ketone product 12 over 15 (Scheme 4.5).  
 
Scheme 4.6: Migratory Acyl Insertion Pathway 
Both mechanisms (Scheme 4.5 and 4.6) are explained by the promotional effect 
from a positive charge built up on carbonyl carbon. However, deuterium isotope effect 
suggested the rate determining step involve aldehydic C-H activation. The first mechanism 
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(Scheme 4.5) undergoes oxidative addition of aldehydic C-H bond, but the second 
mechanism (Scheme 4.6) involves beta hydrogen elimination which is generally 
considered as a fast step. Thus, the migratory acyl insertion pathway can be ruled out, and 
the oxidative addition of aldehyde C-H activation mechanism is more suitable for 
intermolecular Markovnikov selective hydroacylation reaction.   
4.5.5 Characterization of Catalytically Relevant Ruthenium Complexes 
In order to detect the catalytically relevant intermediate species, we prepared the 
mixture of  1 (0.1 mmol), styrene (0.1 mmol) and 13C-enriched benzaldehyde (0.1 mmol, 
99% 13C) in CD2Cl2 (0.5 mL) in a NMR tube. The mixture was heated at 90 
oC for 3 hours. 
The mixture was cooled down to room temperature for NMR analysis. Initially, we 
monitored the disappearance of starting materials, styrene (0.1 mmol) and 13C-enriched 
benzaldehyde. Instead, multiple broad carbonyl peaks coordinated to Ru catalyst were 
observed by 13C{1H} NMR spectrum at the room temperature. To investigate these 
carbonyl peaks deeply, we analyzed the sample again at -40 oC by 13C{1H} NMR spectrum. 
We detected the a distinctively upfield-shifted doublet carbonyl peak at 196.5 (d, Jpc =  18.4 
Hz) ppm (Scheme 4.8) which does not show any neighboring protons as confirmed by 2D 
NMR techniques. Additionally, a small amount of ethylbenzene was observed in the 
reaction mixture (10 %). Thus, we tentatively assigned the structure as a Ru-acyl complex 




Scheme 4.7: Catalytically Relevant Ruthenium Complexes Detected by VT NMR 
 
Scheme 4.8: Detected Ruthenium Acyl Species 16 by 13C{1H} NMR 
4.5.6 H/D Exchange Experiment 
Next, we examined the deuterium labeled hydroacylation product to examine 
hydrogen-deuterium exchange pattern. The coupling product (91% isolated yield) was 
isolated from the reaction mixture of benzaldehyde (98% D, 0.5 mmol), styrene (0.6 mmol), 
and 1 (5 mole %) in toluene (2 mL) at 125 oC after 8 h (eq 4.9). The isolated product was 
analyzed by 1H and 2H NMR (Figure 4.3). The analysis result showed deuterium 
incorporations (14, 42, 30 %) at α-, β-carbon, and ortho-arene of isolated product, 1,2-
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diphenyl-1-propanone, in Figure 4.3. A 10 % of deuterium was slipped through styrene 
dimer byproduct. We observed a relatively high amount of deuterium incorporation to -
carbon position. This high incorporation indicates the facile hydride migration toward the 
terminal carbon.  
  
 
Figure 4.3: 1H and 2H NMR spectra of the the isolated product 3a after 8 h of reaction 
time 
From the deuterium labeling study, we could elucidate two possible mechanistic 
pathways (Scheme 4.9 and 4.10). From previous deuterium isotope effect results, the 
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activation of aldehydic C-H bond is likely the rate determining step of hydroacylation 
reaction. Thus, we could assumed the first step of mechanistic pathways is the C-D 
activation of aldehyde-d1 17 (Scheme 4.9). Then, alkene coordinates to cation acyl 
ruthenium deuteride species form 18.  Alkene insertion of 18 forms 19 and 20. Reductive 
elimination of 19 and 20 generates ketone products. Many reports proposed this mechanism 
to explain the formation of linear (Anti-Markovnikov) selective hydroacylation products.1 
The transition metal catalyst adopts sterically less demanding intermediate 20 over 
intermediate 19. Thus, the selective formation of 20 undergoes the reductive elimination 
to generate the linear selective ketone product 21. However, we do not observe the linear 
selective hydroacyaltion product 21 in the most of cases. This mechanism pathway does 
not matched with our observation. This mechanism is ruled out.  
 
Scheme 4.9: Possible Mechanism via Alkene Insertion to Hydride 
The second pathway is more consist with our observation (Scheme 4.10). The first 
step of the second pathway is the oxidative addition of aldehydic C-H. Alkene coordinates 
to cationic ruthenium catalyst leads to 23. This intermediate 23 undergoes alkene insertion 
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step via 24a and 24b to form 25 and 27. In the view point of steric consideration, ruthenium 
catalyst prefers sterically less demanding intermediate 25 over 27. Then, another aldehyde 
undergoes oxidative addition and reductive elimination of 25 forms a branch selective 
ketone 26 and active catalytic species 16. This mechanistic hypothesis is consisted with 
deuterium isotope effect and deuterium labeling study (facile deuterium incorporation on 
terminal carbon 26). Also, we observed small amount of ethylbenzene which play as the 
hydrogen acceptor during the reaction. This experimental data supported the second 
mechanistic pathway.     
 
Scheme 4.10: the Possible Mechanism via Alkene Insertion to Acyl 
4.5.7 Proposed Mechanism 
We proposed a plausible mechanism of the Markovnikov selective hydroacylation 
based on these experimental results. The first step of this reaction is the formation of 
catalytically active ruthenium acyl species 16 by sequential alkene coordination, aldehydic 
C-H activation, and the reductive elimination steps. We detected ethyl benzene in crude 
reaction mixture by 1H NMR which abstracts hydrides from cationic ruthenium catalyst 1 
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and aldehydic proton. We observed ruthenium acyl species 16 in the stoichiometric 
reaction of 1 with benzaldehyde and styrene by 13C{1H} NMR at -40 oC. This provides a 
strong evidence for the acyl complex as a catalytically active species. Also, the ruthenium-
acyl complexes has been reported as a key intermediate in hydroacylation and 
carbonylation of olefins.6,7 Then, alkene coordinates ruthenium acyl species 16 to form 
alkene coordinated ruthenium acyl complex 29. Migratory alkene insertion generates a 
five-membered ruthenium (II) species 30. This step is the regioselective determination step 
from deuterium labeling study. H/D isotope labeling study shows high quantity of 
deuterium incorporation on β-position of hydroacylation product indicates olefin insertion 
toward a branch structure 30 is more favorable than that toward a linear structure. Then, 
oxidative addition of benaldehyde C-H bond forms ruthenium (IV) acyl species 31.  Both 
the deuterium isotope effect and Hammett studies support that the aldehyde C–H activation 
is the turnover limiting step of the catalytic cycle. A similar mechanism oxydative addition 
have been reported as a rate determining step.5 Then, subsequent reductive elimination of 





Scheme 4.11: Proposed Mechanistic Pathway for the Hydroacylation of Styrene with an 
Aldehyde 
4.6 Conclusions 
In conclusion, we have developed a highly Markovnikov-selective intermolecular 
hydroacylation reaction for the aryl-substituted alkene to form branch ketones by using a 
well-defined cationic ruthenium catalyst. Compared to recent articles in the area of 
Markovnikov-selective intermolecular hydroacylation reaction, our catalytic method has 
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the broadest substrates scope from aliphatic to benzylic aldehydes without using chelate 
directing groups. Additionally, the synthetic utility of our intermolecular Markovnikov 
selective hydroacylation demonstrated the coupling products of simple molecules 
(propanal) to highly bioactive molecules (vinyl estrone, bis(2-formylphenyl)ether). Also, 
our protocol is the first intermolecular hydroacylation which utilized highly useful styrene. 







5 Transition Metal Catalyzed C(sp3)-H Activation and Functionalization 
Reaction 
5.1 Overview of Transition Metal Catalyzed C(sp3)-H Activation and 
Functionalization Reaction 
The direct C-H bond activation and functionalization is one of the most powerful 
synthetic strategies for the construction of complex organic molecules.1 In the past decades, 
extensive C(sp2)-H activation reaction of arenes and alkenes have led to significant 
progress and achievements.1 In contrast, catalytic methods for saturated C(sp3)-H 
activation and functionalization reactions have been much less progressed. Generally, the 
activation and functionalization of sp3 C-H bonds are more difficult due to the lack of 
electron rich π-bonds which can interact with transition metal catalysts. In this regards, the 
design of transition metal catalyzed C-C bond couplings via unreactive C(sp3)-H bond 
activation becomes one of the most challenging and important topics in the field of 
homogeneous catalysis.2  Since Hartwig reported the pioneering work on  a highly effective 
C(sp3)-H borylation of alkanes by using a Rh catalyst,4 many clever strategies have been 
devised to activate sp3 C-H bond. Those strategical descriptions will be surveyed in this 
chapter.  
5.1.1 Catalytic C(sp3)-H Activation and Borylation  
Hartwig’s group reported the C(sp3)-H activation of alkanes by using 
stoichiometric amount of transition metal-boryl complexe 1 (Scheme 5.1).4 A highly 
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selective terminal alkyl boronate ester 2 was generated as a result of the reaction. Iron-, 
ruthenium-, and tungsten-boryl complexes 1 were found to activate the terminal C(sp3)-H 
bond of saturated hydrocarbons to form the corresponding linear alkylboronate 2. The 
borylation with tungsten-boryl complex gave the highest yield (85 %) of product 2 (Scheme 
5.1). The organoborane products 2 are considered to be an important synthetic precursor 
for organic synthesis.4  
 
Scheme 5.1: Stoichiometric Dehydrogenation of Alkanes by Hartwig  
Hartwig’g group successfully developed the catalytic C(sp3)-H activation of saturated 
hydrocarbons under thermal conditions by using a rhodium catalyst, Cp*Rh(η4-C6Me6), 3 
(eq 5.1).5 The reaction of a diboron reagent and octane (solvent) in the presence of 3 (5 
mol %) at 150 oC for 5 hours led to the selective formation of the linear alkylborane product 
4 and a minor pinacolborane byproduct 5 (eq 5.1).  
The isolated intermediate 5 from eq 5.1 reacted with octane in the presence of Rh catalyst 




The proposed catalytic mechanism is shown in Scheme 5.2.5(d) The initial step of the 
proposed mechanism is the dissociation of hexamethylbenzene and the open coordination 
sites of rhodium catalyst caused the sequential oxidative additions of borane or diboron 
compounds to catalyst 3. The catalytically active hydridorhodium boryl complex 6 is 
generated as a result. The reductive elimination of rhodium species 6 generates X-Bpin and 
a coordinatively unsaturated rhodium-boryl species 7. The unsaturated rhodium species 7 
undergoes the oxidative addition of terminal alkane C(sp3)-H bond to generate the alkyl 
rhodium boryl complex 8. The reductive elimination of 8 releases the product (R-Bpin) 
and rhodium hydride complex 9. Then oxidative addition of borane or diborance compound 
generates the active catalyst 6 and completes the catalytic cycle.5(d)    
 
Scheme 5.2:  Proposed Catalytic Cycle of C(sp3)-H Borylation 
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Hartwig’s group extended the scope of saturated hydrocarbons by using the rhodium 
catalyst and diborane.5(c) The borylation reaction of saturated hydrocarbons with (B-pin)2 
was carried out with saturated hydrocarbons containing nitrogen, oxygen, and fluorine 
group (Table 5.1). Hartwig’s group reported the similar borylation reaction by using 
iridium catalyst in 2007.6  
Table 5.1: Rhodium Catalyzed C(sp3)-H Borylation with Diboron Compound  
 
5.1.2 Catalytic C(sp3)-H Activation Reaction with Pyridine Directing Group  
Daugulis’ and coworkers achieved the sp3 C-H activation and functionalization 
reaction of a pyridine directing group containing saturated hydrocarbons by using a Pd(II) 
catalyst.7 The report showed mostly arene C(sp2)-H activation and functionalization 
reaction, but one example comes with C(sp3)-H activation reaction of saturated 
hydrocarbon containing a pyridine direction group (eq 5.3).7(a) The 2-ethylpyridine 10 
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reacted with 4-iodotoluene in the presence of Pd(OAc)2 and silver acetate to generate the 
C(sp3)-H functionalized product 11 at 130 oC after 47 hours. In this report, the authors 
briefly mentioned a plausible Pd(II)/Pd(IV) mechanistic pathway. Later, this mechanism 
was proved by the extensive mechanism study, which was reporeted in 2010.7(c) The 
mechanistic insight of C(sp3)-H will be discussed later in this chapter.  
 
Yu’s group disclosed similar C(sp3)-H activation protocols in assistance of a 
pyridine directing group by using Pd(II) catalyst (eq 5.4).9 Alkanes containing pyridine 
directing group 12 readily reacted with either methylboroxine or alkylboronic acids in the 
presence of Pd (II) catalyst and an oxidant (benzoquinone or silver oxide) to form C(sp3)-
H alkylated product 13. The coupling reaction of alkane with methylboroxine showed good 
functional group compatibilities with ether, ester, and alcohol groups. However, the 




Yu’s group sequentially discovered the enantioselective C(sp2)-H arene alkyl 
coupling protocol by using a chiral palladium catalyst composed of monoprotected chiral 
amino acid ligand 15 (Scheme 5.3). In this report, only one was the enantioselective C(sp3)-
H  alkylation example out of many C(sp2)-H arene alkylation coupling examples (Scheme 
5.3). This example was the first enantioselective C(sp3)-H bond activation and 
functionalization reaction of saturated hydrocarbons by using a chiral transition metal 
catalyst. The reaction was carried out with a chiral palladium catalyst and a 
cyclopropanecarboxylate ligand 15. The yield and enatioselectivity of the coupling product 
14 was 38 % and 37 % respectively.   
 
Scheme 5.3: Enantioselective C(sp3)-H Coupling Reaction by Yu’s Group 
5.1.3 C(sp3)-H Activation Reaction Containing Amide and Carboxylic Acid 
Directing Group  
Daugulis extended the substrate scope of the previous C(sp3)-H bond activation 
reaction shown in eq 5.3 by using the same Pd(II) acetate (eq 5.5 and 5.6).7(b)-(d) This 
reaction used picolinamide as a directing group. The reaction of picolinamide alkene 16 
with aryl iodine led to the -arylation on amine derivatives 17 in neat condition (eq 5.5). 
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The reaction of 8-aminoquinoline amide 18 and aryl iodide afforded -arylation of 
carboxylic acid derivatives 19 (eq 5.6).  
 
The regioselectivity of two different products 17 and 19 came from the preferential 
formation of amine coordinated five membered palladium complexes 20 and 22 (Scheme 
5.4). After this step, oxidative addition of aryl halide to the complexes 20 and 22 is 
expected to form 21 and 23. Then, further reductive elimination processes generate the 
corresponding products 17 and 19. Daugulis’s group screened the reaction with a couple 
of different halogenated arenes (benzene chloride, fluoride, and bromide). Only the 
reaction with iodoarene formed the aryl cross coupling product. The authors tried to 
elucidate the mechanism of sp3 C-H alkane activation and functionalization reaction, but 
they could not decide which oxidative addition steps, either Ar-I or C-H alkane, undergoes 
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first in this report.  Compared to other sp3C-H alkane activation protocols, high efficiency 
was achieved as shown by the maximum turnover number of 650 turnover with 0.1 mol % 
Pd catalyst loading.  
 
Scheme 5.4: Regioselectivity of Daugulis’ C(sp3)-H Activation 
The proposed catalytic mechanism was supported with the strong evidence of x-ray 
crystallography of two intermediates 25, 26 (Scheme 5.5). The first step of the catalytic 
cycle includes the formation of amine coordinated Pd(II) catalyst 24  from Pd(II) acetate 
by releasing acetic acid. The electrophilic C-H activation of 24 formed five membered 
palladium intermediate 25 by releasing another acetic acid. The oxidative addition of aryl 
halide (R-I) formed a Pd(IV) complex 26. Then, the reductive elimination of 26 formed 
Pd(II) iodide intermediate 27. Further substitution reaction by a starting material generated 
the product, and a base in the reaction extracted the iodine to completes the catalytic cycle.  
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Scheme 5.5: Proposed Mechanism for Daugulis’ C(sp3)-H Activation 
Yu’s group developed palladium catalyzed both o-C(sp2)-H activation in benzoic acid and 
β-C(sp3)-H activation in aliphatic acids.9(b) This protocol demonstrated the first example of 
carboxyl-directed Pd-catalyzed β-C(sp3)-H activation by using simple aliphatic acids 28 
(eq 5.7).  The reaction of alkane 28 coupled with aryl-I to form monoarylated product 29 




Authors briefly mentioned that the reaction undergoes via the possible mechanistic 
Pd(II)/Pd(IV) pathway (Scheme 5.6). Additionally, they proposed two key intermediate 
steps for the reaction mechanism. The first key intermediate step is a carboxy group 
directed Pd insertion of C(sp3)-H bond of aliphatic acid to form a Pd(II)(alkyl) species 31. 
The second key intermediate step involves the oxidative addition of aryl iodine to 31 
species to generate a Pd(IV)(alkyl) 32.9(b) 
 
Scheme 5.6: Two Key Intermediates 31 and 32 Proposed by Yu 
Yu’s group extended the substrate scope of the C(sp3)-H activation and functionalization 
reaction shown in eq 5.7. Instead of acetic acid as a directing group, a more strongly 
binding o-methyl hydroxamic acid 33 was applied as the directing group (eq 5.8). This 
carboxylic acid derivatives 33 can be readily converted to esters, amides, and alkanes by 
the redcution.9(c) Alkyl boric acid 34 was used as a coupling reagent. This boric acid can 
install both aliphatic and aryl moieties on β-C(sp3)-H of o-methyl hydroxamic acids to form 
sp3 C-H bond functionalized product 35. The reaction was carried out in a higher yield (61-




5.1.4 Other sp3 C-H Activation Reaction 
Fagnous et al reported a palladium catalyzed C(sp3)-H activation of alkane 36 with 
aryl bromide and chloride to form 2,2-dialkyldihydrobenzofuran 37 (Scheme 5.7).8(b) The 
reaction reached to a near quantitative yield. Additionally, the author conducted density 
function theory (DFT) calculation. They proposed that the C(sp3)-H activation undergoes 
via concerted metalation-deprotonation 38 (Scheme 5.7).8(a),(b) 
 
Scheme 5.7: Palladium Catalyzed C(sp3)-H Activation of Alkanes  
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Next year, Fagnou introduced the site selective arylation of C(sp2)-H aryl and C(sp3)-H 
alkyl on azine and diazine N-oxide substrates (Scheme 5.8).8(c) The selectivity of C(sp2)-H 
vs C(sp3)-H bond came from the nature of base. When using strong base such as NaOtBu, 
C(sp3)-H arylation was dominant 41.8(c),(d) When using weak base such as K2CO3, ortho-
arene C(sp2)-H activation and functionalization was dominant. Author explained the strong 
base such as NaOtBu and NaOH deprotonated the most acidic proton (benzylic proton) 39 
preferably. Then, activated benzylic carbon undergoes a coupling reaction to form the 
product 41 selectively over 40 (Scheme 5.8).  
 
Scheme 5.8: Site Selective C(sp2)-H and C(sp3)-H Arylation on Azine N-Oxide 
Substrates 
To confirm the deprotonation of benzylic hydrogen, the deuterium exchange study was 
carried out (Scheme 5.9). The alkyl of azine N-oxide substrate 39 was prepared in 1 
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equivalent of KOH and D2O solution and heated up at 55 
oC for 15 hours. The starting 
alkyl azine N-oxide 39 was recovered after the reaction and analyzed by both 1H and 2H 
NMR. The results indicated 19 % and 87 % deuterium incorporation on ortho C(sp2)-H  
and benzylic C(sp3)-H of azine N-oxide substrates (Scheme 5.9).8(d)  The results supported 
the notion on preferred deprotonation on benzylic hydrogen over the deprotonation on 
ortho C(sp2)-H arene.    
 
Scheme 5.9: Deuterium Labeling Study of Azine N-oxide Substrate 
The report proposed a mechanism on both arylation of C(sp2)-H aryl and C(sp3)-H alkyl 
compounds. However, only the mechanism of C(sp3)-H activation and functionalization 
reaction will be described  here (Scheme 5.10).8(d) The first step is the oxidative addition 
of aryl halide to Pd(0) catalyst to generate a Pd(II) aryl halide intermediate 43. Then, a 
strong base deprotonates the benzylic hydrogen of N-oxide moiety to afford the five 
membrane palladium (II) intermediate 44. The reductive elimination of 44 releases the 
product 41 and the active catalyst Rh(II) acetates. That completes the catalytic cycle of 




Scheme 5.10: Proposed Mechanism of C(sp3)-H Arylation on Azine and Diazine N-oxide 
Substrates 
5.1.5 Limitations and Challenges on Catalytic sp3 C-H bond Activation and 
Functionalization Reaction 
As described on sp3 C-H activation strategies in the previous section, the substrate 
scope of the direct C(sp3)-H activation and functionalization reactions was limited to the 
directing groups containing substrates such as pyridine derivatives and carboxylic acid 
derivatives. Also, the C(sp3)-H activation site was limited to β and -carbon of carboxylic 
acids or nitrogen groups. Turnover number of most sp3C-H activation and functionalization 
reaction was not practical. In addition, the reaction required various oxidants, cocatalysts, 
strong bases and other additives under harsh condition. 
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5.2 Transition Metal Catalyzed Alkane Dehydrogenation Reactions 
The dehydrogenation of saturated hydrocarbons constitutes an effective way to 
activate C(sp3)-H bonds. This catalytic method does not require any activation groups, and 
shows high atom economy compared to other sp3 C-H activation methods.14 The pioneering 
work on the dehydrogenation of alkanes came from Crabtree’s report in 1979 (Scheme 
5.11).15 The stoichiometric amount of cationic iridium complex 
{[IrH2(acetone)2(PPh3)2][BF4]} 45 was used for the dehydrogenation of cyclopentane or 
cyclooctane (COA) to form the corresponding cationic cyclopentadiene iridium complex 
46 or cyclooctadiene complex 47 in the presence of tert-butylethylene (TBE). TBE was 
used as a sacrificial hydrogen acceptor for the dehydrogenation.15 Felkin’s group reported 
similar stoichiometric dehydrogenation reaction by using (PPh3)2ReH7.
16  
 
Scheme 5.11: Crabtree’s Dehydrogenation of Alkanes 
Felkin reported the first transition metal catalyzed dehydrogenation of alkane in 1983.16(a) 
Furthermore, Felkin and Carbtree advanced on the dehydrogenation of alkanes with 
iridium bis(trialkyphosphine) complexes.16,17 Crabtree and coworkers developed the 
acceptorless dehydrogenation of alkanes by using IrH2(O2CR)(PCy3). For the acceptorless 
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dehydrogenation system, Aoki and Crabtree applied the reflux system to remove hydrogen 
gas constantly. That system gave up 36 turnover number for the dehydrogenation of 
cyclooctane in 48 hours.18 The decomposition of iridium catalyst caused at high reaction 
temperature (150-180 oC), which limited the turnover number of dehydrogenation reaction. 
Later Goldman19, Jensen20, Saito21, Brookhart22, and Huang23 developed robust 
dehydrogenation reactions of alkanes by using pincer ligated Ir and Rh transition metal 
catalysts.1-3 However, these Ir and Rh pincer type catalyst are generally not working with 
the dehydrogenation of heterocycles due to their poor functional group tolerance. Recently, 
Yi’s group reported the dehydrogenation of saturated hydrocarbon by using robust tetra 
ruthenium catalyst.24 Jones reported cobalt and iron catalyzed dehydrogenation of 
alkanes.25 Among many dehydrogenation system introduced above, few representative 
systems are described in this chapter.  
5.2.1 Dehydrogenation of Saturated Heterocycles 
Huang group reported a dehydrogenation protocol of alkanes in 2014 by using 
PSCOP-type Ir(III) pincer complex 49 (Table 5.2). The stability of Huang’s PSCOP-pincer 
iridium catalyst 49 was compared with that of Brookhart’s POCOP-pincer iridium catalyst 
48 (Table 5.2). Turnover number of 48 and 49 was 1186 and 485 respectively after 10 min. 
The turnover number of Brookhart’s Ir catalyst did not improve much after 30 min. 
However, the turnover number of Huang’s PSCOP-pincer iridium catalyst 49 was 
continuously improved (Table 5.2). Brookhart’s Ir catalyst 48 was more active than 
Huang’s Ir catalyst 49 at the beginning of the reaction within 30 min. However, the 
conversion of cyclooctane (COA) to cyclooctene (COE) was not improved after 30 min. 
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Low activity was caused by the decomposition of Brookhart’s Ir catalyst. This data 
indicated that Huang’s iridium catalyst 49 is more robust than the Brookhart’s catalyst 48. 
The maximum turnover number of cyclooctane (COA) dehydrogenation reached to 6000 
after 15 hour. Moreover, the dehydrogenation of an aliphatic alkane (n-octane) showed 
high turnover number up to 1211, and the dehydrogenations of various heterocycles were 
carried out.23         
Table 5.2: Dehydrogenation of Alkanes by Using Ir(III) Pincer Complexs 
 
The dehydrogenation of alkanes was carried out with first row transition metal 
catalysts. Jones’s group introduced the dehydrogenation of heterocycles by using 
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inexpensive and earth abundant transition metal catalysts (Scheme 5.12).25 Recently, the 
dehydrogenation reaction was carried out with iron pincer catalyst 50 and cobalt pincer 
catalyst 51.32(a),(b)  The both dehydrogenation reactions without hydrogen acceptor showed 
the turnover number of 30 and 10 with iron and cobalt catalysts respectively.    
Scheme 5.12: Dehydrogenation of Heterocycles by Using Inexpensive and Earth 
Abundant Transition Metal Catalysts 
5.3 Tandem Dehydrogenation and Functionalization Reaction 
Over the past decades, much research has been focused on the development of 
greener chemistry by using well-defined transition metal catalysts.26 One of the highlighted 
solutions is the one-pot tandem process which replaces the multistep reactions to one 
synthetic operation with a single work process.27 The one-pot tandem reaction circumvents 
the need of solvents for the multiple steps reaction and corresponding isolations processes. 
The reduction of solvent use leads to the same reduction effect on the formation of wastes. 
Additionally, minimizing isolation processes and multiple reaction steps results in 
lowering energy, time, and labor that required for the conventional multistep reactions.27,28 
The main challenge of the tandem reaction involves the tuning of catalyst compatibility 
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with substrates and the catalysts from preceding steps.28 Even with these difficulties, much 
research effort has been devoted to develop the tandem processes due to significant 
advantages over the conventional step-by-step approaches.27,28  One of the important topics 
is the tandem sp3 C-H activation and functionalization of inexpensive saturated 
hydrocarbons.1-3  As discussed in previous chapters, much effort on the activation of 
unreactive hydrocarbon have been devoted. Among many progresses on sp3 C-H bond 
activation, the dehydrogenation of alkane reaches to the practical level closely. One 
example of the tandem heck type reaction is introduced in this chapter. Additionally, there 
were several attempts to manipulate the dehydrogenation reaction into tandem catalysis 
process. The efficient and environmental friendly tandem dehydrogenation and 
functionalization is introduced afterward. Herein, we are going to focus on two important 
topics, tandem reaction and dehydrogenation of saturated hydrocarbon in this chapter.  
5.3.1 One-pot Tandem Tetraheterocyles for the Formation of Linear 1,6-
Dienes  
Hu30 reported the synthesis of tricyclic lactam 55 from linear 1,6-diene 52 
containing acyl group through three cascade Heck type of reactions (Scheme 5.13). The 
reaction begins with oxidative addition of an aryl bromide to palladium catalyst. The alkene 
coordinated palladium (II) catalyst undergoes migratory alkene insertion to form the 
intermediate 53. A second Heck reaction by alkene insertion step generates intermediate 
54. This intermediate 54 activates ary C-H bond and reductive elimination forms product 
55.30 This tandem heck reaction is one of the examples that contains the advantage of 




Scheme 5.13: The Example of Domino (Cascade) Catalysis 
5.3.2 Tandem Dehydrogenation and Olefin Metathesis Reaction 
Majority amount of hydrocarbons is produced from natural sources and 
conventional alkane production (Fischer-Tropsch production). Unfortunately, the 
molecular weight of alkane are varied from C1 to C19. (Any products longer than C19 chain 
length are hydrocracked to lower weight hydrocarbon between C3 and C8.) The range of 
desired fuel product is from C9 to C19. These chain length hydrocarbons give 30 % more 
efficient energy combustion than gasoline. The conversion of these low weight alkanes to 
desired fuel products is a challenge of tremendous importance. One approach to this 
challenge is alkane metathesis. Both Brookhart and Goldman’s group reported an one pot 
alkane dehydrogenation-olefin metathesis to overcome this problem (Scheme 5.14).32 The 
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first reaction of this-one pot catalysis is the dehydrogenation of alkane 58 to form alkene 
59 by using Ir pincer catalyst 56. The alkene 59 undergoes metathesis reaction to form two 
different alkenes 60, 61 by using metathesis catalyst 57. Then, hydrogenation of these 
alkenes 60, 61 generated the corresponding products 62 and 63. 
 
Scheme 5.14:  Tandem Dehydrogenation and Metathesis Catalysis via Iridium Pincer Type 
and Schrock Type Catalysts 
This tandem dehydrogenation and metathesis is very challenge to be achieved due to the 
compatibility between catalysts and the selectivity of a product. Brookhart and Goldman’s 
group screened the various combinations of dehydrogenation and metathesis catalysts for 
the compatibility. Iridium based pincer complexes 56 were selected for a dehydrogenation 
reaction catalyst. Shrock-type catalysts 57 and Grubbs-types catalysts were chosen for a 
metathesis catalyst. During the screening process, they found Grubbs-type catalyst 
deactivated the iridium based dehydrogenation catalysts, but Schrock type catalysts. Thus, 
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Schrock type catalysts 57 were selected for further screenings with iridium based pincer 
catalysts.  
Another challenge of this one-pot tandem dehydrogenation-metathesis reaction was the fast 
isomerization reaction of alkenes by transition metal catalysts. In the case of the coupling 
reaction between two 1-hexenes, the desired product from metathesis is n-decene 60 and 
ethene 61 (Scheme 5.14 top). However, the isomerization reaction of alkenes prior to 
metathesis resulted in various fragmentations of hydrocarbons (Figure 5.15 bottom).  
Scheme 5.15: Product Formation from One-pot Tandem Dehydrogenation-metathesis 
Reaction 
The previous report from Goldman’s group surveyed many Ir pincer type catalysts to 
minimize the alkene isomerization reaction. They found that sterically demanding 
dehydrogenation Ir catalyst [(tBuPCP)Ir] 57 prefer to form kinetically selective 
dehydrogenation at the terminal position of n-alkanes over less sterically demanded 
catalyst such as (tprPCP)Ir.51 From long screening processes, they found that the 
combination of 56 and 57 gave the highest 50 % total C7-C10 products (Scheme 5.15). Even 
though the selectivity of desired products in this tandem reaction was poor, the idea is 
considered as a crucial pinpoint for the tandem dehydrogenation metathesis reaction. 
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Moreover, the turnover number of one-pot tandem catalysis was limited by metathesis 
reaction. Usually, the dehydrogenation reaction required high temperature which caused 
the decomposition of metathesis catalysts. Thus, more robust metathesis catalyst and active 
dehydrogenation catalyst are needed for higher turnover number.     
5.4 Results and Discussion of the Tandem Dehydrogenation-Alkylation 
Reaction of Saturated Hydrocarbons with Alcohols 
5.4.1 Introduction of the Tandem Dehydrogenation-alkylation Reaction of 
Saturated Hydrocarbons with Alcohols 
Previously, our group reported a dehydrogenation reaction of alkanes by using a 
tetranuclear ruthenium-μ-oxo-μ-hydroxo-hydride catalyst 63 (Schem 5.16). The substrate 
scope was broad ranging from unreactive cyclic hydrocarbon to various saturated 
heterocycles (Table 5.6). Our tetra-ruthenium catalyst 63 showed high reactivity toward 
both saturated hydrocarbons and heteroatom hydrocarbons which has a distinctive 
advantages over the pincer-Ir catalysts. Moreover, the maximum turnover number of 




Scheme 5.16: Dehydrogenation of Cyclooctane 
After this report, Yi’s group reported a series of dehydrative C-H alkylation reactions of 
unsaturated hydrocarbons and heterocycles with alcohols (Scheme 5.17).24(b),(c)  The 
alkylation reaction of alkenes with alcohols was carried out in chlorobenzene solvent at 
75-110 oC (Scheme 5.17 Top), while the alkylation reaction of phenols and alcohols was 
carried out in toluene solvent at 100 oC (Scheme 5.17 Bottom).  
 
Scheme 5.17: Catalytic C-H Alkylation Reaction of Alcohols to Unsaturated 
Hydrocarbons and Heterocycles with Alcohols 
Since tetranuclear ruthenium-hydride complex 63 is the precursor for the cationic 
ruthenium hydride 64, we reasoned that one-pot dehydrogenation and alkylation reaction 




5.4.2 Optimization of Tandem Dehydrogenation-alkylation Reaction of 
Saturated Hydrocarbons with Alcohols 
Cationic ruthenium hydride complex 64 was synthesized from the reaction of tetra-
ruthenium catalyst 63 and 5 equivalents of HBF4·OEt2 in benzene solvent. The alkylation 
reaction of alkene and alcohol was carried out in chlorobenzene solvent. To achieve tandem 
dehydrogenation and alkylation reaction, the cationic ruthenium catalyst 64 was 
synthesized in chlorobenzene solvent. Thus, we tested the compatibility of tetraruthenium 
catalyst 63 with various solvent systems. We synthesized the cationic ruthenium hydride 
catalyst in different solvent system. Tetraruthenium catalyst 63 (9 mg, 0.01 mmol) was 
dissolved in various solvents first, and HBF4·OEt2 (10 mg, 0.05 mmol) was added in the 
reaction mixture. The reaction mixture was stirred for 15-20 min until the solution changed 
to yellowish color. The solution mixture was recrystallized and analyzed by NMR method. 
The isolated catalyst was solvent coordinated cationic ruthenium catalysts 64 (eq 5.9). 
However, catalytic solution prepared in chloroform and dichloromethane did not show any 
distinctive color change (remained as red, the color of tetraruthenium catalyst) after 2 hour 
of stirring the mixture. The catalytic activity of in-situ generated ruthenium catalysts in 
chlorobenzene was further tested for the alkylation reaction without a work up process 
(Table 5.3). Cyclooctene (160 mg, 1.5 mmol) and 4-methoxybenzyl alcohol (138 mg, 1.0 
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mmol) were added into the reaction solution and heated at 100 oC for 6 hours. After that, 
the reaction mixture was quenched by liquid nitrogen and analyzed by GC, GC-MS, and 
NMR. Cationic ruthenium catalysts 64 synthesized from toluene, benzene, and 
chlorobenzene showed high activity (83-89 %) toward the alkylation reaction. However, 
cationic ruthenium catalysts generated in chloroform and dichloromethane showed high 
conversion (90 % of starting materials was consumed within 1 h), but with very low 
selectivity (20-33 %).  
Table 5.3: Screening of the Cationic Ruthenium Hydride Catalyst in Various Solvent 
Systema  
 
aReaction condition: tetra ruthenium catalyst 63 (10 mg, 0.01 mmol), HBF4·OEt2 (10 mg, 
0.05 mmol), cyclooctene (160 mg, 1.5 mmol), 4-methoxybenzyl alcohol (138 mg, 1.0 
mmol), solvent (2 mL), reaction time (12 h). 
With the optimized conditions in hand, we further explored the alkylation of 
phenols with alcohols. 1-Naphthol (140 mg, 1.5 mmol) and 4-methoxybenzyl alcohol (138 
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mg, 1.0 mmol) were added into the reaction solution and heated at 100 oC for 6 hours. After 
that, the reaction mixture was quenched by liquid nitrogen and analyzed by GC, GC-MS, 
and NMR. Cationic ruthenium catalysts synthesized from toluene, benzene, and 
chlorobenzene showed high reactivity (88-92 %) toward the alkylation reaction of arene 
with alcohol (Table 5.4).  
Table 5.4: Screening of the Cationic Ruthenium Hydride Catalyst in Various Solvent 
System  
 
aReaction conditions: tetraruthenium catalyst (10 mg, 0.01 mmol), HBF4·OEt2 (10 mg, 
0.05 mmol), cyclooctene (160 mg, 1.5 mmol), 4-methoxybenzyl alcohol (138 mg, 1.0 
mmol), solvents (2 mL), reaction time (12 h) 
We next examined the reaction mixture of 5 mmol of cyclooctane (COA) and 5 
mmol of tert-butylethylene with 0.1 mol % of 63 which was prepared in neat condition. 
The reaction mixture was totally immersed in an oil bath which was preset at 200 oC. The 
hydrogen gas generated from the reaction tube was periodically removed by simply 
opening the reaction tube. After the dehydrogenation reaction reached the maximum 
turnover number, the reaction mixture was quenched in liquid nitrogen. The sacrificial 
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amount of sample was taken for the dehydrogenation reaction progress. The maximum 
turnover number for the dehydrogenation reaction of cyclooctane reached to 320 at 180 oC 
after 8 hours. To get the optimal condition of dehydrogenation reaction, we reconstructed 
the dehydrogenation reaction table (Table 5.5). The turnover number of reactions was 
similar to what have reported previously.24 Among all substrates, 1-tetralone, 2-tetralone, 
1,2-dihydrobenzofuran, and indole derivatives were converted to the corresponding arene 
products without a hydrogen acceptor (Table 5.5).  





Table 5.5: Cont.. 
 
aReaction condition: alkane (5 mmol), TBE (5 mmol), reaction time (2-12 h), neat 
condition. 
For the second alkylation reaction, degassed anhydrous chlorobenzene was added 
into the crude reaction mixture (Scheme 5.18). HBF4·OEt2 (10 mg, 0.05 mmol, 0.5 mol %) 
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was added and stirred in the reaction mixture for 15-20 min to activate the complex 63. 
The solution color was changed to brown-yellowish. Then, excess amount (1.2–1.5 equiv 
based on the cyclooctene generated) of 4-methoxybenzyl alcohol (550 mg, 4 mmole, 1.3 
equiv based on cyclooctene) was added. The reaction tube was heated in an oil bath preset 
at 120 oC. After 8-16 hours of the reaction time, the reaction mixture was quenched, and 
the product mixture was analyzed by GC and GC-MS. We were able to easily isolate the 
coupling product 65 of 4-methoxybenzyl alcohol and cyclooctene by a simple column 
chromatography on silica gel. Total turnover number (284) was calculated based on the 
isolated product 65.  
 
Scheme 5.18: Tandem Dehydrogenation and Alkylation of 4-Methoxybenzyl Alcohol 
with Cyclooctane 
We extended the substrate scope of the tandem reaction. We constructed tandem 
dehydrogenation and alkylation reaction of α-tetralone with 4-methoxybenzyl alcohol 
(Scheme 5.19). The first dehydrogenation reaction was performed with the previously 
established dehydrogenation procedure. The turnover number for dehydrogenation of α-
tetralone reached to 720. The second step of the andem reaction was carried out by 
previously established alkylation reaction procedure (Scheme 5.19). The major component 
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of this reaction was the alkylation product 65 (TON ~100), but we also observed the 
alkylation product 67 which was resulted from the reaction of 1-naphthol 66 and tert-
butylethylene and TBE.  
 
Scheme 5.19: Tandem Dehydrogenation and Alkylation of 4-methoxybenzyl Alcohol 
with -Tetralone 
To improve the turnover number for the tandem reaction of heterocycle, we 
exploered the different methods to circumvent the formation of alkene arene coupling 
product and other side products (Scheme 5.19). Instead of activating catalyst by HBF4·OEt2, 
cationic ruthenium catalyst 64 (2 mol %) was added directly after the dehydrogenation 
reaction (Scheme 5.20). The total turnover was improved dramatically from ~100 to 486. 
We used this alternative method to achieve high turnover number for the tandem alkylation 
reaction.  
 




5.4.3 Scope of the Tandem Dehydrogenation and Alkylation of Akanes and 
Alcohols 
We discovered an effective tandem dehydrogenation-alkylation reaction by using 
well established tetra-ruthenium catalyst 63 and cationic ruthenium catalyst 64 (Scheme 
5.21). With the optimized conditions in hand, we explored the substrate scope of the 
tandem dehydrogenation-alkylation reaction (Scheme 5.21). The dehydrogenated 
cyclooctane reacted with aliphatic and benzylic alcohols to form the corresponding 
products 65a-65b. We initially used 1-hexanol for the coupling reaction of cyclooctane 
with an aliphatic alcohol. However, we observed few different cross-coupling products in 
the reaction mixture due to alkene isomerization, which might have formed before or after 
the alkylation reaction. Instead of using 1-hexanol, 3-phenylpropanol was added after the 
dehydrogenation reaction. Fortunately, we only observed one major coupling product 65a. 
Similarly, in the coupling reaction of cyclooctane with benzylic alcohols, only one major 
coupling isomer was observed. Furthermore, we extended the substrate scope of the tandem 
reaction toward indan and tetrahydronaphthalene. These saturated cyclic hydrocarbons 
readily reacted with both aliphatic and benzyl alcohols to form the alkylation products 65c-
65g.  The extension on substrate scope toward heterocyclic substrates were performed. The 
tandem coupling of hydrobenzofuran led to the C1-alkylation product 65h. The 
dehydrogenated reaction of -tetralone and -tetralone are coupled with benzyl alcohols 
to afford ortho-alkylated phenol products 65k, 65m. However, the tandem reaction of 
cyclohexanone, -tetralone, and -tetralone with aliphatic alcohols did not give high 
selectivity of alkylation products. The reactions showed poor selectivity and turnover 
number of alkylation product 65 as shown in scheme 5.21. Generally, the reaction with 
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aliphatic alcohol and alkene required high temperature (>120 oC) than that of benzyl 
alcohol (100 oC).  
Yi’s group reported that the coordination of phenol derivatives on cationic 
ruthenium catalyst gave a different selectivity (hydrogenolysis) from the previous 
publication.99 In this regards, we applied the second method to generate the products 65i, 
65j, and 65l. Tandem reaction of indole with aliphatic and benzyl alcohol resulted in 
corresponding products 65n-65q. The alkylation of indoline with a chiral alcohol afforded 
the chiral indole product 65q efficiently. The catalytic method achieved a direct alkylation 
of saturated hydrocarbon substrates without using any reactive reagents or generating any 
toxic byproducts. The synthetic potential of the catalytic method has been successfully 
demonstrated from oxygen and nitrogen-containing substrates and from the use of readily 
available alcohols as the alkylating reagent. We achieved the tandem catalysis which 
replaced the two step reactions to one synthetic operation with a single workup process. As 
a result, we minimized the waste formation and solvent needs for the multiple step reaction 
and corresponding isolation processes.  














Table 5.6: Cont… 
 
aReaction conditions Dehydrogenation: hydrocarbon compound (5 mmol), TBE (5 
mmol), 63 (0.05 mol %), 140-200 °C, 2-12 h. Alkylation: alcohol (1-4 mmol), 
HBF4·OEt2 (0.5 mol %), C6H5Cl (2 mL), 100-120 °C, 12 h. Ar = C6H4-4-OMe.
 bReaction 
conditions Dehydrogenation: hydrocarbon compound (5 mmol), 63 (0.05 mol %), 140-
200 °C, 2-12 h. Alkylation: alcohol (1-4 mmol), 64 (2-3 mol %), C6H5Cl (2 mL), 100-
120 °C, 12 h.  
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5.5 Results and Discussion of the Tandem Dehydrogenation and 
Annulation Reactions 
5.5.1 Introduction of the Tandem Dehydrogenation and Annulation 
Reactions 
While surveying the tandem dehydrogenation and alkylation reaction, we observed 
the coupling product 67 from the reaction of 1-naphthol and tertbutylethylene (Scheme 
5.21). We investigated the coupling reaction between heterocycles and alkenes. The 
alkylation reaction of 1-naphthol with styrene was constructed as described in the 
following procedure. Firstly, we prepared the reaction mixture of tetraruthenium catalyst 
63 (1 mol %, 16 mg) and HBF4·OEt2 (5 mol %, 9 mg) in the anhydrous chlorobenzene (2 
mL). The reaction mixture was stirred at room temperature for 20 min to activate the 
catalyst 63. The color of mixture was turned to brown-yellowish. Then, 1-naphthol (1.0 
mmol), styrene (1.2 mmol) were added in the reaction solution. The reaction mixture was 
heated at 90-130 oC for 12 hours. The reaction mixture was analyzed by GC and GC-MS 
to confirm the coupling product. We observed the major component of styrene dimerization 
products at a high temperature (110-130 oC). We observed the cross coupling product at 
the low temperature (90-105 oC), but the styrene dimers was formed as dominant products. 
We could not avoid the formation of the styrene dimers without removing HBF4·OEt2. We 
performed control experiments to understand the alkylation reaction with HBF4·OEt2 
(Scheme 5.23). The reaction mixture with HBF4·OEt2 generated only styrene dimers, and 
we could not detect any cross coupling product. When both HBF4·OEt2 and cationic 
ruthenium catalyst 64 were used, we observed 1:9 ratio of cross coupling product and 
styrene dimers. The cross-coupling product 68 was generated as a major component 
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(>80 %) when only cationic ruthenium catalyst 64 was used in chlorobenzene. From this 
control experiment, we confirmed that HBF4·OEt2 generates styrene dimers which is 
competing with the formation of crossing coupling product in catalyst 64, and resulted in 
lower yield for the product 68.  
 
Scheme 5.22: Catalytic C-H Alkylation Reaction of 1-Naphthol  
To avoid the formation of styrene homodimers, we screened many reaction 
conditions such as temperature (90-130 oC), solvent system (toluene, benzene, 
chlorobenzene, dichloromethane, chloroform, dioxane) and additives (K2CO3, PPh3). The 
optimized conditions for the cross coupling reaction was 1-naphthol (1.0 mmol), styrene 
(1.2 mmol), cationic ruthenium catalyst 64 (3 mol %) in toluene at 120 oC for 12 hour. The 




We screened the reaction scope of various alkenes. Styrene derivatives such as 
styrene, 4-methylstryene, and 4-chlorostyrene, readily reacted with 1-naphthol to form 
corresponding products 68. However, the alkylation reaction of 1-naphthnol with alkynes 
and aliphatic alkenes including propene, 2-methyl propene, 1-hexene, vinyl propyl ether, 
and vinyl acrylate did not yield any coupling products. The coupling reaction of isoprene 
with 1-naphthol gave only annulation product 68 (eq 5.11).  We found that the reaction 
with dienes generally afforded highly selective coupling products. 
 
Next, we began to construct the tandem reaction from the dehydrogenation of 
tetralone (Scheme 5.24). We added HBF4·OEt2 (0.5 mol %) to activate tetraruthenium 
catalyst 63 into dehydrogenated reaction dissolved in anhydrous toluene solution. Then, 
the reaction mixture was heated at 120 oC for 12 h. After that, the reaction mixture was 
analyzed by GC, GC-MS. We observed many coupling products including dimers of 
isoprene, coupling products between TBE and isoprene, and the coupling products between 
TBE or isoprene and 1-naphthol. Also we applied catalyst 64 instead of using HBF4·OEt2 
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directly after dehydrogenation reaction. Similarly we observed the side products resulted 
from the coupling reaction of TBE and 1-naphthol.  
Scheme 5.23: Tandem Dehydrogenation and Annulation of -Tetralone and Isoprene 
Therefore, we applied dehydrogenation reaction without hydrogen acceptor to eliminate 
any coupling product of TBE and starting substrates (Scheme 5.25). The -tetralone (10 
mmol) was prepared with tetraruthenium catalyst 63 (0.1 mol %, 10 mg) in neat conditions. 
After the reaction mixture was heated at 180 oC for 12 h. It was quenched by liquid nitrogen. 
Cationic ruthenium catalyst 64 (3 mol %), and isoprene (4 mmol) were dissolved in toluene 
(2 mL), and the reaction mixture was heated for 12 h at 120 oC. The reaction mixture was 
analyzed by GC, GC-MS, and NMR. The turnover number of coupling product was 
calculated based on the isolated yield of the product.  
 
Scheme 5.24: Tandem Dehydrogenation and Annulation of -Tetralone and Isoprene  
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5.5.2 Scope of the Tandem Dehydrogenation and Annulation Reaction 
Next, we explored the substrate scope of tandem dehydrogenation-alkylation 
reaction (Table 5.10). The indoline derivatives were dehydrogenated without the acceptor 
(TBE). The dehydrogenated product readily reacted with styrene to form two regioisomers 
68a and 68aa. The major coupling product was a C-3-alkylation product 68a, and the ratio 
of major product 68a over minor product 68aa was 5:1 until total turnover number of both 
product of 244. The characterization of each product will be discussed in the next section. 
When the reaction of 4-vinyl-1-cyclohexene with indole was carried out, we only observed 
a single coupling product 68c with high turnover number 430. The reaction of -tetralone 
with styrene and indene generated corresponding coupling products 68e and 68f with the 
turnover number of 364 and 328 respectively. The tandem reaction of isoprene, 4-vinyl-1-
cyclohexene, and 2,5-dimethyl-2,4-hexadiene with -tetralone generated annulation 
products 68g, 68h, and 68i with turnover number of 310, 284, and 266 respectively. The 
characterization of annulation product 68h was discussed in the next section. We surveyed 
the tandem reaction of -Tetralone and alkenes and dienes. The tandem reaction of -
tetarlone with styrene and indene generated two different regioisomers. The ratio of two 
different isomers 68j and 68ja was 10:1. Total turnover of both products number was 308. 
The tandem coupling reaction of -tetarlone with indene resulted in two different 
regioisomers 68h and 68ha as 8 to 1 ratio. The total turnover number of both products was 
288. We performed the tandem reaction of -tetarlone with isoprene, 4-vinyl-1-hexene, 
and (+)-limonene to afford corresponding annulation products 68l-68na with turnover 
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numbers of 240 to 280. The characterization of 68j, 68k, 68m, and 68n are discussed in 
the next chapter.  





Table 5.7: Cont… 
aReaction conditions, Dehydrogenation: hydrocarbon compound (5 mmol), 63 (0.05 
mol %), 140-200 °C, 2-12 h. Alkylation: alcohol (1-4 mmol), 64 (2-3 mol %), C6H5Cl (2 
mL), 100-120 °C, 12 h. 
`We demonstrated a diverse synthetic pathway of saturated hydrocarbons by using 
tandem dehydrogenation-alkylation and -annulation reactions (Scheme 5.25). Our robust 
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tetraruthenium catalyst can tolerate both oxygen and nitrogen functional groups during 
dehydrogenation reaction. Additonally, in-situ generated cationic ruthenium catalyst by the 
addition of  HBF4·OEt2  or the direct addtion  of cationic ruthenium catalyst carried out the 
second alkylation or annulation reactions. The addition of substrates (alcohols, styrene, 
dienes) to the reaction mixture generates alkyaltion product 65 and 68.  
 
Scheme 5.25: Diverse Pathways for the Tandem Reactions 
5.5.3 Spectroscopic Determination of the Stereochemistry and Structure for 
Tandem Annulation Products 
We performed two dimensional NOESY experiment to determine the structure of 
the products 68a and 68aa. We analyzed the starting material by 1H NMR and 13C{1H} 
NMR. The peaks of C-2 and C-3 position on indole at  7.05 and 6.52 ppm and  124.3 
and 102.0 ppm were observed by 1H NMR (Scheme 5.24). The major component from the 
coupling product 68a between indole and styrene was analyzed by both 1H and 13C{1H} 
NMR. The C-3 peak ( 6.52 ppm by 1H NMR and  102.0 ppm by 13C{1H} NMR of major 
product 68a was disappeared. On the other hand, the C-2 peak of major product 68a was 
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still observed at  7.03 ppm by 1H NMR and  121.9 ppm on 13C{1H} NMR (Scheme 5.26). 
Thus, we confirmed the coupling reaction selectively occurred at C-3 position. For the 
minor product, the C-2 peak of 68aa was still observed at  6.48 ppm and  102.6 ppm by 
1H and 13C{1H} NMR. Therefore, we determined that the major coupling product is C-3-
alkylation product 68a and the minor product as C-2 alkylation product 68aa. The reaction 
of 4-vinyl-1-cyclohexene with indole was carried out. In this case, we only observed one 
coupling product 68c which contained the C-2 peak at  6.94 ppm and  122.7 ppm by 1H 
NMR and 13C{1H} NMR (Scheme 5.26) which was consisted with previous results.  
 
Scheme 5.26: Structural Assignment of Indole Coupling Products by 1H 
NMR and 13C{1H}NMR 
Next, we performed NMR analysis for the characterization of 68j and 68ja (Table 
5.10). We characterized 2-naphthol and both annulation products 68j and 68ja by 1H and 
13C{1H} NMR, 2D-NOESY NMR. The NMR data of 2-naphthol and both annulation 
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products 68j and 68ja described in Scheme 5.27. The C-4 hydrogen and carbon peak of 1-
naphthol and both 68j and 68ja were distinctive and intact (Scheme 5.22). These results 
indicated no C-4 coupling product on the tandem reaction. We compared the C-3 and C-1 
hydrogen and carbon peaks of each compound by both 1H, 13C{1H} NMR. In the case of 
68j, the proton peak on C-3 was determined clearly by 1H NMR. but C-3 carbon peak due 
to the presence of a similar carbon peak at  117.7 ppm on 13C{1H} NMR. We performed 
the two dimension NOESY experiment to assure the structure of 68j. We saw a cross peak 
between C-4 proton and ethylene positon CH3. It confirmed the major component 68j as 
C-3 activated alkylation product. For the coupling product 68ja case, both C-1 hydrogen 
and carbon peak of 68ja was disappeared on 1H, 13C{1H}-NMR. This structure was 
confirmed again by comparing with the literature data.  
 
Scheme 5.27: Structural Assignment of 2-Naphthol Coupling Product by 1H, 13C{1H}, 




Analogous analysis was applied to determine the structure of annulation coupling 
products 68l-68na. Similarly, the regioselectivity of 68l, 68m, and 68n were determined 
by both 1H, 13C-NMR (Scheme 5.28). C-3 and C-4 proton and carbon peaks were observed 
on three annulation products 68l, 68m, and 68n. Thus, we confirmed all annulation 
products as C-1-H activated annulation products.   
 




Next, we investigated the stereochemistry on the annulation products 68m and 68n 
(Scheme 5.29). We only found a benzofuran derivative 69 when we surveyed the literature 
for the similar benzofuran derivatives. We only found a benzofuran derivative 69. The 
report showed 1H, 13C{1H}, and 2D-NOESY NMR data of a compound 69. The peak of C-
3-hydrogen appeared on  3.09 (t, J = 5.6 Hz, 1H) ppm by 1H NMR. This cis conformation 
of C-3-hydrogen to methyl hydrogen did not show any coupling pattern. Only adjacent 
hydrogen coupling constant with C-3-H showed J = 5.61 Hz as a triplet. A cross peak 
between methyl proton and C-3-hydrogen was observed by 2D-NOESY NMR. That 
confirmed the benzofuran derivative as cis conformation. We analyzed the coupling pattern 
of C-3-H on both products 68m and 68n, which were  3.77 (m, 1H) and 3.74 (p, J = 3.1 
Hz, 1H) ppm respectively by 1H NMR. The coupling constants of C-3-H vs methyl group 
and between C-3-H vs adjacent hydrogens came out as J = 3.1 Hz, which came from the 
long range W-coupling constant (-1 to 3 Hz).36 Additionally, we performed 2D-NOESY 
NMR, which did not show any cross peaks on the products 68m and 68n between C-3-
proton and methyl peak or ethyl peak on C-2 carbon. That constructed a pentet splitting 
pattern from the triple of triples. The coupling pattern from 1H-NMR and resulted from 
2D-NOESY NMR on 68m and 68n were different than literature analysis data of 69.37 




Scheme 5.29: Determination of Stereochemistry of Annulation Products 68l and 68m 
5.5.4 Plausible Mechanism of the Tandem Dehydrogenation and Alkylation 
The mechanism of dehydrogenation reaction has been well established by 
Brookhart and Goldman’s review paper.1(h) The dehydrogenation reaction with 
tetraruthenium catalyst undergoes the similar reaction mechanism promoted by Ir pincer 
catalyst. The first step of the dehydrogenation reaction is TBE insertion to tetraruthenium 
catalyst 63 to form 70. The reductive elimination of complex 70 forms catalyst 71 and TBA. 
Coordinately unsaturated tetraruthenium catalyst 71 undergoes C(sp3)-H bond activation 
of COA to generate complex 72. Then -hydrogen elimination step of 72 generates COE 
and active tetraruthenium catalyst 63. Then, HBF4·OEt2 is added to the proceeding reaction 
mixture with chlorobenzene solvent. As a result, in-situ cationic ruthenium catalyst 64 is 
generated for the alkylation reaction mechanism. The mechanism of the alkylation reaction 
has been established in Yi’s paper.24(b) The C-H activation of COE to cationic ruthenium 
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catalyst 64 generates cationic ruthenium alkene intermediate 73. Alcohol undergoes 
oxidative addition and reductive elimination.  Ru hydroxyl specie is generated from the 
alkylation product. Another COE is coordinated to Ru hydroxyl species 75. C-H activation 
of COE generate the active catalyst 73 and water which completes the catalytic cycle. 
 
Scheme 5.30: Catalytic Cycle of Tandem Dehydrogenation and Alkylation Reaction 
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The proposed reaction mechanism of annulation is described in Scheme 5.31. The 
first step is the ligand substitution reaction of cationic ruthenium catalyst 66  to form 71. 
Diene is coordinated to cationic ruthenium catalyst 71. Alkoxylation reaction is occurred 
to form 72 via the tertiary carboncationic pathway. Alkene undergoes alkene insertion to 
form 73. Then, the ortho-arene C-H activation generates seven membered ruthenium 
complex 74, which undergoes the reductive elimination of 74 to form the product and 
active catalyst 71. The addition of phenol then completes the catalytic cycle of annulation 
reaction.  
 




In conclusion, we developed a highly chemoselective tandem dehydrogenation-
alkylation and -annulation protocol for saturated hydrocarbons. Our well-defined tetra 
nuclear ruthenium and cationic ruthenium-hydride catalysts showed three different sp3 C-
H activation-functionalization reactions. Our catalytic method tolerates the saturated 
hydrocarbon substrates containing oxygen and nitrogen functional groups without 
requiring reactive reagents or generating any toxic side products. Our tandem reaction 
protocol has a number of advantages of the benefits such as saving time, energy, labor, and 
money of isolation processes and multistep reactions.   
5.7 Conclusions and Future work 
The thesis work described efficient synthetic protocols of unsymmetrical 
etherification, Markovnikov selective hydroacylation of alkenes, and tandem 
dehydrogenation-alkylation and –annulation reaction by using cationic ruthenium catalyst 
64. We have established the stereoselctive formation of chiral ethers in the unsymmetrical 
etherification reaction. We also achieved regioselective the intermolecular hydroacylation 
of alkenes. These results showed for the development of asymmetric version of protocol 
by employing asymmetric phosphine ligands to cationic ruthenium catalyst 64.   
We also showed the tandem dehydrogenation-alkylation and annulation reaction of 
saturated hydrocarbons.  We have been able to extend the tandem dehydrogenation and 
hydroacylation reaction for heterocyclic alkanes such as indoline, cyclohexanone, 1,2-
dihydrobenzofuran, and cyclicdiketones. Since the formation of unsaturated products from 
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saturated hydrocarbons feedstock is a very important topic, the catalytic methods could be 





6 Experimental Section  
6.1 General Information  
All operations were carried out in a nitrogen-filled glove box or by using standard high 
vacuum and Schlenk techniques unless otherwise noted. Solvents were freshly distilled 
over appropriate drying reagents. Tetrahydrofuran, benzene, toluene, hexanes and ether 
were distilled from purple solutions of sodium and benzophenone, and dichloromethane 
and1,2-dichloroethanewere dried over calcium hydride prior to use. All organic substrates 
were received from commercial sources and were used without further purification. The 
1H, 2H, 13C and 31P NMR spectra were recorded on a Varian 300 or 400 MHz FT-NMR 
spectrometer, and the data are reported as: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, b = broad, app = apparent; coupling constant(s) in Hz; integration. Mass 
spectra were recorded from an Agilent 6850 GC-MS spectrometer with a HP-5 (5 % 
phenylmethylpolysiloxane) column (30 m, 0.32mm, 0.25μm).The conversion of organic 
products was measured from a Hewlett-Packard HP 6890 GC spectrometer. High 
resolution mass spectra were obtained at the Center of Mass Spectrometry, Washington 
University, St. Louis, MO. Elemental analyses and the Mass Spectrometry/ICP Lab, 
Department of Chemistry and Biochemistry, University of Wisconsin Milwaukee, 
Milwaukee, WI were performed at the Midwest Microlab, Indianapolis, IN. Optical 
rotations were measured by using a 1 mL cell with a 1 dm path length on a Perkin-Elmer 




6.1.1 Synthesis of [(η6-C6H6)RuH(CO)(PCy3)]
+BF4
- (4) 
In a glove box, complex 3 (200 mg, 0.12 mmol) was dissolved in benzene (10 mL) 
in a 25 mL Schlenk tube equipped with a Teflon screw-cap stopcock and a magnetic stirring 
bar. The tube was brought out of the box, and HBF4·OEt2 (64 μL, 0.48 mmol) was added 
via syringe under N2 stream. The color of the solution was changed from dark red to pale 
yellow immediately. After stirring for 1 h at room temperature, the solvent was removed 
under vacuum, and the residue was crashed by adding hexanes (10 mL). Filtering the 
resulting solid through a fritted funnel and recrystallization from CH2Cl2/hexanes yielded 
the product as a pale yellow powder (262 mg, 95 % yield). Single crystals of 4 suitable for 
X-ray crystallography were obtained from a slow evaporation of benzene and hexanes 
solution. 
For 4: 1H NMR (CD2Cl2, 400 MHz) δ 6.53 (s, C6H6), 2.0-1.2 (m, PCy3), -10.39 (d, JPH = 
25.9 Hz, Ru-H); 13C{1H} NMR (CD2Cl2, 100 MHz), δ 196.4 (d, JCP = 19.3 Hz, CO), 100.0 
(C6H6), 38.4, 38.2, 30.2, 29.9, 27.4, 27.3 and 26.2 (PCy3); 
31P{1H} NMR (CD2Cl2, 162 
MHz) δ 72.9 (PCy3); IR (KBr) νCO = 1991 cm
-1; Anal. Calcd for 4 C25H40BF4OPRu: C, 
52.18; H, 7.01. Found: C, 51.73; H, 6.91. 
6.2 Experimental Section for Unsymmetrical Ethers from the Dehydrative 




6.2.1 General Procedure  
In a glove box, complex 4 (6 mg, 1 mol %) and two different alcohols (1.0 mmol each) 
were dissolved in C6H5Cl (1 mL) in a 25 mL Schlenk tube equipped with a Teflon stopcock 
and a magnetic stirring bar. The tube was brought out of the box, and was stirred for 2-12 
h in an oil bath which was preset at 20-110 °C. The reaction tube was taken out of the oil 
bath, and was cooled to room temperature. After the tube was open to air, the solution was 
filtered through a short silica gel column (hexanes/EtOAc = 2:1), and the filtrate was 
analyzed by GC and GC-MS. Analytically pure product was isolated by a simple column 
chromatography on silica gel (280 to 400 mesh, hexanes/EtOAc = 40:1 to 4:1). 
6.2.2 X-Ray Crystallographic Determination of 5ag, 5aj 
A suitable crystal was selected and mounted on an Oxford Diffraction SuperNova 
kappa-diffractometer equipped with dual microfocus Cu/Mo X-ray sources, X-ray mirror 
optics, Atlas CCD detector and low-temperature Cryojet device. The final wR(F2) was 
0.0705 (all data). A total of 34927 data points were harvested at 100 K by collecting three 
sets of frames with 0.3° scans in  with an exposure time of 30 sec per frame. The structure 
was solved with the XS structure solution program using the Direct Methods and refined 
with the XL refinement package using Least Squares minimizations. All non-hydrogen 
atoms were refined with anisotropic displacement coefficients. All hydrogen atoms were 
included in the structure factor calculation at idealized positions and were allowed to ride 
on the neighboring atoms with relative isotropic displacement coefficients. The furanose 
ring has a C2-envelope conformation with an axial hydroxyl group orientation. The data 
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were processed with CrysAlisPro program package (Oxford Diffraction Ltd., 2010) 
including non-empirical/numerical Gaussian absorption correction based on the real shape 
of the crystal using SCALE3 ABSPACK routine. The structures were solved using 
SHELXS program and refined with SHELXL program within Olex2 crystallographic 
package.  
6.2.3 Characterization Data of the Products. 
 
Data for 5a: 1H NMR (400 MHz, CDCl3) δ 7.49-7.30 (m, 7H), 6.99-6.92 (m, 2H), 4.59 (s, 
2H), 4.55 (s, 2H), 3.85 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.3, 138.5, 
130.4, 129.5, 128.5, 127.9, 127.7, 113.9, 71.9, 71.8, 55.3 ppm; GC-MS m/z = 228 (M+). 
1H and 13C NMR spectral data are in good agreement with the literature data.1  
 
Data for 5b: 1H NMR (400 MHz, CDCl3) δ 7.28-7.14 (m, 5H), 4.42 (s, 2H), 3.35 (t, J = 
6.8 Hz, 2H), 1.65-1.56 (m, 2H), 1.43-1.23 (m, 6H), 0.92 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 139.0, 128.5, 127.7, 127.4, 72.8, 70.2, 31.9, 30.1, 26.0, 22.8, 
14.2 ppm; GC-MS m/z = 192 (M+); Anal. Calcd for C13H20O: C, 81.20; H, 10.48. Found: 




Data for 5c: 1H NMR (400 MHz, CDCl3) δ 7.44-7.26 (m, 5H), 4.43 (q, J = 6.5 Hz, 1H), 
3.34 (q, J = 6.8 Hz, 2H), 1.66-1.57 (m, 2H), 1.49 (d, J = 6.5 Hz, 3H), 1.42-1.25 (m, 6H), 
0.93 (t, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 144.4, 128.4, 127.3, 
126.1, 77.9, 68.8, 31.8, 30.0, 25.9, 24.3, 22.7, 14.1 ppm; GC-MS m/z = 206 (M+); Anal. 
Calcd for C14H22O: C, 81.50; H, 10.75. Found: C, 81.40; H, 11.03. 
 
Data for 5d: 1H NMR (400 MHz, CDCl3) δ 7.33-7.26 (m, 2H), 7.24-7.17 (m, 3H), 3.40-
3.26 (m, 4H), 2.88 (m, 1H), 1.87 (m, 2H), 1.56 (m, 2H), 1.39-1.25 (m, 6H), 1.28 (d, J = 
7.2 Hz, 3H), 0.91 (t, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 147.1, 
128.3, 127.0, 125.9, 71.0, 68.9, 38.1, 36.5, 31.7, 30.0, 25.9, 22.7, 22.4, 14.1 ppm; GC-MS 
m/z = 234 (M+); Anal. Calcd for C16H26O: C, 81.99; H, 11.18. Found: C, 81.76; H, 11.23. 
 
Data for 5e: 1H NMR (400 MHz, CDCl3) δ 7.42-7.22 (m, 5H), 4.50 (s, 2H), 3.54 (q, J = 
7.1 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 138.6, 
128.3, 127.8, 127.5, 72.9, 65.9, 15.1 ppm; GC-MS m/z = 136 (M+). 1H and 13C NMR 




Data for 5f: 1H NMR (400 MHz, CDCl3) δ 7.41-7.25 (m, 5H), 4.42 (q, J = 6.6 Hz, 1H), 
3.35 (q, J = 7.2 Hz, 2H), 1.45 (d, J = 6.6 Hz, 3H), 1.21 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 144.2, 128.5, 127.4, 126.1, 77.5, 63.9, 24.3, 15.2 ppm; GC-
MS m/z = 150 (M+). 1H and 13C NMR spectral data are in good agreement with the 
literature data.3 
 
Data for 5g: 1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 
2H), 4.36 (q, J = 6.5 Hz, 1H), 3.81 (s, 3H), 3.33 (q, J = 7.1 Hz, 2H), 1.42 (d, J = 6.5 Hz, 
3H), 1.17 (t, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.9, 136.2, 127.3, 
113.7, 77.2, 63.6, 55.2, 24.2, 15.4 ppm; GC-MS m/z = 180 (M+). 1H and 13C NMR spectral 
data are in good agreement with the literature data.4  
 
Data for 5h: 1H NMR (400 MHz, CDCl3) δ 7.38-7.34 (m, 4H), 7.32-7.27 (m, 1H), 7.23 (d, 
J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 4.48 (q, J = 6.7 Hz, 1H), 4.38 (d, J = 11.1 Hz, 
1H), 4.22 (d, J = 11.1 Hz, 1H), 3.80 (s, 3H), 1.46 (d, J = 6.7 Hz, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 159.1, 143.8, 130.7, 129.3, 128.5, 127.5, 126.4, 113.8, 76.9, 69.9, 
52.3, 24.3 ppm; GC-MS m/z = 242 (M+). 1H and 13C NMR spectral data are in good 
175 
 
agreement with the literature data.5  
 
Data for 5i: 1H NMR (400 MHz, CDCl3) δ 7.19 (s, 5H), 7.08 (d, J = 8.6 Hz, 2H),  6.71 (d, 
J = 8.6 Hz, 2H), 4.31-4.30 (m, 2H), 3.72 (s, 3H), 1.49-1.48 (m, 6H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 161.1, 136.9, 129.5, 128.5, 128.3, 127.5, 114.1, 72.3, 56.2, 23.2 ppm; 
GC-MS m/z = 256 (M+). 1H and 13C NMR spectral data are in good agreement with the 
literature data.6  
 
Data for 5j (1:1 diastereomeric mixture) Isomer A: 1H NMR (400 MHz, CDCl3) δ 7.42-
7.22 (m, 10H), 4.44 (q, J = 6.5 Hz, 1H), 3.50 (dd, J = 9.2, 6.4 Hz, 1H), 3.40 (dd, J = 9.2, 
5.4 Hz, 1H), 3.07 (qdd, J = 7.0, 6.4, 5.4 Hz, 1H), 1.47 (d, J = 6.5 Hz, 3H), 1.36 (d, J = 7.0 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 144.7, 144.1, 128.4, 128.3, 127.5, 127.3, 
126.3, 126.2, 78.3, 74.6, 40.2, 24.2, 18.4 ppm. Isomer B. 7.42-7.22 (m, 10H), 4.41 (q, J = 
6.5 Hz, 1H), 3.49 (dd, J = 9.2, 5.8 Hz, 1H), 3.38 (dd, J = 9.2, 6.3 Hz, 1H), 3.07 (qdd, J = 
7.0, 6.3, 5.8 Hz, 1H), 1.47 (d, J = 6.5 Hz, 3H), 1.36 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 144.5, 144.2, 128.4, 128.3, 127.5, 127.4, 126.3, 126.2, 78.1, 
74.6, 40.3, 24.3, 18.6 ppm; GC-MS m/z = 240 (M+); Anal. Calcd for C17H20O: C, 84.96; 




Data for 5k (1:1 diastereomeric mixture) Isomer A: 1H NMR (400 MHz, CDCl3) δ 7.21 (d, 
J = 8.8 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 4.35 (q, J = 6.3 Hz, 1H), 3.80 (s, 3H), 3.67 (s, 
3H), 3.46 (t, J = 9.3 Hz, 1H), 3.28 (t, J = 6.4 Hz, 1H),  2.78-2.66 (m, 1H), 1.38 (d, J = 6.3 
Hz, 3H), 1.14 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 175.5, 143.7, 
128.3, 127.4, 126.1, 78.5, 70.5, 51.7, 40.3, 40.3, 24.1, 14.0 ppm. Isomer B: 1H NMR (400 
MHz, CDCl3) δ 7.20 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 4.34 (q, J = 6.3 Hz, 1H), 
3.80 (s, 3H), 3.68 (s, 3H), 3.48 (t, J = 9.3 Hz, 1H), 3.30 (t, J = 6.4 Hz, 1H), 2.78-2.66 (m, 
1H), 1.39 (d, J = 6.3 Hz, 3H), 1.12 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 175.3, 143.7, 128.4, 127.4, 126.1, 78.2, 70.4, 51.7, 40.3, 40.3, 24.1, 14.0 ppm; 
GC-MS m/z = 252 (M+); Anal. Calcd for C14H20O4: C, 66.65; H, 7.99. Found: C, 66.28; H, 
8.21. 
 
Data for 5l: 1H NMR (400 MHz, CDCl3) δ 7.48-7.38 (m, 1H), 7.31-7.19 (m, 3H), 4.94 (dd, 
J = 6.7, 4.6 Hz, 1H), 3.57 (t, J = 6.8 Hz, 2H), 3.12 (ddd, J = 15.8, 8.5, 5.6 Hz, 1H), 2.85 
(ddd, J = 15.8, 8.2, 5.7 Hz, 1H), 2.37 (dddd, J = 13.2, 8.2, 6.7, 5.6 Hz, 1H), 2.08 (dddd, J 
= 13.2, 8.5, 5.7, 4.6 Hz, 1H), 1.64 (tt, J = 7.5, 6.8 Hz, 2H), 1.45-1.26 (m, 6H), 0.92 (t, J = 
6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 143.7, 143.2, 128.2, 126.3, 125.1, 
124.9, 83.2, 68.9, 32.5, 31.8, 30.1, 30.1, 26.0, 22.7, 14.1 ppm; GC-MS m/z = 218 (M+); 




Data for 5m: 1H NMR (400 MHz, CDCl3) δ 7.45-7.23 (m, 6H), 6.95 (d, J = 8.9 Hz, 2H), 
5.73 (dd, J = 6.8, 4.1 Hz, 1H), 3.16 (ddd, J =16.0, 8.6, 5.6 Hz, 1H), 2.94 (ddd, J = 16.0, 
8.6, 5.5 Hz, 1H), 2.56 (dddd, J = 13.8, 8.6, 6.8, 5.6 Hz, 1H) 2.08 (dddd, J = 13.8, 8.6, 5.5, 
4.1 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.0, 144.0, 141.5, 129.4, 129.0, 
126.8, 125.6, 125.2, 125.0, 117.1, 81.8, 32.1, 30.2 ppm; GC-MS m/z = 244 (M+); Anal. 
Calcd for C15H13ClO: C, 73.62; H, 5.35. Found: C, 73.83; H, 5.60. 
 
Data for 5n: 1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 7.6 Hz, 1H), 7.28-7.15 (m, 3H), 
6.92 (d, J = 9.1 Hz, 2H), 6.83 (d, J = 9.1 Hz, 2H), 5.63 (dd, J = 6.6, 4.3 Hz, 1H), 3.75 (s, 
3H), 3.10 (ddd, J = 16.0, 8.6, 5.5 Hz, 1H), 2.87 (ddd, J = 16.0, 8.5, 5.7 Hz, 1H), 2.48 (dddd, 
J = 13.2, 8.5, 6.6, 5.5 Hz, 1H) 2.08 (dddd, J = 13.2, 8.6, 5.7, 4.3 Hz, 1H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 1154.1, 152.6, 144.1, 142.2, 128.9, 126.8, 125.4, 125.1, 117.3, 
114.8, 82.5, 55.9, 32.5, 30.3 ppm; GC-MS m/z = 218 (M+); Anal. Calcd for C16H16O2: C, 
79.97; H, 6.71. Found: C, 79.86; H, 6.78. 
 
Data for 5o: 1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 7.5 Hz, 1H), 7.21-7.19 (m, 2H), 
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7.17 (d, J = 7.5 Hz, 1H), 7.00 (d, J = 9.1 Hz, 2H), 6.88 (d, J = 9.1 Hz, 2H), 5.25 (dd, J = 
4.8, 4.5 Hz, 1H), 3.81 (s, 3H), 2.96-2.87 (m, 1H), 2.83-2.73 (m, 1H), 2.20-1.93 (m, 3H), 
1.84-1.75 (m, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ  154.2, 152.2, 137.7, 135.9, 
129.5, 129.0, 127.9, 126.0, 118.1, 114.7, 75.2, 55.7, 29.2, 28.0, 18.7 ppm; GC-MS m/z = 
254 (M+); Anal. Calcd for C17H18O2: C, 80.28; H, 7.13. Found: C, 80.13; H, 7.03. 
 
Data for 5p: 1H NMR (400 MHz, CDCl3) δ 7.34-7.28 (m, 2H), 6.97-6.92 (m, 3H), 3.98 (t, 
J = 6.6 Hz, 2H), 1.83  (m, 2H), 1.48 (m, 2H), 1.43-1.35 (m, 4H), 0.94 (t, J = 7.2 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.4, 129.6, 120.6, 114.6, 67.9, 31.7, 29.4, 
25.8, 22.8, 14.2 ppm; GC-MS m/z = 178 (M+); Anal. Calcd for C12H18O: C, 80.85; H, 10.18. 
Found: C, 81.07; H, 10.23. 
 
 
Data for 5q: 1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.6 Hz, 
2H), 3.88 (t, J = 6.6 Hz, 2H), 1.74  (m, 2H), 1.50-1.22 (m, 6H), 0.92 (t, J = 7.2 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 157.6, 129.4, 125.3, 116.2, 6.84, 31.7, 29.3, 
25.6, 22.8, 14.1 ppm; GC-MS m/z = 212 (M+); Anal. Calcd for C12H17ClO: C, 67.76; H, 




Data for 5r: 1H NMR (400 MHz, CDCl3) δ 7.40-7.21 (m, 5H), 6.99 (d, J = 8.6 Hz, 2H), 
6.76 (d, J = 8.6 Hz, 2H), 5.27 (q, J = 6.5 Hz, 1H), 2.23 (s, 3H), 1.62 (d, J = 6.5 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 155.8, 143.4, 129.8, 129.8, 128.6, 127.3, 125.6, 
115.8, 76.0, 24.5, 20.4 ppm; GC-MS m/z = 212 (M+); Anal. Calcd for C15H16O: C, 84.87; 
H, 7.60. Found: C, 84.52; H, 7.29. 
 
Data for 5s: 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.7 Hz, 2H), 6.90 (d, J = 8.7 Hz, 
2H), 4.50 (s, 2H), 3.80 (s, 3H), 3.64 (t, J = 6.4 Hz, 2H), 2.59 (t, J = 6.4 Hz, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 159.2, 129.2, 129.1, 117.7, 113.8, 72.9, 64.2, 55.2, 
18.9 ppm; GC-MS m/z = 191 (M+). 1H and 13C NMR spectral data are in good agreement 
with the literature data.7 
 
 
Data for 5t (1:1 diastereomeric mixture) Isomer A: 1H NMR (400 MHz, CDCl3) δ 7.87-
7.71 (m, 8H), 7.51-7.44 (m, 6H), 4.65 (q, J = 6.5 Hz, 2H), 3.52 (m, 4H), 1.55 (d, J = 6.5 
Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 141.3,  133.3, 133.0, 128.3, 127.9, 
180 
 
127.7, 126.0, 125.7, 125.1, 124.3, 78.3, 68.0, 24.1 ppm. Isomer B: 1H NMR (400 MHz, 
CDCl3) δ 7.87-7.71 (m, 8H), 7.51-7.44 (m, 6H),  4.61 (q, J = 6.5 Hz, 2H), 3.52 (m, 4H), 
1.56 (d, J = 6.5 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 141.3,  133.3, 133.0, 
128.3, 127.8, 127.7, 126.0, 125.7, 125.2, 124.3, 78.3, 68.0, 24.2 ppm; GC-MS m/z = 370 
(M+); GC-MS m/z = 370 (M+); Anal. Calcd for C26H26O2: C, 84.29; H, 7.07. Found: C, 
84.20; H, 7.02. 
 
Data for 5v 1H NMR (400 MHz, CDCl3) δ 7.30-7.23 (m, 4H), 5.13 (s, 4H) ppm; 
13C{1H} 
NMR (100 MHz, CDCl3) δ 139.0, 127.2, 121.0, 73.5 ppm; GC-MS m/z = 120 (M
+). 1H 
and 13C NMR spectral data are in good agreement with the literature data.8 
 
Data for 5w: 1H NMR (400 MHz, CDCl3) δ 7.20-7.11 (m, 3H), 7.02-6.97 (m, 1H), 4.80 (s, 
2H), 4.00 (td, J = 5.7, 1.5 Hz, 2H), 2.88 (t, J = 5.7 Hz, 2H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 134.9, 133.2, 128.9, 126.4, 126.0, 124.4, 68.0, 65.4, 28.3 ppm; GC-MS m/z = 




Data for 5aa: 1H NMR (400 MHz, CDCl3) 7.18 (d, J = 8.8 Hz,1H), 6.70 (dd, J = 8.8, 2.7 
Hz, 1H), 6.63 (d, J = 2.7 Hz,1H), 5.39 (m, 1H), 4.08 (m, 1H), 2.91-2.84 (m, 2H), 2.54-0.9 
(m, 41H), 1.05 (s, 3H), 0.92 (d, J = 6.8 Hz, 3H), 0.91 (s, 3H), 0.87 (dd, J = 6.8, 1.8 Hz, 
6H), 0.68 (s, 3H)ppm; 13C NMR (100 MHz, CDCl3) δ 221.1, 155.7, 140.5, 137.7, 131.9, 
126.3, 122.2, 116.0, 113.3, 76.9, 56.8, 56.1, 50.4, 50.2, 48.0, 44.0, 42.3, 39.8, 39.6, 38.8, 
38.3, 37.2, 36.8, 36.1, 35.9, 35.8, 32.0, 31.9, 31.6, 29.7, 28.3, 28.3, 28.0, 26.6, 25.9, 24.3, 
23.8, 22.8, 22.6, 21.6, 21.1, 19.5, 18.6, 13.8, 11.8ppm; HRMS (ESI-TOF)m/z =638 (M+); 
Anal. Calcd for C45H66O2: C, 84.58; H, 10.41. Found: C, 84.40; H, 10.07; [α]
23
D = -61.8° 
(c= 0.5, CH2Cl2). 
5ab 
Data for 5ab:1H NMR (400 MHz, CDCl3) 6.98 (d, J = 8.6 Hz, 2H), 6.80 (d, J = 8.6 Hz, 
2H), 5.92 (s, 1H), 5.38 (m, 1H), 4.80 (m, 1H), 4.17 (q, J = 7.2 Hz, 2H), 4.07 (m, 1H), 
2.95 (d, J = 5.6 Hz, 2H), 2.49-2.30 (m, 3H), 2.05-0.83 (m, 25H), 1.98 (s, 3H), 1.25 (t, J = 
7.2 Hz, 3H), 1.05 (s, 3H), 0.95 (d, J = 6.6 Hz, 3H), 0.86 (dd, J = 6.6, 1.8 Hz, 6H), 0.68 (s, 
3H) ppm; 13C NMR (100 MHz, CDCl3) δ 171.8, 169.6, 158.9, 140.3, 133.3, 127.6, 122.3, 
115.9, 77.1, 61.5, 56.7, 56.1, 53.2, 50.2, 42.3, 39.7, 39.5,38.6, 37.2, 37.0, 36.8, 36.2, 35.8, 
32.0, 31.9, 29.7, 29.6, 28.2, 28.0, 24.3, 23.8, 23.2, 22.8, 22.6, 21.1, 19.4, 18.7, 14.2, 
11.9ppm;HRMS (ESI-TOF) m/z = 619 (M+); Anal. Calcd for C40H61NO4: C, 77.50; H, 





Data for 5ac: 1H NMR (400 MHz, CDCl3) δ 7.22 (m, 5H), 5.19 (d, J = 5.3 Hz, 1H), 5.03 
(s, 1H), 3.60 (s, 3H), 3.36 (tt, J = 11.1, 4.59 Hz, 1H), 2.40-0.84 (m, 40H), 0.62 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 159.2, 141.2, 128.6, 128.5, 127.1, 121.9, 113.9, 78.4, 
69.7, 56.9, 56.3, 55.4, 50.3, 42.5, 39.9, 39.7, 39.3, 37.4, 37.0, 36.3, 35.9, 32.1, 32.0, 28.6, 
28.4, 28.2, 24.4, 24.0, 23.0, 22.7, 21.2, 19.5, 18.9, 12.0 ppm; HRMS (ESI-TOF) m/z = 
534.81 (M+); Anal. Calcd for C36H54O3: C, 80.85; H, 10.18. Found: C, 80.54; H, 10.24. 
5ad 
Data for 5ad: 1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.9 Hz, 2H), 6.87 (d, J = 8.9 Hz, 
2H), 5.34 (d, J = 5.3 Hz, 1H), 4.49 (s, 2H), 3.80 (s, 3H), 3.26 (tt, J = 11.1, 4.60 Hz, 1H), 
2.40-0.84 (m, 40H), 0.67 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.0, 141.0, 
131.1, 129.1, 121.5, 113.8, 78.3, 69.6, 56.8, 56.1, 55.3, 50.2, 42.3, 39.8, 39.5, 39.2, 37.3, 
36.9, 36.2, 35.8, 31.9, 31.9, 28.4, 28.2, 28.0, 24.3, 23.8, 22.8, 22.6, 21.1, 19.4, 18.7, 11.9 
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ppm; HRMS (ESI-TOF) m/z = 506.41 (M+); Anal. Calcd for C35H54O2: C, 82.95; H, 10.74. 
Found: C, 82.57; H, 10.52. 
 5ae 
Data for 5ae: 1H NMR (400 MHz, CDCl3) δ 5.53 (d, J = 5.0 Hz,1H), 5.33 (m, 1H), 4.59 
(dd, J = 8.0, 2.3 Hz,1H), 4.30 (dd, J = 5.0, 2.3 Hz,1H), 4.27 (dd, J = 8.0, 1.9 Hz,1H), 3.91 
(dd, J = 6.4, 1.9 Hz,1H), 3.67 (dd, J = 10.1, 6.4 Hz,1H), 3.62 (dd, J = 10.1, 6.5 Hz,1H), 
3.20 (m, 1H), 2.40-0.84 (m, 52H), 0.67 (s, 3H)  ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ141.1, 121.5, 109.1, 108.5, 96.3, 79.8, 71.1, 70.6, 70.6, 67.0, 66.7, 56.8, 56.1, 50.1, 42.3, 
39.8, 39.5, 39.0, 37.2, 36.8, 36.2, 35.8, 31.9, 31.9, 28.4, 28.2, 28.0, 26.1, 26.0, 24.9, 24.4, 
24.3, 23.8, 22.8, 22.6, 21.1, 19.4, 18.7, 11.8 ppm; GC-MS m/z = 628 (M+); Anal. Calcd for 




Data for 5af: 1H NMR (400 MHz, CDCl3) δ 5.69 (s, 1H), 5.36 (s, 1H),4.67 (m, 1H), 4.10-
3.94 (m, 1H),2.82-2.64 (m, 3H), 2.50-0.9 (m, 44H), 1.39 (s, 3H),1.00 (s, 3H),0.89 (s, 3H), 
0.84 (d, J = 6.6 Hz, 6H), 0.77 (s, 3H), 0.65 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 209.7, 208.9, 199.8, 174.6, 168.8, 139.1, 124.5, 123.2, 75.9, 72.9, 69.4, 62.9, 56.6, 55.7, 
54.2, 52.7, 49.9, 47.1, 46.1, 42.3, 39.7, 38.2, 38.0, 36.9, 36.1, 34.8, 33.7, 32.1, 31.9, 28.2, 
27.6, 24.8, 24.2, 23.8, 22.6, 21.7, 21.0, 19.3, 17.2, 14.4, 13.1, 11.1, 0.0 ppm; 
Isomer B: 1H NMR (400 MHz, CDCl3) δ 5.69 (s, 1H), 5.36 (s, 1H), 4.67 (m, 1H), 4.10-
3.94 (m, 1H),2.82-2.64 (m, 3H), 2.50-0.9 (m, 44H), 1.39 (s, 3H), 1.00 (s, 3H), 0.89 (s, 3H), 
0.84 (d, J = 6.6 Hz, 6H), 0.77 (s, 3H), 0.65 (s, 3H)ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 209.7, 208.9, 199.8, 174.5, 168.8, 139.0, 124.5, 123.1, 75.4, 72.9, 69.4, 62.6, 57.5, 56.1, 
53.9, 53.0, 49.9, 47.1, 46.1, 42.3, 39.5, 38.2, 38.0, 36.5, 35.8, 34.7, 33.7, 32.2, 31.8, 28.0, 
27.7, 24.2, 23.8, 23.5, 22.8, 21.0, 18.7, 17.2, 14.4, 13.1, 11.8, -0.0 ppm; HRMS (ESI-
TOF)m/z = 728 (M+); Anal. Calcd for C48H72O5: C, 79.07; H, 9.95. Found: C, 79.43; H, 
9.71; [α]23D 64.7° (c= 0.5, CH2Cl2). 
 
5ag 
Data for 5ag: 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 Hz, 
2H), 5.98 (d, J = 3.8 Hz, 1H), 4.58 (d, J = 11.6 Hz, 1H), 4.50 (d, J = 2.8 Hz, 1H), 4.49 (d, 
J = 11.6 Hz  1H), 4.27 (d, J = 2.8 Hz  1H), 4.22 (dd, J = 6.6, 3.5 Hz, 1H), 3.93 (dd, J = 
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11.0, 4.1 Hz, 1H), 3.89 (dd, J = 11.0, 3.5 Hz, 1H), 3.80 (s, 1H), 3.69 (br, 1H), 1.47 (s, 1H), 
1.31 (s, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.5, 129.6, 129.1, 113.9, 111.5, 
104.8, 85.3, 77.9, 76.7, 73.8, 67.9, 55.3, 26.7, 26.1 ppm; GC-MS m/z = 310 (M+); Anal. 
Calcd for C16H22O6: C, 61.92; H, 7.15. Found: C, 61.87 H, 7.23. 
5ah 
Data for 5ah: 1H NMR (400 MHz, CDCl3) δ 8.47 (d, J = 8.5 Hz,1H), 8.03 (dd, J = 8.1, 1.4 
Hz, 1H), 7.63 (d, J = 9.5 Hz,1H), 7.52 (d, J = 7.7 Hz, 1H), 7.50 (d, J = 7.5 Hz, 1H), 7.43-
7.40 (m,1H), 7.34 (td, J = 7.7, 0.9 Hz 1H), 7.26-7.18 (m, 4H), 7.08 (t, J = 7.5 Hz, 1H), 
6.97 (d, J = 8.1 Hz, 1H), 6.77 (d, J = 9.5 Hz, 1H), 5.23 (t, J = 6.4 Hz, 1H), 4.00 (s, 3H), 
3.04 (ddd, J = 16.0, 8.6, 4.7 Hz, 1H), 2.80 (ddd, J = 16.0, 8.2, 5.4 Hz, 1H), 2.49 (dddd, J 
= 12.0, 8.2, 6.4, 4.7 Hz, 1H), 1.95 (dddd, J = 12.0, 8.6, 6.4, 5.3 Hz, 1H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ177.1, 149.7, 145.1, 143.3, 141.0, 133.8, 132.2, 130.7, 129.0, 
128.7, 128.3, 127.9, 127.0, 126.7, 126.5, 125.9, 124.9, 124.3, 121.7, 121.6, 116.0, 111.2, 
76.4, 56.0, 35.9, 29.8ppm; GC-MS m/z = 394 (M+); Anal. Calcd for C26H22N2O2: C, 79.16; 




Data for 5ai: 1H NMR (400 MHz, CDCl3) 7.23 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.7 Hz, 
2H), 4.10 (q, J = 6.6 Hz, 1H), 3.81 (s, 3H), 3.25 (t, J = 7.1 Hz, pss), 1.82 (m, pss), 1.42 (d, 
J = 6.6 Hz, 3H),0.97 (dd, J = 6.6, 1.4 Hz,pss), 0.61 (t, J = 7.2 Hz,pss) ppm; 13C NMR (100 
MHz, CDCl3) δ 158.9, 136.2, 127.3, 113.7, 77.2, 70.6, 55.2, 30.1, 25.9, 24.8, 23.9, 
23.0,20.9, 10.1 ppm;HRMS (ESI-TOF)m/z =619 (M+). 
 
6.3 Experimental Section for Intermolecular Markovnikov-Selective 
Hydroacylation of Olefins Catalyzed by a Cationic Ruthenium-Hydride 
Complex 
 
6.3.1 General Procedure  
In a glove box, complex 1 (30 mg, 4 mol %), aldehyde (1.0 mmol), unstaturated 
carbons were dissolved in toluene (2 mL) in a 25 mL Schlenk tube equipped with a Teflon 
stopcock and a magnetic stirring bar. The tube was brought out of the box, and was stirred 
for 8-36 h in an oil bath which was preset at 100-130 °C. The reaction tube was taken out 
of the oil bath and immediately quenched by liquid nitrogen. After the tube was opened to 
air, the solution was filtered through a short silica gel column (dichlromathane, 5 mL), and 
the filtrate was analyzed by GC and GC-MS. Analytically pure product was isolated by a 
simple column chromatography on silica gel (280 to 400 mesh, hexanes/diethylether = 





6.3.2 Characterization Data of the Product 3. 
 
Data for 3a: 1H NMR (400 MHz, CDCl3) δ 8.00 (d, J = 7.1 Hz, 2H), 7.43-7.22 (m, 8H), 
4.73 (q, J = 6.8 Hz, 1H), 1.59 (d, J = 6.8 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 200.3, 141.5, 136.5, 132.8, 129.0, 128.8, 128.5, 127.8, 126.9, 47.9, 19.6 ppm; GC-MS 
m/z = 210 (M+); 1H and 13C NMR spectral data are in good agreement with the literature 
data.10 
 
Data for 3b: 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.7 Hz, 2H), 7.28 (t, J = 4.9 Hz, 
4H), 7.24-7.13 (m, 1H), 6.86 (d, J = 8.7 Hz, 2H), 4.64 (q, J = 6.9 Hz, 1H), 3.82 (s, 3H), 
1.52 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.0, 163.4, 142.1, 
131.2, 129.5, 129.1, 127.9, 126.9, 113.8, 55.6, 47.7, 19.8 ppm; GC-MS m/z = 240 (M+); 




Data for 3c: 1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 4.4 Hz, 
4H), 7.20 (dd, J = 11.0, 6.2 Hz, 3H), 4.68 (q, J = 6.8 Hz, 1H), 2.35 (s, 3H), 1.53 (d, J = 6.9 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 200.0, 143.7, 141.8, 134.1, 133.7, 129.3, 
129.1, 127.9, 126.9, 47.9, 21.7, 19.6 ppm; GC-MS m/z = 224 (M+); 1H and 13C NMR 
spectral data are in good agreement with the literature data.11 
 
Data for 3d: 1H NMR (400 MHz, CDCl3) δ 8.10-7.84 (m, 2H), 7.40-7.01 (m, 7H), 4.62 (q, 
J = 6.8 Hz, 1H), 1.52 (d, J = 6.8 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.0, 
141.0, 139.1, 134.6, 130.2, 129.1, 128.8, 127.6, 127.0, 48.0, 19.4 ppm; GC-MS m/z = 244 
(M+); 1H and 13C NMR spectral data are in good agreement with the literature data.12 
 
Data for 3e: 1H NMR (400 MHz, CDCl3) δ 8.10-7.84 (m, 2H), 7.42-7.14 (m, 5H), 7.13-
6.92 (m. 2H), 4.63 (q, J = 6.5 Hz, 1H), 1.53 (d, J = 6.5 Hz, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 198.6, 165.4 (d, JCF = 254.4 Hz), 141.3, 132.8, 131.3 (d, JCF = 9.5 Hz), 
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129.0, 127.7, 126.9, 115.5 (d, JCF = 21.7 Hz), 48.0, 19.4 ppm; GC-MS m/z = 228 (M+); 1H 
and 13C NMR spectral data are in good agreement with the literature data.13 
 
Data for 3f: 1H NMR (400 MHz, CDCl3) δ 7.23-7.31 (m, 5 H), 3.76 (q, J = 7.0 Hz, 1H), 
2.35 (t, J = 7.5 Hz, 2H), 1.59-1.49 (m, 2H), 1.36 (d, J = 7.0 Hz, 3H), 1.25-1.09 (m, 4H), 
0.85-0.75 (m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 211.5, 141.0, 129.0, 128.0, 
127.2, 53.1, 41.1, 31.3, 23.7, 22.5, 17.6, 14.0 ppm; GC-MS m/z = 204 (M+). 1H and 13C 
NMR spectral data are in good agreement with the literature data.14  
 
 
Data for 3g: 1H NMR (400 MHz, CDCl3) δ 7.16-7.07 (m, 4H), 3.71 (t, J = 6.9 Hz, 1H), 
2.36-2.28 (m, 5H), 1.56-1.40 (m, 2H), 1.36 (d, J = 6.9 Hz, 3H), 1.25-1.09 (m, 4H), 0.83 (t, 
J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 211.3, 137.8, 136.7, 129.6, 
127.8, 52.5, 41.0, 31.3, 23.6, 22.5, 21.1, 17.5, 14.0 ppm; GC-MS m/z = 218 (M+); Anal. 




Data for 3h: 1H NMR (400 MHz, CDCl3) δ 7.25-7.20 (m, 2H), 7.13-7.08 (m, 2H), 3.76 (t, 
J = 7.9 Hz, 1H), 2.36 (t, J = 7.5 Hz, 2H), 1.59-1.49 (m, 2H), 1.36 (d, J = 7.9 Hz, 3H), 1.25-
1.09 (m, 4H), 0.83 (t, J = 7.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 209.9, 
139.2, 133.3, 129.4, 129.3, 53.0, 43.0, 31.3, 23.4, 22.4, 17.5, 13.9 ppm; GC-MS m/z = 238 
(M+); HRMS (APCI): Calculated for C14H19ClO ([M+H]
+) 239.1197, Found: 239.1192.  
 
Data for 3i: 1H NMR (400 MHz, CDCl3) δ 7.33-7.28 (m, 2H), 7.28-7.20 (m, 3H), 7.19-
7.12 (m, 3H), 7.11-7.04 (m, 2H), 3.71 (d, J = 7.1 Hz, 1H), 2.91-2.73 (m, 2H), 2.73-2.61 
(m, 2H), 1.39 (d, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 209.9, 141.0, 
140.45, 128.9, 128.4, 128.3, 127.9, 127.2, 126.0, 53.2, 42.6, 30.0, 17.3 ppm; GC-MS m/z 
= 238 (M+); 1H and 13C NMR spectral data are in good agreement with the literature data.15 
 
Data for 3j: 1H NMR (400 MHz, CDCl3) δ 7.32 (t, J = 7.7 Hz, 2H), 7.28-7.20 (m, 3H), 
3.76 (q, J = 7.1 Hz, 1H),  2.37 (dq, J = 8.70, 7.30 Hz, 2H), 1.39 (d, J = 7.1 Hz, 3H), 0.97 
(t, J = 7.1 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 211.6, 140.9, 128.9, 127.8, 
127.1, 52.7, 34.3, 17.5, 8.0 ppm; GC-MS m/z = 204 (M+). 1H and 13C NMR spectral data 




Data for 2k: 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 15.9 Hz, 1H), 7.47-7.43 (m, 2H), 
7.37-7.30 (m, 5H),  7.29–7.23 (m, 3H),  6.70 (d, J = 15.9 Hz, 1H), 4.02 (q, J = 7.0 Hz, 1H), 
1.49 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.5, 142.6, 140.6, 
134.5, 130.4, 129.0, 128.8, 128.3, 128.1, 127.1, 124.5, 51.9, 17.9,  ppm; GC-MS m/z = 236 
(M+); 1H and 13C NMR spectral data are in good agreement with the literature data.17 
 
Data for 3l: 1H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 8.04 (dd, J = 8.6, 2.3 Hz, 1H), 7.91 
(d, J = 8.6 Hz, 1H), 7.82 (dd, J = 8.8, 2.3 Hz, 2H), 7.58-7.47 (m, 2H), 7.40-7.28 (m. 4H), 
7.24-7.18 (m, 1H), 4.87 (q, J = 6.9 Hz, 1H), 1.62 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 200.3, 141.6, 135.4, 133.8, 132.5, 130.5, 130.0, 129.0, 128.4, 128.3, 
127.8, 127.7, 126.9, 126.7, 124.6, 47.9, 19.6 ppm; GC-MS m/z = 260 (M+); HRMS (ESI-
TOF): Calculated for C19H16O ([M+H]
+) 261.1274, Found: 261.1268. 
  
Data for 3m: 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 1.6 Hz, 1H), 7.35–7.19 (m, 5H), 
7.14 (d, J = 3.6 Hz, 1H), 6.45 (dd, J = 3.6, 1.6 Hz, 1H), 4.49 (q, J = 6.9 Hz, 1H), 1.53 (d, J 
= 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 189.7, 152.4, 146.6, 141.1, 129.0, 
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128.1, 127.3,118.1, 112.4, 48.2, 18.6 ppm; GC-MS m/z = 200 (M+); 1H and 13C NMR 
spectral data are in good agreement with the literature data.18 
 
Data for 3n: 1H NMR (400 MHz, CDCl3) δ 7.90-7.79 (m, 2H), 7.37-7.29 (m,1H), 7.24 (t, 
J = 7.2 Hz, 2H), 7.22-7.10 (m, 4H), 7.12-7.03 (m, 1H), 4.31 (t, J = 7.2 Hz, 1H), 2.21-1.96 
(m, 1H), 1.85-1.62 (m, 1H), 0.79 (t, J = 7.6 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 200.2, 139.7, 137.1, 132.9, 128.9, 128.7, 128.6, 128.3, 127.1, 55.5, 27.2, 12.4 ppm; GC-
MS m/z = 224 (M+); 1H and 13C NMR spectral data are in good agreement with the 
literature data.19 
 
Data for 3o: 1H NMR (400 MHz, CDCl3) δ 7.34-7.28 (m, 2H), 7.25-7.14 (m, 3H), 3.51 (t, 
J = 7.4 Hz, 1H), 2.33 (td, J = 6.8, 2.5 Hz, 2H), 2.11-1.98 (m, 1H), 1.76-1.65 (m, 1H), 1.55-
1.39 (m, 2H), 1.25-1.05 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H), 0.81 (t, J = 7.4 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 210.9, 139.0, 128.7, 128.3, 127.1, 60.8, 41.9, 31.2, 
25.3, 23.4, 22.4, 13.9, 12.1 ppm; GC-MS m/z = 218 (M+); HRMS (APCI): Calculated for 
C15H22O ([M+H]




Data for 3p: 1H NMR (400 MHz, CDCl3) δ 7.91-7.87 (m, 2H), 7.37-7.32 (m,2H), 7.32-
7.24 (m,4H), 7.23-7.18 (m, 1H), 4.48 (t, J = 7.3 Hz, 1H), 2.19-2.08 (m, 1H), 1.86-1.74 (m, 
1H), 1.39-1.16 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
198.8, 139.5, 139.2, 135.2, 130.1, 129.0, 128.8, 128.1, 127.1, 53.5, 36.0, 20.8, 14.1 ppm; 
GC-MS m/z = 272 (M+); HRMS (ESI-TOF): Calculated for C17H17ClO ([M+H]
+) 
273.1041, Found: 273.1042.  
 
Data for 3q: 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.8 Hz, 2H), 7.35 (d, J = 8.8 Hz, 
2H), 7.32-7.18 (m, 5H), 4.37 (t, J = 7.3 Hz, 1H), 2.25-2.11 (m, 1H), 1.91-1.78 (m, 1H), 
0.89 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 198.8, 139.3, 139.2, 
135.2, 130.1, 129.0, 128.8, 128.2, 127.1, 55.6, 27.0, 12.2 ppm; GC-MS m/z = 258 (M+); 
HRMS (ESI-TOF): Calculated for C16H15ClO ([M+H]
+) 259.0884, Found: 259.0889. 
 
Data for 3r: 1H NMR (400 MHz, CDCl3) δ 7.32-7.24 (m, 2H), 7.23-7.11 (m, 7H), 3.41 (p, 
J = 8.6 Hz, 1H), 3.20-3.06 (m, 4H), 2.94 (t, J = 7.4 Hz, 2H), 2.86 (t, J = 7.4 Hz, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 210.5, 141.5, 141.2, 128.5, 128.4, 126.6, 126.1, 124.4, 
51.3, 43.1, 35.0, 29.8 ppm; GC-MS m/z = 250 (M+); Anal. Calcd for C18H18O1: C, 86.36; 




Data for 3s: 1H NMR (400 MHz, CDCl3) δ 7.24-7.12 (m, 4H), 3.46 (p, J = 8.4 Hz, 1H), 
3.17 (ddd, J = 27.6, 15.7, 8.4 Hz, 4H), 2.53 (t, J = 7.3 Hz, 2H), 1.63 (m, 2H), 1.32 (m, 4H), 
0.91 (t, J = 6.6 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 211.07, 141.6, 126.6, 
124.4, 51.2, 41.4, 35.1, 31.5, 23.5, 22.5, 14.0 ppm; GC-MS m/z = 216 (M+); Anal. Calcd 
for C15H20O1: C, 83.28; H, 9.32; Found: C, 83.04; H, 9.28. 
 
Data for 3t: 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 8.7 Hz, 2H), 7.33 (d, J = 8.7 Hz, 
2H), 7.32-7.20 (m, 5H), 5.02 (dd, J = 9.9, 4.9 Hz, 1H), 3.65 (s, 3H), 3.37 (dd, J = 17.0, 9.9 
Hz, 1H), 2.70 (dd, J = 17.0, 4.9 Hz, 1H)  ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 197.4, 
172.5, 139.4, 137.7, 134.4, 130.3, 129.3, 128.8, 128.0, 127.7, 51.9, 50.0, 38.3 ppm; GC-






Data for 3u: 1H NMR (400 MHz, CDCl3) δ 7.37-7.23 (m, 3H), 7.21-7.16 (m, 2H), 4.17 
(dd, J = 9.9, 4.8 Hz, 1H), 3.64 (s, 3H), 3.22 (dd, J = 17.0, 9.9 Hz, 1H), 2.52 (dd, J = 17.0, 
4.8 Hz, 1H), 2.48-2.30 (m, 2H), 1.57-1.40 (m, 2H), 1.26-1.06 (m, 4H), 0.81 (t, J = 7.3, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 209.2, 172.6, 137.5, 129.1, 128.2, 127.6, 54.1, 
51.8, 41.5, 36.8, 31.1, 23.3, 22.3, 13.9 ppm; GC-MS m/z = 262 (M+); HRMS (ESI-TOF): 
Calculated for C17H15ClO3 ([M+H]
+) 263.1642 Found: 263.1640. 
 
Data for 3v: 1H NMR (400 MHz, CDCl3) δ 8.00-7.98 (m, 2H), 7.49-7.16 (m, 8H), 5.22 (dd, 
J = 12.0, 3.6 Hz, 1H), 3.48(dd, J = 16.4, 10.4 Hz, 1H), 2.98 (s, 3H), 2.88 (s, 3H), 2.61 (dd, 
J = 16.0, 3.6 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 197.4, 172.5, 139.4, 137.7, 
134.4, 130.3, 129.3, 128.8, 128.0, 127.7, 51.9, 50.0, 38.3 ppm; GC-MS m/z = 281 (M+); 
1H and 13C NMR spectral data are in good agreement with the literature data.20 
 
 
Data for 3w (-)-(R,R): 1H NMR (400 MHz, CDCl3) δ 7.39-7.29 (m, 3H), 7.22-7.16 (m, 
4H), 7.11-7.07 (m, 2H), 3.81 (q, J = 6.8 Hz, 1H), 3.76 (q, J = 7.0 Hz, 1H), 2.37 (s, 3H), 
1.27 (d, J = 6.8 Hz, 3H), 1.26 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 210.5, 141.1, 138.0, 136.8, 129.7, 129.0, 127.9, 127.1, 50.7, 50.5, 21.1, 18.1, 18.1 ppm; 
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GC-MS m/z = 252 (M+); HRMS (ESI-TOF): Calculated for C18H20O ([M+H]
+) 253.1587 
Found: 253.1586 [α]20D +31.2° (c = 0.4, CH2Cl2). 
 
Data for 3w (+)-(R,S): 1H NMR (400 MHz, CDCl3) δ 7.39-7.29 (m, 3H), 7.22-7.16 (m, 
4H), 7.11-7.07 (m, 2H), 3.81 (q, J = 6.8 Hz, 1H), 3.76 (q, J = 7.0 Hz, 1H), 2.37 (s, 3H), 
1.27 (d, J = 6.8 Hz, 3H), 1.26 (d, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 211.6, 140.2, 137.0, 136.5, 129.1, 128.4, 128.1, 127.9, 126.8, 51.3, 51.1, 21.0, 18.4, 18.3 
ppm; GC-MS m/z = 252 (M+); HRMS (ESI-TOF): Calculated for C18H20O ([M+H]
+) 
253.1587 [α]20D -26.4° (c = 0.4, CH2Cl2).  
 
Data for 3x: 1H NMR (400 MHz, CDCl3) δ 8.03 (dd, J = 5.4, 3.6 Hz, 2H) 7.86-7.74 (m, 
4H), 7.52-7.42 (m, 4H), 7.38 (t, J = 7.3 Hz, 2H), 4.88 (q, J = 6.8 Hz, 1H), 1.66 (d, J = 6.8 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 200.3, 139.1, 136.5, 133.8, 132.9, 132.4, 
128.9, 128.6, 127.8, 127.7, 126.5, 126.3, 126.0, 125.9, 48.1, 19.6 ppm; GC-MS m/z = 281 




Data for 3aa: 1H NMR (400 MHz, CDCl3) Isomer A:δ 7.31-7.16 (m, 5H), 6.79-6.75 (m, 
1H), 4.37 (q, J = 7.0 Hz, 1H), 2.89 (td, J = 5.6, 1.5 Hz, 1H), 2.44-2.30 (m, 3H), 2.09-2.02 
(m, 1H), 1.40 (d, J = 7.0 Hz, 3H), 1.26 (s, 3H), 0.86 (d, J = 8.9 Hz, 1H), 0.63 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 199.3, 148.2, 142.0, 136.8, 128, 127.7,126.6, 46.3, 
40.2, 40.1, 37.3, 32.5, 30.9,  25.8, 20.7, 19.3 ppm;  
Isomer B: δ 7.31-7.16 (m, 5H), 6.74-6.71 (m, 1H), 4.41 (q, J = 7.0 Hz, 1H), 2.92 (td, J = 
5.7, 1.5 Hz, 1H), 2.44-2.30 (m, 3H), 2.09-2.02 (m, 1H), 1.40 (d, J = 7.0 Hz, 3H), 1.25 (s, 
3H), 0.98 (d, J = 8.9 Hz, 1H), 0.42 (s, 3H)  ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.2, 
148.3, 142.5, 137.3, 128, 127.5, 126.5, 46.4, 40.1, 40.0, 37.5, 32.5, 31.0, 25.8, 20.3, 19.1 
ppm; GC-MS m/z = 254 (M+); HRMS (ESI-TOF): Calculated for C18H22O ([M+H]
+) 
255.1743 Found: 255.1741. 
 
Data for 3ab: 1H NMR (400 MHz, CDCl3) mixture of two diasteromers: δ 7.37-7.12 (m, 
5H), 7.00-6.92 (m, 1H), 4.63-4.74 (m, 2H), 4.41(q, J = 6.9 Hz, 1H), 2.57-2.38 (m, 1H), 
2.36-2.23 (m, 1H), 2.22-2.00 (m, 2H), 1.90-1.78 (m, 1H), 1.76-1.25 (m, 8H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 201.1, 201.1, 148.8, 148.8, 142.3, 142.2, 139.8, 138.1, 138.1, 
128.8, 127.5, 127.5, 126.6, 126.6, 109.2, 109.1, 46.1, 46.1, 40.2, 40.0, 31.4, 26.9, 26.9, 
24.1, 23.9, 20.7, 20.6, 19.6, 19.5  ppm (few carbon peaks are not resolved); GC-MS m/z = 






Data for 3c: 1H NMR (400 MHz, CDCl3) Isomer A:δ 7.34-7.21 (m, 3H), 7.15-7.11 (m, 
2H), 6.72 (d, J = 7.9, 1H), 6.59-6.52 (m, 2H), 5.93 (dd, J = 5.7, 1.5 Hz, 2H), 3.41 (q, J = 
6.9 Hz, 1H), 2.91-2.73 (m, 2H), 2.46 (dd, J = 13.1, 6.7 Hz, 1H), 1.24 (d, J =6.9, 3H), 0.85 
(d, J = 6.7 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 214.3, 147.6, 146.0, 140.1, 
133.4, 128.9, 128.2, 127.1, 121.8, 109.1, 108.2, 100.9, 53.7, 47.0, 40.4, 17.3, 17.1 ppm; 
Isomer B: δ 7.25-7.18 (m, 3H), 7.04-7.01 (m, 2H), 6.56 (d, J = 7.9 Hz, 1H), 6.33(dd, J = 
7.9, 1.8 Hz, 1H), 6.28 (d, J = 1.8 Hz, 1H), 5.87 (s, 2H), 3.81 (q, J = 6.9 Hz, 1H), 2.91-2.73 
(m, 2H), 2.35 (dd, J = 13.5, 6.8 Hz, 1H), 1.33 (d, J =6.9, 3H), 1.05 (d, J = 6.8 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 213.2, 147.2, 145.6, 139.6, 133.5, 128.7, 128.1, 
127.0, 121.9, 109.2, 107.8, 100.6, 52.0, 46.5, 38.5, 17.5, 17.4 ppm; GC-MS m/z = 296 (M+); 
HRMS (ESI-TOF): Calculated for C19H20O3 ([M+H]
+) 297.1412 Found: 297.1415. 
 
 
Data for 3d: 1H NMR (400 MHz, CDCl3) δ 8.45-8.40 (m. 1H), 7.74 (s, 1H), 7.34-7.32 (m, 
3H), 7.27-7.14 (m, 5H), 4.36 (t, J = 7.4 Hz, 1H), 3.82 (s, 3H), 3.66 (s, 3H), 3.43-3.32 (m, 
2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 187.8, 170.5, 139.0, 137.5, 136.5, 128.9, 
128.5, 126.5, 126.5, 123.8, 123.0, 122.8, 115.8, 109.6, 57.9, 52.5, 34.8, 33.7  ppm; GC-MS 
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m/z = 321 (M+); HRMS (APCI): Calculated for C20H19NO3 ([M+H]







Data for 3af: 1H NMR (400 MHz, CDCl3) δ 7.66 (dd,  J = 7.8, 1.6 Hz, 2H), 7.28-7.04 (m. 
14H), 6.45 (d, J = 8.2 Hz, 2H), 4.46 (q, J = 7.0 Hz, 2H), 1.41 (d, J = 6.9 Hz, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 202.2, 154.5, 140.8, 132.9, 131.1, 128.6, 128.1, 126.7, 
123.7, 119.2, 51.7, 19.3 ppm; GC-MS m/z = 434 (M+); HRMS (APCI): Calculated for 
C30H26O3 ([M+H]
+) 435.1955 Found: 435.1952. 
 
Data for 3ah: 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.0 Hz, 2H), 7.38-7.20 (m, 5H), 
7.13 (s, 1H), 4.64 (q, J = 7.0 Hz, 1H), 2.97-2.90 (m, 2H), 2.60-2.48 (m, 1H), 2.45-2.38 (m, 
1H), 2.36-2.00 (m, 4H), 1.99-1.44 (m, 10H), 0.95 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 220.6, 200.3, 139.8, 136.5, 135.6. 134.3, 134.2, 129.6, 129.1, 128.8, 128.0, 126.3, 
50.4, 48.0, 47.7, 44.4, 38.1, 35.8, 31.5, 29.3, 26.4, 25.7, 21.6, 19.6, 13.8 ppm; HRMS (ESI-
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TOF): Calculated for C27H30O2 ([M+H]
+) 387.2319 Found: 387.2318. [α]20D +168.8° (c = 
0.6, CH2Cl2). 
6.4 Experimental Section for Tandem Alkylation and Annulation Reactions 
 
6.4.1 General Procedure  
 
In a glove box, complex 63 (16 mg, 0.1 mol %), hydrocarbon (10.0 mmol) and TBE 
(10.0 mmole) were added in a 10 mL Schlenk tube equipped with a Teflon stopcock and a 
magnetic stirring bar. The sealed tube was brought out of the box and stirred for 8-36 h in 
an oil bath which was preset at 160-200 °C. The reaction tube was taken out of the oil bath 
and immediately quenched by liquid nitrogen. The quenched reaction mixture was brought 
into a glove box. The sacrifical amount of sample was taken from the mixture to analyze 
the reaction progress by HNMR, GC, and GC-MS. For the second step, 2 mL of anhydrous 
chlorobenzene was added in the reaction mixture. HBF4·OEt2 (7 L, 0.4 mol %) was added 
in the reaction mixture and stirred for 15 min to ativate the complex 1. Alcohol (5-10 
mmole) was added in the reaction mixtrue. The sealed tube was brought out of the box and 
stirred for 8-16 h in an oil bath preset at 80-120 °C. The reaction tube was taken out of the 
oil and quenched by liquid nitrogen. After the tube was opened to air, the solution was 
filtered through a short silica gel column (dichlromathane, 5 mL), and the filtrate was 
analyzed by GC and GC-MS. Analytically pure product was isolated by a simple column 
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chromatography on silica gel (280 to 400 mesh, hexanes/diethylether = 40:1 to 4:1). An 
alternative method for step 2, 2 mL of anhydrous chlorobenzene or toluene was placed in 
the reaction mixture. [(C6H6)(PCy3)(CO)RuH]
+BF4
- (24 mg, 4 mol %) was added in the 
reaction mixture. Alcohol (5-10 mmole) was added in the reaction mixtrue. The sealed 
tube was brought out of the box and stirred for 8-16 h in an oil bath preset at 80-130 °C. 
The reaction tube was taken out of the oil and quenched by liquid nitrogen. After the tube 
was opened to air, the solution was filtered through a short silica gel column 
(dichlromathane, 5 mL), and the filtrate was analyzed by GC and GC-MS. Analytically 
pure product was isolated by a simple column chromatography on silica gel (280 to 400 
mesh, hexanes/diethylether = 40:1 to 4:1).  
 
 
6.4.2 Characterization Data of the Products 65. 
 
 
Data for 65a: 1H NMR (400 MHz, CDCl3) δ 7.10 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.7 Hz, 
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2H), 5.34 (t, J = 8.1 Hz, 1H), 3.79 (s, 3H), 2.55 (t, J = 8.1 Hz, 2H), 2.16-2.04 (m, 4H), 
2.02 (t, J = 7.7 Hz, 2H), 1.76-1.64 (m,2H), 1.53-1.40 (m, 8H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 157.6, 140.6, 134.9, 129.3, 123.9, 113.6, 55.2, 37.2, 34.9, 30.2, 30.0, 
28.9, 28.9, 26.5, 26.3, 26.3 ppm; GC-MS m/z = 258 (M+); HRMS (ESI-TOF): Calculated 
for C18H26O ([M+H]
+) 258.1984.  
 
Data for 65b: 1H NMR (400 MHz, CDCl3) δ 7.02 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 8.6 Hz, 
2H), 5.28 (t, J = 8.0 Hz, 1H), 3.72 (s, 3H), 3.16 (s, 2H), 2.00 (m, 4H), 1.38 (m, 8H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 157.8, 140.5, 132.5, 130.0, 125.5, 113.5, 55.2, 43.2, 
30.0, 28.5, 28.5, 26.5, 26.4, 26.3 ppm; GC-MS m/z = 157.8 (M+); 1H and 13C NMR spectral 
data are in good agreement with the literature data.21  
 
Data for 2c: 1H NMR (400 MHz, CDCl3) δ 7.37 (d, J = 7.4 Hz, 1H), 7.25 (d, J = 7.2 Hz, 
1H) 7.21 (t, J = 7.2 Hz, 1H), 7.09 (t, J = 7.4 Hz, 1H), 6.49 (s, 1H), 3.30 (s, 2H), 2.47 (t, J 
= 7.2 Hz, 2H), 1.66-1.50 (m, 2H), 
1.41-1.15 (m, 6H), 0.89 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
151.1, 145.7, 143.1, 126.2, 126.0, 123.5, 123.4, 119.8, 41.0, 31.2, 29.1, 29.0, 22.6, 14.1 
ppm; GC-MS m/z = 200 (M+); 1H and 13C NMR spectral data are in good agreement with 




Data for 65d: 1H NMR (400 MHz, CDCl3) δ 7.39-7.22 (m, 8H), 7.13 (td, J = 7.4, 1.3 Hz, 
1H), 6.55 (s, 1H), 3.85 (s, 2H), 3.32 (s, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
149.2, 145.1, 143.5, 139.9, 128.9, 128.4, 127.8, 126.1, 126.0, 124.0, 123.4, 119.9, 40.8, 
37.9 ppm; GC-MS m/z = 206 (M+); 1H and 13C NMR spectral data are in good agreement 
with the literature data.22 
 
Data for 65e: 1H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 7.2 Hz, 1H), 7.29 (d, J = 7.2 Hz, 
1H), 7.23 (t, J = 7.2 Hz, 1H), 7.18 (d, J = 8.6 Hz, 2H), 7.12 (td, J = 7.2, 1.4 Hz, 1H), 6.87 
(d, J = 8.6 Hz, 2H), 6.51 (s, 1H), 3.82 (s, 3H), 3.78 (s, 2H), 3.29 (s, 2H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 158.1, 149.9, 145.4, 143.5, 132.1, 129.8, 127.6, 126.3, 123.9, 
123.5, 120.5, 113.9, 55.3, 40.8, 37.1 ppm; GC-MS m/z = 236 (M+); 1H and 13C NMR 
spectral data are in good agreement with the literature data.21 
 
Data for 65f: 1H NMR (400 MHz, CDCl3) δ 8.03-7.96 (m, 1H), 7.89-7.84 (m, 1H), 7.77 
(d, J = 8.2 Hz, 1H),  7.48-7.40 (m, 3H), 7.31-7.24 (m, 3H), 7.22-7.18 (m, 3H), 4.46 (s, 2H) 
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ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 140.6, 136.6, 133.9, 132.1, 128.7, 128.6, 128.4, 
127.3, 127.1, 126.0, 126.0 ,125.5, 125.5, 124.3, 39.0 ppm; GC-MS m/z = 218 (M+); 1H and 
13C NMR spectral data are in good agreement with the literature data.23 
  
Data for 65g: 1H NMR (400 MHz, CDCl3) δ 8.05-7.31 (m, 5H), 7.15 (d, J = 8.2 Hz, 2H), 
6.85 (d, J = 8.5 Hz, 2H), 4.42 (s, 2H), 3.81 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 158.1, 137.2, 134.1, 132.9, 132.2, 129.7, 128.7, 127.3, 126.0, 125.7, 124.5, 113.9, 55.5, 
38.2 ppm; GC-MS m/z = 248 (M+); 1H and 13C NMR spectral data are in good agreement 
with the literature data.24 
 
Data for 65h: 1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 7.6 Hz, 1H),7.45 (d, J = 7.6 Hz, 
1H), 7.209-7.18 (m, 4H), 6.91 (d, J = 8.6 Hz, 2H), 6.39 (s, 1H), 4.08 (s, 2H), 3.83 (s, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.7, 158.5, 155.2, 130.1, 129.4, 123.6, 
122.7, 120.6, 114.2, 111.1, 103.3, 55.5, 34.3 ppm; GC-MS m/z = 238 (M+); 1H and 13C 





Data for 65i: 1H NMR (400 MHz, CDCl3) δ 7.16 (d, J = 8.6 Hz, 2H), 7.13 (d, J = 7.6 Hz, 
2H), 6.09 (t, J = 7.6 Hz, 1H), 6.86 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 7.6 Hz, 1H), 4.87 (s, 
1H), 3.95 (s, 2H), 3.78 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.1, 153.8, 
131.8, 130.8, 129.7, 127.8, 127.3, 120.9, 115.7, 114.1, 55.3, 35.6 ppm; GC-MS m/z = 214 
(M+); 1H and 13C NMR spectral data are in good agreement with the literature data.25  
 
Data for 65j: 1H NMR (400 MHz, CDCl3) δ 8.14-8.12 (m, 1H), 7.79-7.77 (m, 1H), 7.50-
7.38 (m, 3H), 7.26-7.24 (m, 1H), 5.15 (s, 1H), 2.74 (t, J = 7.8 Hz, 2H), 1.72-1.64 (m, 2H), 
1.45-1.27 (m, 6H), 0.89 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
148.1, 133.3, 128.2, 127.7, 125.4, 125.3, 124.5, 121.4, 121.0, 120.2, 31.8, 30.1, 30.0, 29.3, 
22.7, 14.2 ppm; GC-MS m/z = 228 (M+); 1H and 13C NMR spectral data are in good 
agreement with the literature data.26 (Method 2) 
 
 
Data for 65k: 1H NMR (400 MHz, CDCl3) δ 8.09-8.04 (m, 1H), 7.81-7.76 (m, 1H), 7.50-
7.41 (m, 4H), 7.32-7.29 (m, 4H), 7.25-7.19 (m, 1H), 5.15 (s, 1H), 4.17 (t, J = 7.8 Hz, 1H), 
2.24-2.13 (m, 2H), 0.98 (t, J = 7.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
148.6, 143.9, 133.3, 128.8, 128.0, 127.6, 126.7, 125.9, 125.7, 125.3, 125.0, 124.2, 121.2, 
120.4, 46.7, 27.7, 12.7 ppm; GC-MS m/z = 262 (M+); HRMS (ESI-TOF): Calculated for 
C19H18O ([M+H]






Data for 65l: 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.7 Hz, 1H), 7.78 (d, J = 8.2 Hz, 
1H), 7.63 (d, J = 8.7 Hz, 1H), 7.49 (t, J = 7.7 Hz, 1H), 7.34 (t, J = 7.7 Hz, 1H), 7.07 (d, J 
= 8.2 Hz, 1H), 4.85 (s, 1H), 3.03 (t, J = 8.0 Hz, 2H), 1.73-1.62 (m, 2H), 1.52-1.34 (m, 4H), 
0.92 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 150.5, 133.4, 129.7, 
128.8, 127.8, 126.5, 123.3, 123.3, 120.6, 117.9, 32.4, 29.8, 25.3, 22.9, 14.3 ppm; GC-MS 




Data for 65m: 1H NMR (400 MHz, CDCl3) δ 7.97-7.93 (m, 2H), 7.84 (d, J = 8.0 Hz, 1H), 
7.74 (d, J = 8.9 Hz, 1H), 7.50-7.05 (m, 7H), 5.21 (s, 1H), 4.50 (s, 2H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 151.6, 140.4, 134.1, 130.0, 129.0, 129.0, 128.9, 128.7, 127.1, 126.6, 
123.8, 126.7, 119.0, 118.3, 31.1 ppm; GC-MS m/z = 234 (M+); 1H and 13C NMR spectral 




Data for 65n: 1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.0 Hz, 1H), 7.31 (d, J = 8.0 Hz, 
1H), 7.23 (m, 3H), 7.10 (t, J = 7.2 Hz, 1H), 6.85 (d, J = 8.4 Hz, 2H), 6.76 (s, 1H), 4.07 (s, 
2H), 3.80 (s, 3H), 3.73 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.0, 137.4, 
133.7, 129.8, 128.0, 127.2, 121.7, 119.4, 118.9, 114.9, 113.9, 109.3, 55.4, 32.8, 30.8 ppm; 
GC-MS m/z = 251 (M+); 1H and 13C NMR spectral data are in good agreement with the 
literature data.28  
 
Data for 65o: 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 7.9 Hz, 1H), 7.32 (d, J = 8.0 Hz, 
1H), 7.26 (t, J = 7.6 Hz, 1H), 7.15 (t, J = 7.4 Hz, 1H), 6.86 (s, 1H), 3.77 (s, 3H), 2.79 (t, J 
= 7.9 Hz, 2H), 1.80-1.70 (m, 2H), 1.51-1.31 (m, 6H),  0.95 (t, J = 7.1 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 137.2, 128.2, 126.2, 121.6, 119.3, 118.6, 115.9, 109.3, 32.7, 
32.1, 30.7, 29.6, 25.3, 22.9, 14.4 ppm; GC-MS m/z = 215 (M+); 1H and 13C NMR spectral 
data are in good agreement with the literature data.21 (Method 2) 
 
 
Data for 65p: 1H NMR (400 MHz, CDCl3) δ 7.49-7.46 (m, 1H), 7.34-7.26 (m, 5H), 7.22-
208 
 
7.17 (m, 2H), 7.05-7.00 (m, 1H), 6.88 (s, 1H), 4.07 (dd, J = 8.1, 6.9 Hz, 1H), 3.76 (s, 3H), 
2.30-2.18 (m, 1H), 2.11-1.98 (m, 1H), 0.97 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 145.7, 137.4, 128.4 (x2), 128.2, 127.4, 126.0, 126.0, 121.6, 119.8, 118.8, 
109.3, 45.0, 32.9, 29.4, 13.1 ; GC-MS m/z = 249 (M+); HRMS (ESI-TOF): Calculated for 
C18H20O ([M+H]
+) 250.1590 Found: 250.1585.  
 
Data for 65q: 1H NMR (400 MHz, CDCl3) δ 7.65-7.61 (m, 1H), 7.38-7.22 (m, 7H), 7.17-
7.11 (m, 1H), 6.72 (s, 1H), 3.74 (s, 3H), 3.22-3.07 (m, 2H), 3.00-2.92 (m, 1H), 1.33 (t, J 
= 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.1, 137.1, 128.5 (x2), 128.4, 
127.3, 127.2, 126.1, 121.5, 119.3, 118.7, 113.7, 109.3, 40.9, 34.4, 32.8, 21.9 ppm; GC-MS 
m/z = 249 (M+); HRMS (ESI-TOF): Calculated for C18H19N ([M+H]
+) 250.1590 Found: 
250.1580. (Method 2) 
 
Data for 65r: 1H NMR (400 MHz, CDCl3) δ 7.09-7.05 (m, 2H), 6.84-6.80 (m, 2H), 6.56 
(m, 1H), 6.05 (m, 1H), 5.87 (m, 1H), 3.87 (s, 2H), 3.78 (s, 3H), 3.42 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 158.0, 131.9, 131.6, 129.4, 121.8, 113.9, 107.8, 
106.6, 55.2, 33.8, 32.0 ppm; GC-MS m/z = 201 (M+); 1H and 13C NMR spectral data are 




Data for 65s: 1H NMR (400 MHz, CDCl3) δ 7.46-7.22 (m, 5H), 6.86-6.76 (m, H),  3.98 
(s, 2H), 3.89 (s, 3H), 3.87 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 149.0, 147.6, 
141.4, 133.7, 128.8, 128.5, 126.0, 121.0, 112.3, 111.3, 55.9, 55.8, 41.5 ppm; GC-MS m/z 
= 228 (M+); 1H and 13C NMR spectral data are in good agreement with the literature 
data.30 
  
Data for 65t: 1H NMR (400 MHz, CDCl3) δ 7.12 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 
2H), 6.81 (d, J = 7.9 Hz, 1H), 6.72 (m, 2H), 3.89 (s, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 3.79 
(s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.1, 149.0, 147.4, 134.3, 133.6, 
129.8, 120.9, 114.0, 112.2, 111.3, 56.0, 55.9, 55.4, 40.7 ppm; GC-MS m/z = 258 (M+); 
1H and 13C NMR spectral data are in good agreement with the literature data.31 
  
Data for 65u: 1H NMR (400 MHz, CDCl3) δ 7.09 (d, J = 8.4 Hz, 4H), 6.82 (d, J = 8.7 Hz, 
4H), 3.87 (s, 2H), 3.78 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 158.1, 134.0, 
130.0, 114.1, 55.5, 40.3 ppm; GC-MS m/z = 228 (M+); 1H and 13C NMR spectral data are 




Data for 68a: 1H NMR (400 MHz, CDCl3) δ 7.91 (br, 1H), 7.42-7.25 (m, 6H), 7.24-7.14 
(m, 2H), 7.07-6.99 (m, 2H), 4.40 (q, J = 6.9 Hz, 1H), 1.73 (d, J = 6.9 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 147.0, 136.8, 128.5, 127.6, 127.1, 126.1, 122.1, 
121.6, 121.3, 119.9, 119.4, 111.2, 37.1, 22.6 ppm; GC-MS m/z = 221 (M+);1H and 13C 
NMR spectral data are in good agreement with the literature data.32  (Method 2) 
 
Data for 68c: 1H NMR (400 MHz, CDCl3) δ 7.89 (br, 1H), 7.67 (d, J = 7.9 Hz, 1H), 7.36 
(dt, J = 8.1, 0.9 Hz, 1H), 7.21-7.17 (m, 1H), 7.14 (m, 1H), 6.94 (d, J = 2.3 Hz, 1H), 5.60 
(q, J = 1.7 Hz, 1H), 3.76-3.69 (m, 1H), 2.11-1.97 (m, 5H), 1.80-1.59 (m, 3H), 1.07 (t, J = 
7.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 139.9, 136.5, 126.6, 122.7, 121.7, 
121.5, 121.2, 119.3, 118.9, 111.0, 32.7, 30.6, 30.1, 28.3, 21.3, 12.5 ppm; GC-MS m/z = 
225 (M+); HRMS (ESI-TOF): Calculated for C16H19N ([M+H]
+) 226.1590. (Method 2) 
 
Data for 68e: 1H NMR (400 MHz, CDCl3) δ 8.08 (m, 1H), 7.80 (m, 1H), 7.50-7.40 (m, 
4H), 7.35-7.29 (m, 4H), 7.24 (m, 1H), 5.10 (s, 1H), 4.47 (d, J = 7.2 Hz, 1H), 1.74 (d, J = 
7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.4, 144.7, 133.4, 129.0, 127.5, 
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127.4, 126.9, 125.8, 125.7, 125.3, 125.0, 124.9, 121.3, 120.4, 39.4, 21.0 ppm; GC-MS 
m/z = 248 (M+); 1H and 13C NMR spectral data are in good agreement with the literature 
data.26 (Method 2) 
 
Data for 68f: 1H NMR (400 MHz, CDCl3) δ 8.17-8.13 (m, 1H) 7.84-7.79 (m, 1H), 7.51-
7.47 (m, 2H), 7.44 (d, J = 8.4 Hz, 1H), 7.40 (d, J = 7.4 Hz, 1H), 7.31-7.27 (m, 1H), 7.24 
(d, J = 8.4 Hz, 1H), 7.20 (d, J = 7.4 Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 5.14 (s, 1H), 4.68 
(t, J = 9.0 Hz, 1H), 3.20-2.98 (m, 2H), 2.70-2.60 (m, 1H), 2.29-2.16 (m, 1H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 148.8, 144.6, 144.1, 133.6, 127.9, 127.5, 127.5, 
127.0, 125.8, 125.3, 125.1, 125.0, 124.8, 122.9, 121.3, 120.4, 47.5, 34.4, 32.0 ppm; GC-




Data for 68g: 1H NMR (400 MHz, CDCl3) δ 8.26-8.18 (m, 1H) 7.78-7.72 (m, 1H), 7.46-
7.41 (m, 2H), 7.32 (d, J = 8.2 Hz, 1H), 7.18 (d, J = 8.6 Hz, 1H), 2.89 (t, J = 6.7 Hz, 2H), 
1.91 (t, J = 6.7 Hz, 2H), 1.44 (s, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.7, 
133.3, 127.8, 127.3, 125.7, 125.5, 124.9, 121.6, 118.8, 114.3, 74.49, 32.8, 26.9(x2), 22.8 
ppm; GC-MS m/z = 212 (M+); 1H and 13C NMR spectral data are in good agreement with 




Data for 68h: 1H NMR (400 MHz, CDCl3) δ 8.26-8.21 (m, 1H) 7.76-7.72 (m, 1H), 7.46-
7.38 (m, 2H), 7.29 (d, J = 8.3 Hz, 1H), 7.12 (d, J = 8.3 Hz, 1H), 3.16 (p, J = 3.2 Hz, 1H), 
2.05-1.97 (m, 1H), 1.95-1.87 (m, 1H), 1.85-1.68 (m, 5H), 1.57-1.31 (m, 3H), 1.07 (t, J = 
7.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 151.5, 133.4, 127.4, 126.8, 125.4, 
124.7, 124.2, 121.7, 119.3, 118.2, 77.1, 37.6, 34.9, 33.6, 33.0, 32.6, 18.2, 7.6 ppm; GC-




Data for 68i: 1H NMR (400 MHz, CDCl3) δ 8.26-8.20 (m, 1H) 7.77-7.72 (m, 1H), 7.46-
7.40 (m, 2H), 7.40-7.34 (m, 2H), 3.02 (d,d,d, J = 6.9, 4.1, 3.9 Hz, 1H), 2.70-2.58 (m, 
1H), 1.78 (dd, J = 13.4, 6.9 Hz, 1H), 1.78 (dd, J = 13.4, 12.1 Hz, 1H), 1.56 (s, 3H), 1.26 
(s, 3H), 1.12 (d, J = 6.9, 3H), 0.66 (d, J = 6.9, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 149.2, 133.0, 127.1, 125.9, 125.6, 124.9, 124.9, 122.0, 119.1, 117.9, 74.6, 36.8, 
32.4, 30.5, 29.1, 23.9, 20.8, 15.6 ppm; GC-MS m/z = 254 (M+); HRMS (ESI-TOF): 
Calculated for C18H22O ([M+H]




Data for 68j: 1H NMR (400 MHz, CDCl3) δ  7.72-7.68 (m, 1H), 7.62 (s, 1H), 7.60-7.56 
(m, 1H), 7.35-7.12 (m, 6H), 7.11-7.04 (m, 2H), 4.84 (s, 1H),  4.28 (q, J = 7.2 Hz, 1H), 
1.72 (d, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 153.0, 146.4, 141.5, 
133.1, 129.6, 128.9, 128.4, 127.7, 127.5, 126.5, 126.1, 125.2, 117.7, 109.3, 44.6, 21.8 
ppm; GC-MS m/z = 248 (M+); 1H and 13C NMR spectral data are in good agreement with 
the literature data.34 (Method 2) 
 
Data for 68ja: 1H NMR (400 MHz, CDCl3) δ 7.78-7.74 (m, 1H), 7.55-7.48 (m, 1H), 7.39-
7.37 (m, 1H), 7.18 (t, J = 7.2 Hz, 1H), 7.13-7.01 (m, 5H), 6.95 (t, J = 8.8 Hz, 1H), 4.88 
(q, J = 7.2 Hz, 1H), 4.58 (s, 1H), 1.49 (d, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 151.5, 143.6, 132.7, 129.8, 129.0, 128.9, 128.7, 127.2, 126.8, 126.7, 123.8, 123.1, 
122.6, 119.5, 34.8, 17.0 ppm; GC-MS m/z = 248 (M+); 1H and 13C NMR spectral data are 
in good agreement with the literature data.21 (Method 2)  
 
Data for 68k: 1H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 8.6 Hz, 1H), 7.86 (d, J = 8.0 
Hz, 1H), 7.75 (d, J = 8.7 Hz, 1H), 7.58-7.53 (m, 1H), 7.45-7.38 (m, 2H), 7.35-7.30 (m, 
1H), 7.24 (t, J = 7.4 Hz, 1H), 7.15 (d, J = 7.4 Hz, 1H),  7.11 (d, J = 8.7 Hz, 1H), 5.36 (t, 
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J = 9.5 Hz, 1H), 4.80 (s, 1H), 3.28-3.07 (m, 2H), 2.74-2.64 (m, 1H), 2.33-2.20 (m, 1H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 152.3, 144.7, 142.8, 133.7, 129.5, 128.9, 
128.9, 128.0, 127.4, 126.7, 125.8, 124.5, 123.2, 122.2, 119.9, 119.8, 43.1, 33.0, 32.1 
ppm; GC-MS m/z = 260 (M+); HRMS (ESI-TOF): Calculated for C19H16O ([M+H]
+) 
261.1274. (Method 2) 
 
Data for 68l: 1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 8.6 Hz, 1H), 7.78 (d, J = 8.2 Hz, 
1H), 7.64 (d, J = 8.9 Hz, 1H), 7.51 (t, J = 8.2 Hz, 1H), 7.35 (t, J = 8.2 Hz, 1H), 7.05 (d, J 
= 8.9 Hz, 1H), 3.06 (t, J = 6.7 Hz, 2H), 1.98 (t, J = 6.7 Hz, 2H), 1.40 (s, 6H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 151.6, 133.3, 128.9, 128.6, 128.0, 126.4, 123.2, 
122.1, 120.0, 112.6, 74.2, 32.9, 26.8(x2), 19.6 ppm; GC-MS m/z = 212 (M+); 1H and 13C 
NMR spectral data are in good agreement with the literature data.33  (Method 2) 
 
Data for 68m: 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.5 Hz, 1H), 7.77-7.74 (m, 
1H), 7.61 (d, J = 8.9 Hz, 1H), 7.47-7.42 (m, 1H), 7.31-7.26 (m, 1H), 7.07 (d, J = 8.9 Hz, 
1H), 3.74 (q, J = 3.2 Hz, 1H), 2.00-1.85 (m, 4H), 1.81-1.28 (m, 6H), 1.00 (t, J = 7.6 Hz, 
3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 154.3, 131.8, 128.5, 128.5, 127.5, 126.1, 
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122.4, 121.4, 118.2, 116.8, 76.4, 38.1, 34.6, 33.3, 30.7, 28.0, 18.9, 7.5 ppm; GC-MS m/z 
= 252 (M+); HRMS (ESI-TOF): Calculated for C18H20O ([M+H]
+) 253.1587. (Method 2) 
 
Data for 68n: 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.5 Hz, 1H), 7.77-7.73 (m, 1H), 
7.61 (d, J = 8.9 Hz, 1H), 7.48-7.42 (m, 1H), 7.31-7.25 (m, 1H), 7.05 (d, J = 8.9 Hz, 1H), 
3.77 (m, 1H), 2.08 (dd, J = 13.2, 2.7 Hz, 1H), 2.00-1.89 (m, 1H), 1.86-1.77 (m, 1H), 
1.73-1.62 (m, 2H), 1.52-1.39 (m, 6H), 1.26 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 154.2, 131.8, 128.7, 128.7, 127.6, 126.2, 
122.5, 121.3, 118.2, 118.2 ,74.5, 44.5, 35.9, 30.6, 29.7, 29.2, 26.5, 22.1, 21.4, 20.8 ppm; 
GC-MS m/z = 252 (M+); HRMS (ESI-TOF): Calculated for C20H24O ([M+H]
+) 




6.4.3 X-Ray Data 
Table 2.4: Crystal Data and Structure Refinement for 5ad 
Identification code yi2l 
Empirical formula C16H22O6 
Formula weight 310.34 
Temperature/K 100.00(10) 
Crystal system  monoclinic 










μ/mm-1  0.858 
F(000) 332.0 
Crystal size/mm3 0.35 × 0.22 × 0.12 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/o 6.14 to 141.52 
Index ranges -11 ≤ h ≤ 9, -6 ≤ k ≤ 6, -17 ≤ l ≤ 17 
Reflections collected 8093 
Independent reflections 2853[R(int) = 0.0200] 
Data/restraints/parameters 2853/1/206 
Goodness-of-fit on F2 1.065 
Final R indexes [I>=2σ (I)] R1 = 0.0271, wR2 = 0.0703 
Final R indexes [all data] R1 = 0.0274, wR2 = 0.0705 




Table 2.4: Crystal Data and Structure Refinement for 5ag 
Identification code yi2m 
Empirical formula C35H54O2 
Formula weight 506.78 
Temperature/K 100.00(10) 
Crystal system  monoclinic 












Crystal size/mm3 0.6896 × 0.1863 × 0.0598 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/o 6.5 to 147.32 
Index ranges -14 ≤ h ≤ 14, -11 ≤ k ≤ 11, -16 ≤ l ≤ 16 
Reflections collected 15140 
Independent reflections 5725 [Rint = 0.0383, Rsigma = 0.0408] 
Data/restraints/parameters 5725/1/340 
Goodness-of-fit on F2 1.065 
Final R indexes [I>=2σ (I)] R1 = 0.0474, wR2 = 0.1138 
Final R indexes [all data] R1 = 0.0549, wR2 = 0.1222 
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